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Abstract 
Extracellular matrix (ECM) remodeling by metalloproteinases is 
crucial during development. The ADAMTS (A Disintegrin and 
Metalloproteinase with Thrombospondin type I motifs) enzymes are 
secreted, multi-domain matrix-associated zinc metalloendopeptidases 
that have diverse roles in tissue morphogenesis and patho-physiological 
remodeling. The human family includes 19 members. In this study 
Xenopus was used as an in vivo model for studying the function of 
ADAMTSs during development. 19 members of the ADAMTS family were 
identified in Xenopus. A phylogenetic study and synteny analysis 
revealed strong conservation of the ADAMTS family, provided a view of 
the evolutionary history and contributed to a better annotation of the 
Xenopus genomes.  
The expression of the ADAMTS family was studied from early 
stages to tadpole stages of Xenopus with a focus on ADAMTS9 showing 
expression in neural crest (NC) derivative tissues and in the pronephros. 
ADAMTS9 function was investigated in these structures. ADAMTS9 
knock-down does not affect NC migration but causes a phenotype in the 
pronephros defined by a delay of development from early tailbud stage of 
pronephric nephrostomes, tubules and duct. Versican, a matrix 
component substract of ADAMTS9, is expressed in the pronephros at 
tailbud stage but not at tadpole stage suggesting a transient role during 
development. The lack of its degradation by ADAMTS9 could be the 
cause of the delay of pronephros development. 
The expression of the ADAMTS family as well as other 
metalloproteinases, ECM components and tissue inhibitor of 
metalloproteinases was studied in the skin, the brain and the heart 
undergoing remodeling during Xenopus laevis metamorphosis, as well as 
in the heart after ventricular resection to look at regeneration during 
Xenopus laevis metamorphosis. The results showed specific gene 
regulation depending on the stage of development and in response to 
heart injury revealing an important role for the ECM and its remodeling 
during these processes. 
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1 Chapter I: Introduction 
  
	   2 
This study looks at the role of the extracellular matrix (ECM) and its 
remodeling by metalloproteinases during organogenesis using Xenopus laevis 
and tropicalis as a model organism. 
1.1 Xenopus as an animal model 
1.1.1 Life cycle and advantages 
Xenopus laevis and Xenopus tropicalis are two species of African clawed 
frog commonly used as vertebrate animal models for studying early and late 
development (Heasman, 2006) (Blitz et al., 2006). The Xenopus life cycle is 
separated into key developmental stages according to the (Nieuwkoop and 
Faber, 1994) fate map as a standard of Xenopus stages. Xenopus laevis 
develops into a frog in twelve months when incubated at 25°C, incubating at 12-
25°C slows-down their development so that precise control over staging can be 
established. Below 12°C embryos do not develop (figure 1-1).  
	  
Figure 1-1: Xenopus life cycle. Key developmental steps are indicated by different 
colors. Cleavage, stage 1 to stage 4 (red). Blastula, stage 4 to stage 9 (orange). 
Gastrula, stage 9 to stage 12 (yellow). Neurula, stage 11 to stage 20 (green). 
Organogenesis, including tailbud stages, stage 20 to stage 35/36 (blue). Finally tadpole 
stages from stage 35/36 to stage 57 (purple) and metamorphosis from stage 57 to 
adult (grey). The developmental stage representations are from (Nieuwkoop and 
Faber, 1994). 
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Large numbers of synchronous embryos can be generated ex utero. 
Xenopus laevis eggs are large (1.2-1.4mm in diameter) allowing easy 
manipulation. The embryos are extremely robust to microinjection and surgical 
manipulation, allowing specific ablation and transplantation experiments 
(Harland and Grainger, 2011). Xenopus tropicalis embryos are more commonly 
used today for genetic studies as they have a well-sequenced diploid genome 
unlike the Xenopus laevis allo-tetraploid genome (Session et al., 2016). Gain of 
function experiments can be realised by injection of mRNA of the gene of 
interest and loss of function experiments can be carried out by injection of small 
antisense oligonucleotides (around 20 nucleotides) called morpholinos. In 
addition genetic engineering techniques such as CRISPR/Cas9 are also 
possible. Well characterised cell-fate maps allow blastomere-specific 
microinjection to target specific tissues and organs (Harland and Grainger, 
2011), (Guo et al., 2014) (Dale and Slack, 1987). 
1.1.2 Animal model to study ECM remodeling during organogenesis 
 The development and the morphology of most organs are conserved 
between Xenopus and mammals, which makes it a good model to study 
developmental processes giving rise to functional organs. The focus of the 
present study was the matrix remodeling during neural crest cell migration and 
pronephros development. 
Neural crest (NC) are a transient embryonic cell population found 
exclusively in vertebrates that differentiate into many different cell types 
including enteric ganglia, neuroendocrine cells, glial cells, neurons, 
melanophores, craniofacial cartilage, skeletal bones and connective tissue (Le 
Douarin and Dupin, 2003) (Crane and Trainor, 2006). Cell-ECM interaction 
modulation and ECM remodeling are necessary to allow NC migration. The NC 
are restricted to very precise routes by the presence of negative and positive 
signals at the borders of each route (Szabo et al., 2016). 
The mammalian kidney is a complex structure when compared to the 
Xenopus embryonic kidney, which has a simpler structure with conserved 
organisation that makes it a robust model to study kidney organogenesis and 
disease. The embryonic structure called the pronephros, consisting of a single 
nephron, is conserved in vertebrates. In Xenopus this embryonic kidney is 
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found on each side of the tadpole and is functional, regulating salt balance and 
filtering fluids, although in mammals the pronephros is not functional. The 
pronephros is then replaced by the mesonephros at metamorphosis and 
becomes the adult kidney in Xenopus whereas the metanephric kidney replaces 
the mesonephros in mammals (Krneta-Stankic et al., 2017). ECM remodeling 
plays an important role in kidney organogenesis and ECM composition depends 
on the location in the kidney such as the glomular and tubular basement 
membranes and the interstitial ECM. Regulated degradation of the kidney ECM 
by metalloproteinases is an important process (Genovese et al., 2014). 
1.1.3 Animal model to study ECM remodeling during metamorphosis  
Xenopus laevis, a fully aquatic tadpole moving by undulatory 
movements, metamorphoses into a tetrapod semiaquatic adult frog leading to 
drastic changes in most of the organs. Xenopus is an anuran amphibian 
meaning that it loses the tail at metamorphosis. This complex process is 
regulated by a peak of thyroid hormone (TH) at the metamorphic climax, 
between seven and eight weeks of development (stage 59 to 66) (Brown and 
Cai, 2007). Metamorphosis is divided into three periods: pre-metamorphosis (no 
secretion of TH), pro-metamorphosis (low level of secreted TH and first 
metamorphic changes) and metamorphic climax (peak of TH, remodelling of the 
tadpole) (figure 1-2) (Brown and Cai, 2007). The thyroid axis is conserved 
between mammals and Xenopus laevis. Thyroxine (T4) is produced by the 
thyroid gland (located between the eyes) and it is converted by deiodinase 
activity in peripheral tissues to the active hormone 3,5,3′-triiodothyronine (T3). 
T3 binds to the nuclear TH receptor (TR), a heterodimer with 9-cis retinoic acid 
receptor (RXR), and acts as a transcription factor to regulate gene expression 
with TH response elements (TREs) in their promoter. Two types of TR are 
found in Xenopus laevis, TRα and TRβ. TRα is expressed during pre-
metamorphosis when the level of plasmatic T3 is low whereas TRβ is 
expressed during climax when TH concentration increases (Ishizuya-Oka, 
2011). 
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Figure 1-2: Schematic representation of plasma level of thyroid hormones during 
Xenopus laevis metamorphosis. Different metamorphosis periods are indicated in 
the grey boxes, schematic representation of a Xenopus during these periods is shown 
below. The diagram shows the level of plasmatic thyroid hormone on the vertical axis 
in function of different Xenopus stages indicated on the horizontal axis. The 
developmental stage representations are from (Nieuwkoop and Faber, 1994). 
  The peak of TH at metamorphic climax is similar to that at birth for 
humans and so it is comparable to post embryonic development in mammals. 
The dependence of metamorphosis on the thyroid hormone regulation is a good 
model for perinatal development in humans. A lack of thyroid hormone during 
human perinatal development can lead to cretinism. Although perinatal and 
post-embryonic organ remodelling in mammals is not under the control of TH 
the processes are similar and studying Xenopus can help us to understand the 
mechanisms (Brown and Cai, 2007; Buchholz, 2015).  
 Matrix remodeling in skin and brain during metamorphosis was the focus 
of the present study. Embryonic and adult Xenopus laevis skin structures 
remodeling are similar to the mammalian foetal skin called ‘periderm’ and 
vertebrate adult skin (Brown and Cai, 2007). Cell-cell, cell-ECM interactions and 
ECM remodeling are important to regulate apoptosis of embryonic cells and 
differentiation and proliferation of adult cells in the skin remodeling during 
metamorphosis (Suzuki et al., 2009). Although the central nervous system 
(CNS) circuits are simpler in Xenopus than in mammals the basic organisation 
is conserved making Xenopus an easier model for studying brain development 
and neurodevelopmental disorders. The CNS is remodeled during 
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metamorphosis (Lee-Liu et al., 2016) (Pratt and Khakhalin, 2013). ECM 
composition and its remodeling is important for CNS development such as 
tenascin-C that regulates neural stem cells maintenance in the sub-ventricular 
zone stem cell niche by modulation of FGF2 and BMP4 signaling (Garcion et 
al., 2004) and MMP2 that plays a role in the guidance of the retinal ganglion cell 
axons by potential cleavage of guidance molecules or ECM components 
modulating signaling pathways (Hehr et al., 2005). 
1.1.4 Animal model to study ECM remodeling during regeneration 
 Xenopus tadpole has the ability to regenerate the lens, tail and limb. This 
capacity diminishes during development and is completely lost past 
metamorphosis. The stage-dependant capacity for regeneration is comparable 
to that of in mammals (Beck et al., 2009). 
Heart development is a highly regulated process conserved in 
vertebrates involving cell specification and differentiation along with remodeling 
of the cardiac tissue. Compared to mammals and birds that have a four-
chambered heart with two atria and two ventricles, amphibians have a three-
chambered heart with a single ventricle similar to the mammalian left ventricle. 
Fish have a two-chambered heart. Although the adult heart in vertebrates have 
a different final morphology the early-embryonic events are highly conserved 
(Hempel and Kühl, 2016). ECM remodeling is an important process for heart 
development. 
The focus of the present study was heart regeneration before, during and 
after metamorphosis. The heart of adult mammals has limited regenerative 
capacity and cardiovascular disease remains one of the biggest health risks 
worldwide (World Health Organisation, The top 10 causes of death, 2017). An 
infarcted adult heart cannot regenerate the loss of cardiomyocytes and replaces 
damaged tissue with a fibrotic scar due to the accumulation of collagen leading 
to a loss of contractile capacity of the heart. Cardiac regeneration therapies are 
very exciting future therapy possibilities. The adult human heart cannot 
regenerate whereas heart regeneration does occur in neonatal mammals, some 
fish and amphibians after injury. Understanding the process of regeneration in 
these species could help improve cell-based therapies and re-activation of 
regenerative processes in the human adult after myocardial infarction 
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(Kochegarov and Lemanski, 2016). Cardiomyocyte proliferation, activation of 
epicardial tissue and neo-vascularization are key processes for heart 
regeneration. Amphibians are excellent models to study heart regeneration as 
they metamorphose from an aquatic tadpole to a tetrapod terrestrial or 
semiaquatic adult frog, comparable to post embryonic development in 
mammals. These transitions lead to adaptation of the cardiovascular system 
and are associated with the decrease of cardiac regeneration. Although little is 
known about heart regeneration in Xenopus, studies on limb, retina and nerve 
tissue show that they have the ability to regenerate only at tadpole stages 
(Vivien et al., 2016). It has been shown that the Xenopus laevis adult heart 
cannot regenerate after ventricle resection (Marshall et al., 2017) but Xenopus 
laevis tadpoles at pro-metamorphosis stage have the ability to regenerate their 
heart after amputation (unpublished data by Dr. Laurent Coen). It will be 
interesting to look at the difference in gene expression that leads to this loss of 
cardiac regeneration after metamorphosis. 
1.2 ECM in development  
 The extracellular matrix is present in all tissues and organs providing a 
physical scaffold and regulating cellular processes such as migration, 
differentiation, survival and morphogenesis. ECM regulates these processes by 
direct interaction with cells, via specific surface receptors, by regulating the 
availability of growth factors, via binding with ECM components, and so 
intracellular signalling pathways. The ECM is formed of a well-organised three-
dimensional network of macromolecules that can vary during development and 
between tissues. The pericellular and the interstitial matrices are the two distinct 
types of ECM different in their composition, structure and localisation. The 
pericellular matrices are close to the cells, for example basement membrane 
located at the interface between parenchyma and connective tissue, whereas 
the interstitial matrices surround cells. The major matrix components are 
collagens, fibronectin (FN), laminins, glycoproteins, proteoglycans (PGs), and 
glycosaminoglycans (GAGs) (Theocharis et al., 2016).  
 Specific matrix components, described below, and their function during 
morphogenesis in Xenopus were investigated in the present study. 
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1.2.1 Collagen 
 Collagen is the most abundant component of the interstitial and 
pericellular ECM and is mainly secreted by fibroblasts. The collagen superfamily 
in vertebrates is composed of twenty-eight different collagen types that are 
formed by at least forty-six distinct polypeptide chains (α chains). Vertebrate 
collagens are given a Roman numeral, from I to XXVIII. Collagens are triple α 
chain helix proteins with non-triple helical domains at their N- and C-termini 
called ‘non collagenous’ (NC) domains and numbered from the C-terminus 
(NC1, NC2, etc.). Collagen type I represents the basic organisation, composed 
of triple helix without imperfections (without interruption in the helix) and without 
NC domains assembling into fibrils providing structural scaffolds in a large 
number of tissues. α chains can assemble into homo- and heterotrimeric 
helices. For example type I collagen is formed of two identical α chains 1 and a 
different third α chain 2 whereas collagen II is formed of three identical α chains. 
The nomenclature of these proteins is [α1(I)]2α2(I) for collagen I and [α1(II)]3 for 
collagen II. Members of the superfamily of collagens can be divided into seven 
sub-families based on their structures and functions. They are fibrillar and 
network-forming collagens, FACITs (fibril-associated collagens with interrupted 
triple helices), MACITs (membrane-associated collagens with interrupted triple 
helices), anchoring fibrils, beaded-filament-forming collagens, and 
MULTIPLEXIN (multiple triple-helix domains and interruptions) / endostatin-
producing collagens (table 1-1 and figure 1-3). Collagen can bind to different 
cell surface receptors such as integrins that are cell-surface heterodimeric  
(formed of two subunits α and β) receptors that link the ECM with the 
intracellular cytoskeleton.  Collagen scaffolds provide a structural support for 
the tissues and regulate intra-cellular signaling affecting various cellular 
functions including cell migration, adhesion, angiogenesis, tissue development, 
and repair (Theocharis et al., 2016).  
Regulation of col1a1 expression in Xenopus laevis heart during 
metamorphosis and after ventricular resection was investigated in the present 
study. Homozygous mutation is lethal in mice due to aortic rupture at 14 days of 
gestation indicating that col1a1 is not essential for early development but for 
late morphogenesis as a structural support for blood vessels (Lohler et al., 
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1984). Mutations of col1a1 making it resistant to the cleavage by MMP1 and 
MMP13 in the helical domain of the collagen α1(I) chain lead to a delay of 
wound healing showing the important role of the rapid col1a1 cleavage in 
wound repair (Beare et al., 2003). Col1a1 is conserved in Xenopus (Aldea et 
al., 2013). 
 
Table 1-1: Different sub-families of collagens with their different members. 
Sub-family of collagens Members 
fibrillar I / II / III / V / XI / XXIV / XXVII 
network-forming IV / VIII / X 
FACITs IX / XII / XIV / XVI / XIX / XX/ XXI / XXII 
MACITs XIII / XVII / XXIII / XXV 
anchoring fibrils VII 
beaded-filament-forming VI / XXVI / XXVIII 
MULTIPLEXIN XV / XVII 
 
 
Figure 1-3: Schematic representations of two types of collagens. (A) Type I 
collagen belongs to the fibrillar collagens sub-family and represent the typical collagen 
structure. It is synthetised as procollagen protein with N-terminal and C-terminal NC 
proteins that are cleaved by procollagen N-propeptidases (such as ADAMTS2, 3 and 
14) and by procollagen C-propeptidases (such as BMP1 and tolloid). The mature type I 
collagen is composed of a triple helix without interruption and can form collagen fibrilin 
stabilised by non-reducible covalent crosslinks necessary for mechanical properties of 
collagen-containing tissues.  (B) Type XVII collagen belong to the MACITs sub-family 
composed of transmembrane collagens that can act as cell surface receptors and after 
cleavage of the ectodomain by proteases such as ADAMs (ADAM9, 10 and 17) in a 
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process called ‘ectodomain shedding’ they act as soluble collagens in the ECM 
Theocharis et al. (2016). 	  
1.2.2 Fibronectin 
 Fibronectin (FN) mostly exists as a dimer composed of two nearly 
identical subunits linked covalently near their C-termini by a pair of disulfide 
bonds. Each monomer consists of three types of repeating units (FN repeats): 
type I, type II and type III. Variants of FN can be found due to alternative 
splicing of a single pre-mRNA from a single gene. FN can be soluble in the 
plasma, synthesized by hepatocytes, and less soluble cellular FN synthesized 
by many cell types including fibroblasts, endothelial cells, chondrocytes, 
synovial cells and myocytes. The cellular FN sub-families are composed of 
different isoforms due to cell-type-specific and species-specific splicing 
patterns. FN can bind to cell surface receptors, such as integrins and syndecan, 
and to ECM components, such as collagen, heparan sulfate (HS) proteoglycans 
and fibrin. Several distinct structural and functional domains of FN protein 
mediate these interactions. FN binds more effectively to denatured 
collagen/gelatin (after proteolytic cleavage) than to native collagen. Insoluble 
FN fibrils assemble into the ECM during a highly regulated process called FN 
fibrillogenesis or FN matrix assembly. FN matrix is essential during embryonic 
development and is a dynamic matrix during formation, remodeling, or repair of 
tissues (Theocharis et al. (2016). 
 Mutant mice for fibronectin die before birth at ED10 due to cardiovascular 
and vascular defects (George et al., 1993). It has recently been shown that after 
ventricular resection, adult Xenopus laevis heart do not regenerate but present 
a fibrotic scar composed of fibronectin (Marshall et al., 2017). In the present 
study the regulation of fibronectin expression was assessed in Xenopus laevis 
heart after ventricular resection during metamorphosis in order to identify 
difference of regulation between heart with the capacity of regeneration 
(tadpole) and heart unable to regenerate (adult). 
1.2.3 Proteoglycans 
Proteoglycan can be classified into four different families, intracellular, cell 
surface, pericellular-basement membrane, and extracellular defining in function 
of their localisation and their structures (Theocharis et al., 2016). 
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1.2.3.1 Hyalectans 
The hyalectan/lectican family of chondroitin sulfate proteoglycans is named 
after their ability to bind to hyaluronan (HA) and lectin. The family comprises 
aggrecan, versican, neurocan and brevican, which belong to the extracellular 
family of proteoglycans. They are composed of a core glycoprotein and side 
chains of glycosaminoglycan (GAG) attached by a covalent bond to serine 
residues (Brunet et al., 2012). GAGs are long highly negatively charged 
heteropolysaccharides that comprise different types such as chondroitin sulfate 
(CS), dermatan sulfate (DS), heparan sulfate, keratan sulfate (KS) and 
hyaluronan (Stanton et al., 2011). The core protein is composed of an N-
terminal globular (G) 1 domain comprising an immunoglobulin-like domain (Ig) 
and two proteoglycan tandem repeats (PTR) domains binding to hyaluronan, 
variable sizes and properties GAG-attachment regions and a C-terminal G3 
domain comprising a variable number of epidermal growth factor (EGF) like 
domains, a lectin-like domain, and a complement regulatory protein (CRP) like 
domain (Avram et al., 2014). 
Aggrecan (encoded by the ACAN gene) is the major proteoglycan in 
articular cartilage. Its core protein is formed of an N-terminal G1 domain, G2 
domain comprising two PTRs. Keratan sulfate can bind between those two 
domains, it also has GAG-attachment regions, where KS and chondroitin 
sulfate can bind, and a C-terminal G3 domain (figure 1-4). The G3 domain 
interacts with ECM components such as fibulin, fibrillin and tenascin. The two 
PTR of the G2 domain do not interact with HA. G1 domain binds to HA and 
cartilage link proteins (LP) stabilize this interaction.  The complex aggrecan/HA 
are negatively charged, which makes them highly hydrated, which in turn 
creates a loose ECM that confers viscoelasticity to the cartilage. Degradation of 
aggrecan in articular cartilage is a major factor of osteoarthritis (OA) (Roughley 
and Mort, 2014). 
The versican (encoded by the VCAN gene) core protein is formed of an N-
terminal G1 domain, central GAG-attachment regions (GAGα and GAGβ) where 
CS can bind and a C-terminal G3 domain comprising two EGF-like domains. 
Versican can be found in five isoforms (V0, V1, V2, V3 and V4), that differ by 
their GAG-attachment regions; V0 has both GAGα and GAGβ containing up to 
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23 CS chains, V1 has just GAGβ and up to 15 CS chains binding, V2 only has 
GAGα and up to 8 CS chains, V3 does not have any GAG-attachment regions 
and V4 has a truncated GAGβ domain with 5 predicted CS chains (figure 1-4) 
(Nandadasa et al., 2014). The G3 domain can bind to ECM components such 
as fibrillin, fibulins, fibronectin, tenascins, cellular receptors such as integrin β1 
and EGF receptors via its EGF-like repeat to regulate cell proliferation. CS 
chains can bind to the cell surface glycoprotein CD44. Versican G1 domain can 
bind to hyaluronan via two link modules (Wu et al., 2005). These complexes 
form macro-aggregates that regulate viscoelasticity and hydration of the skin, 
HA and CS chains are negatively charged and attract water. Versican-HA 
complexes create a loose hydrated matrix. Hyaluronan cell surface receptor 
CD44 mediates cell interaction with the versican-HA complexes (Smith and 
Melrose, 2015). V0 and V1 are expressed in the heart and limb during 
development, vascular smooth muscle cells, fibroblasts, whereas versican V2 
and V3 are mostly expressed in the nervous system (Nandadasa et al., 2014).  
Homozygous mutant mice for versican (called hdf (heart defect) mice) die 
before birth between ED10.5 and 11 with severe heart development defects 
(Yamamura et al., 1997). Versican is an important matrix component during 
development creating a loose hydrated ECM permissive for morphogenesis and 
remodeling. It has been shown to play a role in neural crest migration by 
defining migratory routes providing confinement to allow directional migration 
(Szabo et al., 2016).  
Brevican and neurocan (encoded by BCAN and NCAN genes respectively) 
are specifically expressed in the central nervous system. They have an N-
terminal G1 domain, GAG-attachment regions, where chondroitin sulfate can 
bind, and a C-terminal G3 domain comprising two EGF-like domains in 
neurocan (figure 1-4). An isoform of brevican can have the C-terminal G3 
domain replaced by a glycosylphosphatidylinositol (GPI)-anchor. Neurocan is 
able to bind matrix components such as HA, tenascin and neural cell adhesion 
molecule (NCAM). Brevican can bind to tenascin. NCAN mutation is associated 
with psychiatric disorders such as bipolar disorder and schizophrenia (Avram et 
al., 2014) (Bandtlow and Zimmermann, 2000). 
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Figure 1-4: Hyalectan/lectican family. (A) The four members of the family all have an 
N-terminal G1 domain containing an Ig-like domain and PTR domains that can bind to 
hyaluronan (HA), central GAG binding regions where keratan sulfate (KS) and 
chondroitin sulfate (CS) can bind by covalent bonds, and a C-terminal G3 domain 
containing one or two EFG-like domains, a lectin-like domain and a CRP-like domain. 
Only aggrecan has a G2 domain separated from the G1 domain by a GAG binding 
region where KS can bind. (B) The five versican isoforms all have the same G1 and G3 
domain but their GAG attachment regions, GAGα and GAGβ, differ. V0 have GAGα 
and GAGβ, V1 has only GAGβ, V2 has only GAGα, V3 does not have any GAG and 
V4 has a truncated GAGβ.	  
1.2.3.2 Syndecans 
 Syndecans are a family of four type I transmembrane heparan sulfate 
proteoglycans (HSPGs), syndecan-1 to -4. Three distinct domains constitute 
their core protein, a short cytoplasmic domain containing various binding motifs, 
a single transmembrane domain and an ectodomain domain where several 
glycosaminoglycans chains are attached to specific serine residues. The 
extracellular part of syndecans varies between syndecan family members, in 
contrast to the transmembrane and cytoplasmic domains, which are highly 
conserved. Various GAGs can bind covalently to the ectodomain, HS, CS or DS 
are attached to syndecan-1 and -3 but only HS is attached to syndecan-2 and -
4. The transmembrane domain is necessary for the dimerisation of syndecans 
into homodimers. Their cytoplasmic domain is composed of two conserved 
regions (C1 and C2) separated by a variable region (V) that can interact with 
several intracellular kinases and the actin cytoskeleton, promoting various cell 
functions. Ectodomains of syndecans mediate several cell–cell and cell–matrix 
interactions via the GAG chains. Syndecans can bind to FN, collagen, 
thrombospondin (TSP) and tenascin-C (TN-C). Syndecans are cellular 
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receptors for growth factors (GFs) and can act as co-receptors with growth 
factor receptors (GFRs) and with integrins regulating downstream signalling. 
Proteases can cleave syndecans in the process of ectodomain shedding 
(Theocharis et al., 2016).  
 Knockout for syndecans do not give rise to severe developmental 
phenotype however it causes defects under pathological conditions such as 
wound healing and cardiac fibrosis. Knockout mice for syndecan 4 present a 
defect in heart function and an increase of mortality due to cardiac rupture after 
myocardial infarction (MI). In the absence of syndecan 4 the number of 
fibroblasts and myofibroblasts was reduced as a result of a decrease in 
migration due to a dysregulation of the fibronectin-induced signaling leading to 
an impaired granulation tissue formation. In addition a reduced angiogenesis is 
observed in this mice following MI as a result of an impaired bFGF-induced 
signaling because syndecan 4 acts as a coreceptor for bFGF (Matsui et al., 
2011). Similar phenotype is observed in mice when shed form of syndecan 4 is 
overexpressed showing that it acts as an inhibitor of the endogenous syndecan 
4 signaling (Matsui et al., 2011). In the present study the expression of 
syndecans was measured in Xenopus laevis heart during metamorphosis and 
after ventricular resection. Syndecans are conserved in Xenopus and syndecan 
4 has been shown to be essential for convergent extension movements during 
early development by regulation of the non-canonical Wnt pathways through 
activation of syndecan4 by fibronectin and Frizzled7 by Wnt ligands (Munoz et 
al., 2006). 
1.2.4 Matricellular proteins 
 Matricellular proteins are in the ECM, interact with cells to modulate 
cellular functions but do not contribute to the structure of the ECM. The 
matricellular family contains a large number of members such as 
thrombospondin (TSP), tenascins (TN), cartilage oligomeric protein (COMP, or 
TSP-5) and fibulins. All matricellular proteins can directly or indirectly regulate 
cellular function by interaction with cellular receptors, ECM macromolecules, 
growth factors, and proteases. They can be localised at the plasma membrane, 
intracellularly, in body fluids as soluble proteins, or in the ECM. They can be 
cleaved by proteases generating protein fragments. They are incorporated into 
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the ECM of remodeling tissues during development, wound healing, and in 
response to injury and stress, especially in fibrotic ECM (Theocharis et al., 
2016). Tenascin-C is expressed in the cardiac regenerative matrix after 
ventricle amputation in newt and regulates the proliferation of cardiomyocytes 
by increasing their cell cycle re-entry (Mercer et al., 2013). In the present study 
the expression of tenascin-C was investigated in Xenopus laevis tadpoles, 
juveniles and adults hearts after ventricular resection to look at its regulation 
during cardiac regeneration. 
1.3 Metalloproteinases  
Proteolysis of the ECM is a highly regulated important process in 
development, morphogenesis, tissue remodeling and repair and its 
dysregulation can cause many diseases. Proteases are highly conserved from 
archaea to bacteria and from plant to animals. The repertoire of proteases 
produced by cells, comprise of at least 569 human proteases or protease-like 
proteins and homologs and 156 human protease inhibitors, is known as the 
“degradome” (Quesada et al., 2009). 
The A Disintegrin and Metalloproteinase with Thrombospondin type-1 
motifs (ADAMTS) family will be the main focus of the present study, as well as 
A Disintegrin And Metalloproteinases (ADAM) and Matrix Metalloproteinases 
(MMP) involved in ECM remodeling. They belong to the metzincin family so-
called for the conserved Met residue at the active site and a zinc-binding motif 
(HEXXHXXGXXH) in the active site of the protease domain necessary for the 
enzymatic reaction (figure 1-5) (Huxley-Jones et al., 2007). The 
metalloproteinases belong to the MA (M from metallo, A as a classifier) clan. In 
this clan MMPs belong to the M10A family, and ADAMs and ADAMTs to the 
M12B family in the MEROPS database of proteolytic enzymes (Rawlings et al., 
2008). 
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Figure 1-5: Basic domain organisation of ADAMTS, ADAM and MMP proteins. 
Names of the different domains are indicated in the key below the diagrams. 	  
1.3.1 Matrix Metalloproteinases (MMP) 
The MMPs are one of the major families of proteinases that can degrade 
all major ECM components, adhesion molecules, growth factors, cytokines, 
chemokines and receptors leading to tissue remodeling and regulation of cell 
behaviour. MMPs are essential for embryogenesis, bone growth, angiogenesis, 
wound healing and tissue regeneration. They are expressed mostly in 
fibroblasts and are also found in neutrophils, monocytes, macrophages and 
endothelial cells. Fragments generated after MMP cleavage can regulate 
cellular activities by interacting with specific receptor;, they are called 
matrikines. The first MMP was identified in 1962, in frog by an in vitro 
experiment looking at the resorption of the tail during metamorphosis (Gross 
and Lapiere, 1962). They named it collagenase-1, now referred to as MMP-1. 
24 members have been identified in vertebrates comprising MMP-1 to MMP-28 
without MMP-4, MMP-5, MMP-6 and MMP-22 that were identified by different 
research teams at the same time (Loffek et al., 2011) (Jablonska-Trypuc et al., 
2016). They are divided into six sub-families, based on their molecular structure 
and substrate preference, collagenases, gelatinases, stromelysins, matrilysins, 
membrane-type and others (table 1-2) (Loffek et al., 2011) (Jablonska-Trypuc et 
al., 2016).  
MMP-7 and -26 represent the basic molecular organization of an MMP. 
The basic MMP structure consists of a signal peptide, a propeptide and a 
metalloproteinase domain containing the zinc-binding consensus sequence 
HEXGHXXGXXHD common to all metalloproteinases. Generally, a hemopexin-
like domain is linked to the metalloproteinase domain by a linker or hinge 
	   17 
domain (figure 1-6). The addition of these two domains is found in MMP-1, -3, -
8, -10, -11, -12, -13, -18, -19, -20, -21, -27 and -28. MMP-2 and MMP-9 have a 
fibronectin-like domain between the pro-domain and the metalloproteinase 
domain. Transmembrane MMPs (MMP-14, -15, -16 and -24) have a 
transmembrane domain and a short cytoplasmic domain. MMP-17 and -25 have 
a GPI anchor domain. MMP-23 has a unique organisation containing an N-
terminal transmembrane domain, a pro-domain, a metalloproteinase domain, a 
cysteine-rich domain and an immunoglobulin domain (Loffek et al., 2011) 
(Jablonska-Trypuc et al., 2016). 
 
Table 1-2: Sub-families of the main members of MMP family. 
Sub-family Sub-family name General name 
Collagenases 
Collagenase-1 MMP-1 
Collagenase-2 MMP-8 
Collagenase-3 MMP-13 
Gelatinases 
Gelatinase A MMP-2 
Gelatinase B MMP-9 
Stromelysins 
Stromelysin-1 MMP-3 
Stromelysin-2 MMP-10 
Stromelysin-3 MMP-11 
Matrilysins 
Matrilysin MMP-7 
Metalloelastase MMP-12 
Matrilysin-2 MMP-26 
Membrane-type 
MT1-MMP MMP-14 
MT2-MMP MMP-15 
MT3-MMP MMP-16 
MT4-MMP MMP-17 
MT5-MMP MMP-24 
MT6-MMP MMP-25 
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Figure 1-6: Basic domain organisation of MMP proteins. Names of the different 
domains are indicated in the key below the diagrams. Some MMPs do not have the 
hinge and hemopexin-like domain and some other have additional domains.	  
MMPs are initially synthesised as inactive pro-forms called zymogens, 
their pro-domain is cleaved by an endoproteinase for activation. The latency of 
the enzyme is maintained by the “cysteine switch” motif that interacts with the 
catalytic zinc ion and prevents binding and cleavage of the substrate. Some 
MMPs, including the membrane-type MMPs, as well as MMP-11, -23 and -28 
have a conserved furin cleaveage site (RX(R/K)R) before their 
metalloproteinase domain and thus can be activated in the trans-Golgi and act 
as active proteases on the cell surface or secreted in the ECM. The other 
MMPs are secreted as zymogens and must be activated by cleavage of their 
pro-domain by proteases including some MMPs such as MMP-1, -2, -8 and -9 
as well as membrane-type MMPs. Tissue inhibitors of metalloproteinases 
(TIMPs) can inhibit the active forms of MMPs and the process of activation or 
conversion of the pro-MMPs into MMPs (Loffek et al., 2011) (Jablonska-Trypuc 
et al., 2016). 
Mice knocked-out for single MMPs in general do not show severe 
phenotypes however combined knock-out mice for several MMPs present more 
severe phenotypes, such as MMP-2/MMP-14 knock-out die after birth due to 
respiratory failure and vascular defects, suggesting functional redundancy of 
MMPs (Oh et al., 2004). Over expression of both MMP-2 and MMP-14 in 
Xenopus laevis lead to developmental defects and embryonic death (Hasebe et 
al., 2007a). Mutated mice for MMP9 show a defect in wound healing and 
regeneration of the corneal epithelium due to dysregulation of the level of the 
cytokine IL-1α and the accumulation of fibrin (Mohan et al., 2002). MMP1 has 
been shown to be necessary for keratinocytes migration on type I collagen 
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toward the wound healing site by cleavage of type I collagen creating a loose 
matrix and reducing the association of α2β1 integrin with native collagen 
allowing cell migration. The association of α2β1 integrin with native collagen, in 
the frontobasal end of the cells, regulates this process by activating MMP1 
expression (Pilcher et al., 1997). MMP2 and MMP9 can activate TGF- β 
signaling by cleavage of the latent TGF- β. MMP9 is associated to the cell 
surface hyaluronan receptor CD44 and cleave latent TGF- β at the cell surface 
(Yu and Stamenkovic, 2000). In the present study the regulation of expression 
of the several MMPs was investigated in Xenopus laevis heart during 
metamorphosis and after ventricular resection. 
1.3.2 ADAM 
 A Disintegin And Metalloproteinases (ADAMs) are type-I transmembrane 
and soluble glycoproteins that have diverse functions in cell adhesion, 
migration, proteolysis and signaling. Forty ADAM genes have been identified in 
mammalian genomes so far. 22 ADAMs are expressed in human but only 12 
(ADAM8, 9, 10, 12, 15, 17, 19, 20, 21, 28, 30 and 33) are active proteinases 
containing the consensus sequence (HEXGHXXGXXHD) common to zinc-
binding metalloproteases, eight are inactive missing the consensus sequence in 
their metalloproteinase domain (ADAM2, 7, 11, 18, 22, 23, 29 and 32) and two 
are described as pseudogenes (ADAM5P and 6). Some ADAMs (ADAM9, 12 
and 28) have splicing variants that are expressed as soluble active proteinases 
without the transmembrane and cytoplasmic regions (Edwards et al., 2008). 
ADAMs are composed of a N-terminal signal peptide, a pro-domain, a 
metalloproteinase domain, a disintegrin domain, a cysteine-rich domain, an 
EGF-like domain (except for ADAM10 and 17), a transmembrane domain and a 
cytoplasmic domain (figure 1-7). The EGF-like domain can bind cell surface 
proteoglycans. The cytosolic tail is the most variable region between members 
and has been shown to regulate ADAMs proteolytic activity, intracellular 
transport, localisation and cell signaling (Weber and Saftig, 2012). 
	   20 
 
Figure 1-7: Basic domain organisation of ADAM proteins. ADAMS 10 and 17 do 
not have an EGF-like domain and soluble ADAMs do not have a transmembrane and a 
cytoplasmic domain. The cytosolic tail is the most variable region between members. 
Names of the different domains are indicated in the key below the diagrams.	  
ADAMs are widely expressed and play fundamental roles during 
developmental processes. The best-characterised function of the 
transmembrane ADAMs is their involvement in ectodomain shedding, which is 
the cleavage of type I and type II transmembrane proteins and GPI-anchored 
proteins close to the cell surface. This process has been shown to regulate 
signaling pathways in the host cells or in neighbouring cells by down-regulation 
of cell surface receptors or by increasing the liberation of soluble ligands. 
ADAM19 knockout mice show heart development defects due to the lack of 
ectodomain shedding of ErbB ligands, such as Neuregulin necessary for ErbB 
signaling essential for heart development (Kurohara et al., 2004). Knockout for 
ADAM9 leads to a faster re-epithelialization during wound repair as a result of 
the lack of collagen XVII ectodomain shedding that acts as an inhibitor of 
keratinocyte motility (Mauch et al., 2010). In addition, ectodomain shedding can 
generate cleaved intracellular domains that translocate to the nucleus and 
regulate gene transcription. This process is called ‘‘regulated intramembrane 
proteolysis” (RIP). ADAM10 knockout mice die at E9.5 due to multiple 
malformation such as delay of heart development similar to the phenotype 
obtain in Notch1 knockout mice (Hartmann et al., 2002). ADAM10 has been 
shown to be essential for extracellular cleavage of Notch removing the 
extracellular domain allowing a second cleavage by γ-secretase releasing the 
intracellular domain that enters the nucleus (van Tetering et al., 2009)..The 
function of inactive ADAMs is still unclear but they can act as adhesion 
molecules (Weber and Saftig, 2012). ADAMs play key roles in development and 
morphogenesis. The ADAM family has been shown to be conserved in 
Xenopus with the exception of ADAM7 and ADAM8 (Wei et al., 2010). In the 
present study their expression was assessed in Xenopus laevis heart and after 
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ventricular resection during metamorphosis. 
1.3.3 ADAMTSL 
ADAMTS-like is a family of 7 members, ADAMTSL1 to 6 and papilin. 
They are secreted protein without a proteinase domain so they do not have 
proteolytic activity (figure 1-8). The C-terminal region is the most variable 
between members with additional Thrombospondin type 1 Sequence Repeat 
(TSR) domain and specific domains such as Immunoglobulin domain and PLAC 
domain (Dancevic et al., 2013). Little is known about this family. In human, 
ADAMTSL2 mutations cause geleophysic dysplasia, an inherited condition that 
affects many parts of the body and is characterized by abnormalities involving 
the bones, joints, heart, and skin, and ADAMTSL4 mutations cause ectopia 
lentis, an inherited connective tissue disorder characterised by lens dislocation 
of the eye, which can cause serious vision problems. ADAMTSL4 and 6 
promote the formation of microfibril network in vitro (Dubail and Apte, 2015). 
 
Figure 1-8: Basic domain organisation of ADAMTS-like proteins. ADAMTS-like 
proteins do not have a proteinase domain but only an ancillary domain with a C-
terminal variable region between the 7 members of the family. Names of the different 
domains are indicated in the key below the diagrams.	  
1.3.4 ADAMTS 
The ADAMTSs are extracellular, secreted enzymes that have diverse 
functions in development and disease. 19 members are present in mammalian 
genomes. The first ADAMTS gene, ADAMTS1, was identified in 1997 as a gene 
associated with inflammation (Kuno et al., 1997).  The characterisation of the 
ADAMTS family in Xenopus laevis and Xenopus tropicalis was the focus of the 
present study. 
1.3.4.1 Evolutionary history 
The evolutionary history of the 19 mammalian ADAMTS genes has been 
marked by duplication and retrotransposition events giving rise to different 
subfamilies, in association with the organism’s complexity, creating 
neofunctionalization. Comparisons of protostomes (such as insects and 
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nematodes) and deuterostomes (chordates and vertebrates) genomes show 
that an ancestral ADAMTS gene duplicated prior to their divergence, around 
650 million years ago (Ma). This is the origin of the distinction between the 
aggrecanases (ADAMTS1, 4, 5, 8, 15, 9 and 20) and the other subfamilies of 
ADAMTS (figure 1-9 and 1-10). ADAMTS-A and CG4096 represent these two 
distinct evolutionary branches in Drosophila melanogaster (figure 1-9) (Ismat et 
al., 2013). But the nematode Caenorhabditis elegans only has one gene, Gon-
1. This is similar to the aggrecanases subfamily, more specifically to ADAMTS9 
and 20, suggesting a loss of the founder gene of the other ADAMTS subfamilies 
(figure 1-9) (Nicholson et al., 2005). In chordates duplication and 
retrotransposition events occurred generating new clades of ADAMTS. In the 
ascidian Ciona intestinalis, four genes are duplicated from the ancestral gene 
represented by CG4096 in D. melanogaster, they are Ciona ADAMTS7, Ciona 
ADAMTS6, Ciona ADAMTS18 and Ciona ADAMTS3. Retrotranspositions of the 
ancestral gene of the other branch, represented by CG6107 in D. melanogaster 
and Gon-1 in C. elegans, gives rise to Ciona ADAMTS9 and Ciona ADAMTS15 
(figure 1-9). In mammals, the expansion of the ADAMTS family occurred by two 
whole genome duplication events. This suggests that Ciona ADAMTS7 is the 
ancestral gene of vertebrate ADAMTS7 and ADAMTS12, Ciona ADAMTS6 for 
vertebrate ADAMTS6 and ADAMTS10, Ciona ADAMTS18 for vertebrate 
ADAMTS16 and ADAMTS18, Ciona ADAMTS3 for vertebrate ADAMTS2, 
ADAMTS3 and ADAMTS14, Ciona ADAMTS9 for vertebrate ADAMTS9 and 
ADAMTS20 and Ciona ADAMTS15 for vertebrate ADAMTS1, ADAMTS4, 
ADAMTS5, ADAMTS8 and ADAMTS15 by gain of new introns (figure 1-9). No 
ancestral genes are present in C. intestinalis for the vertebrate ADAMTS13 and 
the pair ADAMTS17/19, suggesting that they were derived from duplication 
during evolution from chordate ancestors (figure 1-9) (Huxley-Jones et al., 
2005).  
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Figure 1-9: Schematic representation of the evolutionary history of the ADAMTS 
family. A duplication event of an ancestral gene prior to divergence between 
protostomes and deuterostomes lead to two branches of ADAMTS genes.  Other 
duplications and retrotranspositions events increased the diversity of ADAMTS 
subfamily in chordates. The 19 ADAMTS present in vertebrates derive from duplication 
and gain of intron of chordate ancestral genes. The figure is not to scale for 
evolutionary distance. Names of the genes are indicated in the boxes corresponding to 
the specie such as cio15 for Ciona ADAMTS15, 1 for mammals ADAMTS1. 
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1.3.4.2 Molecular structure 
All ADAMTS proteins have the same basic domain organisation defined 
by a proteinase domain and an ancillary domain. The proteinase domain 
comprises an amino (N)-terminal signal peptide, a pro-domain and a catalytic 
domain containing the metalloproteinase domain and the disintegrin-like 
domain. The basic ancillary domain has a central Thrombospondin type 1 
Sequence Repeat (TSR), a cysteine-rich domain and a spacer region. 
ADAMTS4 is the only member of the family to have this basic structure (figure 
1-10). The carboxy (C)-terminal region of the ancillary domain is the most 
variable between the ADAMTSs. The differences in domain organisation and 
function define eight sub-groups of ADAMTSs: the 
hyalectanases/aggrecanases (ADAMTS1, 4, 5, 8, 9, 15 and 20), the pro-
collagen N-propeptidases (ADAMTS2, 3 and 14), the von-Willebrand Factor 
(vWF) cleaving protease (ADAMTS13), the Cartilage Oligomeric Matrix Protein 
(COMP) proteinases (ADAMTS7 and 12) and the “orphan” (ADAMTS6, 10, 16, 
18,17 and 19) (figure 1-9) (Kelwick et al., 2015a). 
1.3.4.2.1 Pro-domain 
The ADAMTS pro-domain is composed of 220 to 300 amino acids except 
for ADAMTS13 that has a short 70 amino acid pro-domain. All ADAMTSs 
contain at least one site capable of being cleaved by furin-like pro-protein 
convertases (PPC). PPC enzymes can act extracellular, intracellular or on the 
cell surface. These different locations of action can regulate some ADAMTS 
activity. Pro- ADAMTS4 and 1 are cleaved intracellularly, in the trans-Golgi 
network, by PPC enzymes and are secreted in the mature form (Wang et al., 
2004) (Rodriguez-Manzaneque et al., 2000). Pro-ADAMTS 5 is cleaved 
extracellularly whereas pro-ADAMTS 9 is cleaved on the cell surface via 
formation of a complex with the cellular chaperone heat shock protein 
gp96/GRP94 (Longpre et al., 2009) (Koo and Apte, 2010). The pro-domain can 
have different roles in the regulation of ADAMTSs activities. Some ADAMTSs 
do not have to lose their pro-domain to be active. For example, it has been 
shown that the efficiency of ADAMTS9 for cleaving versican is reduced without 
its pro-domain (Koo et al., 2007). ADAMTS13 and 7 have a catalytic activity 
with their pro-domain (Majerus et al., 2003) (Somerville et al., 2004).	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Figure 1-10: Molecular structure of the 19 members of the ADAMTS family. 
ADAMTS4 is the only member with the ‘basic’ organisation common to all members 
composed of a proteinase domain containing an amino (N)-terminal signal peptide, a 
pro-domain and a metalloproteinase domain and a disintegrin-like domain. The basic 
ancillary domain has a central TSR, a cysteine-rich domain and a spacer region. The 
carboxy (C)-terminal region of the ancillary domain is the most variable between the 
ADAMTSs containing one to fourteen additional TSR motifs and specific domains 
defining different sub-groups. Names of the different domains are indicated in the key 
below the diagrams. The different ADAMTS representations are drawn to scale of their 
amino acids indicated on the axis below. Adapted from (Kelwick et al., 2015a). 	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1.3.4.2.2 Catalytic domain 
This domain is composed of the metalloproteinase and disintegrin-like 
domains. The metalloproteinase domain is composed of 227 to 247 amino 
acids and contains the zinc-binding motif HEXXHXBG(/N/S)BXHD. It forms an 
active site cleft where substrates can bind, common configuration to the 
metzincin family (Gomis-Ruth, 2009). The substrate specificity of this domain 
defines the different sub-groups of the ADAMTS family. The disintegrin-like 
modules of the ADAMTSs are approximately 65 amino acids and are highly 
conserved between all members. The disintegrin-like domains do not interact 
with integrins. ADAMTS1, 4 and 5 disintegrin-like domain is a cysteine-rich 
region located close to the active site cleft and has a possible regulatory role or 
function on the substrate preference (Gerhardt et al., 2007) (Mosyak et al., 
2008). ADAMTS 4 and 5 have two alternative conformations states (‘open’ and 
‘closed’) for their active site depending on additional Ca2+ ion binding that can 
possibly be used as a regulation of their catalytic activity through the binding to 
other proteins (Mosyak et al., 2008). 
1.3.4.2.3 Ancillary domain 
 The ancillary domain can interact with ECM components and can 
regulate ADAMTSs activity and their binding to their specific substrates. This 
domain contains up to 15 TSR domains, composed of around 50 amino acids, 
including a central common at all ADAMTSs. These domains are similar to the 
type I repeats of thrombospondins 1 and 2. The central TSR is followed by a 
cysteine-rich domain composed of around 100 amino acids in all ADAMTSs 
except ADAMTS12 that has a smaller cysteine-rich domain, and a spacer 
domain composed of 103 to 160 amino acids. The C-terminal region of the 
ancillary domain is the most variable between ADAMTSs, except in ADAMTS4 
the spacer domain is followed by additional TSR domains and specific domains 
defining the different sub-groups. The ADAMTS9, 20 pair contains 14 additional 
TSRs and a gonadal (GON) domain in C-terminal. ADAMTS13 has two CUB 
(complement C1r/C1s, Uegf (epidermal growth factor-related sea urchin 
protein), BMP-1 (bone morphogenetic protein-1)) domains in addition to 7 
additional TSRs. Several ADAMTSs (ADAMTS2, 3, 6, 7, 10, 12, 14, 16, 17, 18 
and 19) contain a PLAC (protease and lacunin) domain. In the pro-collagen N-
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propeptidases (ADAMTS2, 3 and 14) sub-group the PLAC domain is embedded 
within a region unique to these enzymes, while in all others the PLAC modules 
mark the C-terminus of the proteins. In ADAMTS7 and 12, a 
mucin/proteoglycan domain is interposed between the 7 additional TSRs, 
precisely between TSR4 and TSR5 (figure 1-9) (Kelwick et al., 2015a). 
1.3.4.3 Post-translational modifications 
ADAMTSs are subject to post-translational modifications that can affect 
their association with the cell surface or the ECM, as well as their activation and 
their catalytic functions. Their pro-domain is N-glycosylated, except for 
ADAMTS4 and for ADAMTS9 this modification is necessary for its secretion. 
TSR domains can be modified by C-mannosylation of tryptophans residues and 
O-fucosylation of Ser/Thr residues in the TSRs. ADAMTS7 mucin domain is 
modified by addition of CS chains (Somerville et al., 2004) (Kelwick et al., 
2015a). Proteolysis of the ancillary domain has been shown for a number of 
ADAMTSs such as ADAMTS4 (Kashiwagi et al., 2004). 
1.3.4.4 Functions in development 
ADAMTSs are large, highly post-translationally modified by glycosylation 
and proteolysis of the ancillary domain, have a low secretion level by cells and 
have catalytic activity depending on the recognition of their specific substrate, 
such as the interaction of ADAMTS5 ancillary domain with CS chains of 
versican (Foulcer et al., 2014). These features make them difficult to study in 
vitro. Mouse genetics have provided a useful tool for characterising the function 
of these proteinases in development in vivo. Identification of a mutation 
responsible for a phenotype (forward genetic), creation of a mutation and 
analysis of the phenotype (reverse genetic), have both been used (Dubail and 
Apte, 2015). 
1.3.4.4.1 Aggrecanase/Hyalectanase family 
 The largest subgroup of the ADAMTS family is the 
aggrecanases/hyalectanases comprising ADAMTS1, 4, 5, 8, 9, 15 and 20. 
These enzymes are so-called because they are able to cleave members of the 
hyalectan (also known as lectican) family of hyaluronan-binding chondroitin 
sulphate proteoglycan (CSPG) extracellular proteins, which include aggrecan, 
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versican, brevican and neurocan (Stanton et al., 2011). Antibodies against a 
neo-epitope generated after the cleavage of these substrates by these 
ADAMTSs and ‘cleavage-resistant’ substrates have been used in vitro and in 
vivo to characterise the mode of action of the hyalectanases. These different 
techniques have identified that all hyalectanases, except ADAMTS20, can 
cleave aggrecan, the cleavage of versican has been shown to be processed by 
ADAMTS1, 4, 5, 9 and 20. Neurocan and brevican can be cleaved by 
ADAMTS1, 4 and 5 (Stanton et al., 2011). The cleavage of versican at the 
Glutamic acid (GLU) 441- Alanine (ALA) 442 position in the GAGβ domain 
generates a fragment containing the G1 domain and exposing the neo-epitode 
DPEAAE at the C-terminal position. This shorter versican fragment is called 
‘versikine’. These smaller fragments of proteoglycans generated after 
proteolysis by the hyalectanses can have a biological function different from the 
intact form such as promoting apoptosis during interdigital web regression by 
decreasing the threshold of BMP required to induce apoptosis (McCulloch et al., 
2009b). 
Hyalectanases play diverse roles during development. ADAMTS1 cleaves 
the surrounding versican-rich matrix during ovulation, which allows release of 
the oocyte and its maturation within the oocyte-cumulus complex (Brown et al., 
2010). Mutated mice for ADAMTS1 and 4 show perinatal renal development 
failure. ADAMTS1 and 4 have redundancy functions in this process as the renal 
phenotype observed in ADAMTS4 mutants can be compensated when 
ADAMTS1 is not mutated but ADAMTS4 cannot rescue the ADAMTS1 renal 
phenotype in ADAMTS1 mutated mice. When ADAMTS1 and 4 are both 
mutated the phenotype is more severe. The mode of action of these proteases 
in renal development remains unclear but it is independent of versican and 
aggrecan proteolysis as the quantity of cleaved forms of these proteoglycans is 
unchanged in the mice mutants (Boerboom et al., 2011). A mature matrix 
containing collagen, proteoglycan and elastin replaces the initially immature 
versican-rich ECM during heart morphogenesis (Stankunas et al., 2008). 
ADAMTS5 and 9 are essential for heart development by cleaving versican 
(Dupuis et al., 2011) (Kern et al., 2010). ADAMTS5 is required for maintaining 
the correct architecture of the skin (Hattori et al., 2011). ADAMTS4 has been to 
shown to have a role in brain development and brain pathologies (Hisanaga et 
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al., 2012). ADAMTS9-/- mice die before gastrulation although a conditional 
mouse allele has been generated. It has been shown that ADAMTS9, 20 and 5 
have non-redundant and cooperative roles in interdigital web regression by 
degrading versican (Dubail et al., 2014) (McCulloch et al., 2009b). ADAMTS20 
mutant mice  (belted) have a distinctive coat with a white belt in the lumbar 
region suggesting the role of ADAMTS20 in the development of skin 
pigmentation (Rao et al., 2003). This phenotype is stronger when they are also 
heterozygous for an Adamts9 null allele suggesting cooperation between 
ADAMTS9 and 20 for melanoblast survival (Silver et al., 2008) (Rao et al., 
2003). The double mutated mice (ADAMTS9+/-; bt/bt) have a cleft palate 
associated with decreased versican cleavage and reduced cell proliferation in 
the palatal shelves showing that versican proteolysis is necessary for cell 
proliferation in the fusing palate (Enomoto et al., 2010). 
1.3.4.4.2 Procollagen N-propeptidase family  
Another group of ADAMTSs (ADAMTS 2, 3 and 14) are pro-collagen N-
propeptidases that are essential for the maturation of triple helical collagen 
fibrils. ADAMTS2 is a procollagen N-proteinase necessary for the maturation of 
the collagen by cleaving the propeptide of the α chains. Mature α chains 
assemble to form collagen fibrils. ADAMTS2 is expressed in type I collagen-rich 
tissues such as the collagen lamella in the skin. The mutation of ADAMTS2 in 
human and mouse leads to skin fragility due to collagen fibril anomalies causing 
Ehlers–Danlos syndrome type VIIc (or dermatosparaxis type). The 
aminoprocollagen, chain of collagen with a propeptide at the N-terminal position 
due to the lack of cleavage by ADAMTS2, accumulates and does not assemble 
correctly creating a structure with poor mechanical properties leading to skin 
fragility (Bekhouche and Colige, 2015). 
1.3.4.4.3 von-Willebrand Factor family 
ADAMTS13 is the von-Willebrand Factor (vWF)-cleaving protease that 
processes large multimeric vWF precursor proteins, which generate vWF of 
optimal size for blood coagulation. ADAMTS13 mutations or inhibition by 
autoantibodies cause hereditary or acquired thrombotic thrombocytopenic 
purpura (TPP) leading to vWF platelet aggregation and abnormal coagulation in 
targeted organs such as kidney, heart and brain (Zheng et al., 2001).  
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1.3.4.4.4 COMP proteinases family 
ADAMTS7 and 12 cleave cartilage oligomeric matrix protein (COMP). 
ADAMTS7 and 12 have not been shown to play important roles during 
development. No phenotype has been reported for knock-out mice for 
ADAMTS7 (Dubail and Apte, 2015). 
1.3.4.4.5 “orphan” family 
The remaining sub-group of ADAMTSs do not have an identified 
substrate and are called “orphan”. It includes three sets of pairs based on their 
domain organizations; ADAMTS 6 and 10; ADAMTS 16 and 18; ADAMTS 17 
and 19. ADAMTS10 and ADAMTS17 mutations in human cause Weill–
Marchesani Syndrome (WMS), a disorder leading to eye and skeletal 
abnormalities. This syndrome is also due to a mutation in fibrilin-1 (WMS2), an 
ECM molecule that assembles and form microfibrils structures. ADAMTS10 and 
ADAMTS17 play a critical role in crystalline lens zonules and connective tissue 
formation (Morales et al., 2009). ADAMTS6 and ADAMTS10 play opposite roles 
in heparan sulphate-rich cellular interfaces such as focal adhesions and 
epithelial cell-cell junctions in vitro. ADAMTS6 disrupt these structures by 
affecting microfibril deposition by its metalloproteinase activity whereas 
ADAMTS10 down regulates ADAMTS6 and is required for the integrity of these 
structures. ADAMTS10 function appears to be independent of its protease 
activity (Cain et al., 2016). ADAMTS8 knock-out mice show developmental 
defects in the lungs, eye and females are infertile (Ataca et al., 2016). 
ADAMTS10 is implicated in the sperm–oocyte interactions through sperm 
adhesion to the zona pellucida (Dun et al., 2012).  
1.3.4.5 Different mode of actions 
 Little is known about the non-catalytic mode of action of ADAMTSs. It 
has been shown that ADAMTS1 can bind to vascular endothelial growth factor 
(VEGF) and block the activation of VEGF signalling pathway via VEGF receptor 
2 (VEGFR2) (Dancevic et al., 2013). In Xenopus ADAMTS1 has been shown to 
negatively regulate FGF independently to its catalytic activity (Suga et al., 
2006). ADAMTS15 reduces breast cancer cell migration, which is independent 
of its protease activity and is dependant on the number of cell surface 
syndecan-4 (Kelwick et al., 2015b). 
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1.3.4.6 Functions in cancer and diseases 
 ADAMTSs are not only important during development but have been 
shown to play roles in angiogenesis (Rodriguez-Manzaneque et al., 2015), in a 
number of cancers (Cal and Lopez-Otin, 2015), in diseases such as arthritis 
(Kelwick et al., 2015a) and in central nervous system disorders (Gottschall and 
Howell, 2015).  
1.3.5 TIMP 
 Tissue inhibitors of metalloproteinases (TIMPs) are secreted inhibitors of 
active metalloproteinases. There are four TIMPs, TIMP1, 2, 3 and 4 in 
mammals. TIMP2 and 4 are similar whereas TIMP1 is the most unique member. 
They all use a similar mode of inhibition, they comprise two domains, a small 
carobxy-terminal domain and a larger amino-terminal domain. The N-terminal 
specifically folds within itself and is responsible for wedging into the active site 
of metalloproteinases, above the catalytic Zn2+ necessary for catalytic activity, 
which thus inhibits these proteins. The C-terminal domain is responsible for the 
binding of TIMPs to metalloproteinases. In contrast to plasma α 2-
macroglobulin, which traps proteases and leads them to be cleared by 
endocytosis, TIMPs bind specifically to an active metalloproteinase in their 
catalytic domain and inhibit their protease activity. TIMPs can also bind to the 
zymogen forms of MMPs, interacting with their C-terminal domain, which does 
not bind to the catalytic site. The N-terminus is still free to bind to other 
metalloproteinases to inhibit them. TIMP2, through its C-terminal domain, forms 
a complex with MMP14 and pro-MMP2, which activates pro-MMP2 at the cell 
surface. TIMP4 can form a similar complex with MMP14 and pro-MMP2 but 
does not lead to the activation of pro-MMP2. All TIMPs are secreted, with only 
TIMP3 incorporated into the ECM, TIMP2 is ubiquitous and constitutively 
expressed whereas TIMP1 and TIMP3 are expressed in many tissues 
specifically. TIMPs inhibit all MMPs but are ADAMs and ADAMTs specific (table 
1-3) (Jackson et al., 2017). 
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Table 1-3: Specific action of each TIMP on the inhibition of metalloproteinases 
and the binding to pro-MMPs. 
  Metalloproteinases inhibited 
TIMPs Pro-MMPs MMPs ADAMs ADAMTs 
TIMP1 9 All 10  
TIMP2 2 All 10, 12  
TIMP3 9, 2 All 10, 12, 17, 28, 33 1, 2, 4, 5 
TIMP4 2 Most 10, 17, 28, 33  
Mouse knock-out studies have shown that TIMP1 is important for the 
development of reproductive organs and the heart, TIMP2 plays a role in 
muscular and central nervous system development and TIMP3 is the main 
regulator of ECM degradation by metalloproteinases leading to regulation of 
structural and cellular aspects of tissue architecture (Brew and Nagase, 2010). 
1.4 Aims of the project 
Extracellular matrix remodeling by metalloproteinases is a highly 
regulated key process during development and disruption of this process can 
be lethal or cause severe developmental defects. The aim of this study is to 
understand the role of ADAMTSs in organogenesis during Xenopus 
development from egg to tadpole and during metamorphosis. 
The identification of the ADAMTS gene family in Xenopus laevis and 
Xenopus tropicalis and its evolutionary history analysis will be the first steps of 
this study.  
Spatio-temporal expression of ADAMTSs will be assessed during 
Xenopus development from egg to tadpole stages. The function of ADAMTS9 
will be investigated in Xenopus during organogenesis, specifically in neural 
crest and pronephros using loss of function experiments (figure 1-11).  
The expression of the ADAMTS gene family as well as ADAMs, MMPs, 
TIMPs and ECM components will be measured in the skin, the brain and the 
heart during Xenopus laevis metamorphosis. Finally, their regulation during 
cardiac regeneration will be analysed in Xenopus laevis hearts after ventricular 
resection at different stages of metamorphosis (figure 1-11). 
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Figure 1-11: Aims of the project. Xenopus is used as model organism to investigate 
organogenesis during tailbud and tadpole stages (from stage 25 to stage 40), 
specifically neural crest cell migration and pronephros development, and at 
organogenesis during metamorphosis, specifically skin, brain and heart. Heart 
regeneration before, during and after metamorphosis is used as a model to determine 
regenerative capacity. The aims of the project are to look at the role of ECM 
remodeling during these different developmental processes. There are two types of 
ECM, the interstitial and pericellular matrices. For example basement membrane is a 
type of pericellular matrix and is found between epithelial cells and connective tissue 
mostly composed of collagen. The schematic representation of the interstitial matrix 
represents the main components presented in this study. It is composed of collagen 
fibrils, secreted proteoglycans such as hyalectans, hyaluronan (HA) and matricellular 
proteins that interact with each other to create a dynamic three-dimensional network. 
Cell-ECM interactions are mediated by cell surface receptors, such as integrins and 
cell surface proteoglycans such as syndecan, which activate signaling pathways and 
regulate cellular functions. ECM regulates the availability of growth factors (GF) that 
are sequestered by binding to ECM components such as proteoglycans. 
Metalloproteinases such as MMPs, ADAMs and ADAMTSs cleave ECM components 
leading to tissue remodeling and dysregulation of their proteolytic activities causes 
diseases. TIMPs regulate the metalloproteinases activity. 
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2.1 Data source of ADAMTS gene sequences 
The ADAMTS genes reported by (Brocker et al., 2009) were retrieved from 
Genbank (http://www.ncbi.nlm.nih.gov). With these genes as queries, the Basic 
Local Alignment Search Tool (BLAST) program was used to search in National 
Center for Biotechnology Information (NCBI) and in The UniProt 
Knowledgebase (UniProtKB) against M.musculus and H.sapiens genome 
assemblies.  
Orthologs of known human ADAMTS genes in Xenopus were identified by 
using BLAT sequence-based searches of the Xenopus genomes hosted at The 
Francis Crick Institute (UCSC Genome Bioinformatics Site). The version 
xenTro9.0 assembly was used for Xenopus tropicalis and xenLae9.1 assembly 
was used for Xenopus laevis. Nucleotide sequences were translated to a 
protein sequence using ExPASy - Translate tool. 
2.2 Alignment and phylogenetic analysis 
Multiple sequence alignments were constructed with Clustal Omega. 
Phylogenetic trees were constructed using the amino acid residues of the full-
length genes. Trees were generated using MEGA (Molecular Evolutionary 
Genetics Analysis) version 6 software (Tamura et al., 2013). Synteny analyses 
were carried out using UCSC Genome Browser. 
2.3 Obtaining Xenopus laevis and Xenopus tropicalis embryos 
Embryos were obtained by in vitro fertilisation. This process required a 
series of procedures, priming and inducing females, priming the male for 
Xenopus tropicalis, male testes dissection, and then manual massage of the 
abdomen to collect eggs.  
The priming technique was performed 5-10 days before eggs required with 
100 units of Pregnant Mare Serum Gonadotrophin (PMSG) into the dorsal 
lymph sac on one side. To induce ovulation 14-16 hours before the eggs were 
required primed females were injected with 500 units of human chorionic 
gonadotrophin (hCG, Chorulon®) into the dorsal lymph sac on each side. Frogs 
were stored at 18°C for 14-16 hours prior to egg collection. To obtain eggs, the 
abdomen of the frog was manually squeezed over a clean petri dish. Testes 
were isolated from a male frog euthanized with 0.5g tricaine methane 
sulphonate (MS-222) dissolved in 300ml distilled H20 for 1 hour at 4°C. Testes 
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were then stored in testes buffer composed of 80% Foetal Bovine Serum (FBS) 
and 20% 1x Marc’s Modified Ringers (MMR: 100mM NaCl, 2mM KCl, 1mM 
MgCl2, 2mM CaCl2, 5mM HEPES, pH 7.5) at 4°C. The testes solution 
containing a small piece of male testes crushed with 1ml of 1xMMR was 
distributed over the collected eggs and left for 5 minutes at 18°C. 0.1xMMR 
(10mM NaCl, o.2mM KCl, 0.1mM MgCl2, 0.2mM CaCl2, 0.5mM HEPES, pH 7.5) 
was then added to cover the eggs for a period of 20 minutes at 18°C. Once 
fertilised, eggs needed the jelly coat removed to allow experimental 
manipulation. The eggs were gently swirled in 2% cysteine pH 8.0 dissolved in 
1xMMR until de-jellying was complete. Eggs were then immediately washed 
several times in 1xMMR then 0.1xMMR to remove trace amounts of cysteine. 
Embryos could then be left to develop in 0.1xMMR with Bovine Serum Albumin 
(BSA) at 18°C or 23°C depending on the purpose of the experiment and the 
stage of development desired. 
2.4 Fixing and storage of Xenopus embryos 
The required stage of development was according to (Nieuwkoop and 
Faber, 1994) (www.xenbase.org). Once embryos reached their desired stage 
they were fixed using MEMFA: 3.7% formaldehyde, 1xMEM salts (0.1M MOPS, 
2mM EGTA, 1mM MgSO4, pH7.4) made up with distilled H2O. They were then 
dehydrated in 100% methanol and left at -20°C for storage. 
2.5 Skin and brain dissection from stage 57 to stage 66 
Tadpoles at the right stage according to (Nieuwkoop and Faber, 1994) 
were anesthetized in 0.01% tricaine methane sulphonate (MS-222) and placed 
on ice under sterile conditions in order to remove the skin from the head and 
the trunk and the brain. The skin was peeled away and transferred to a sterile 
tube on dry ice. The whole brain was dissected as described in (Hamodi and 
Pratt, 2015), transferred to a sterile tube on dry ice. Samples were kept at -
80°C. 
2.6 RNA extraction 
2.6.1 For Xenopus embryos from unfertilised egg to stage 45 
10 embryos were placed in a 1.5ml microcentrifuge tube and all fluid was 
removed. Embryos were then flash frozen in liquid nitrogen for 15 minutes. At 
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this step frozen dry embryos could be stored at -80°C. Samples were kept on 
ice and all reagents had to be cold. 1ml (1 volume) of TRIzol® was added to dry 
embryos. All animal tissue was broken by vortexing until solution was 
homogenised. Then 500µl (half volume of TRIzol) of Chloroform was added and 
after centrifugation at 4°C proteins/lipids, DNA and RNA were separated. The 
aqueous upper phase containing RNA was put into a new 1.5ml 
microcentrifuge tube. To precipitate RNA 500µl (half volume of TRIzol volume) 
of isopropanol, 50µl of 5M NaCl and 2µl of glycogen were added. After 
centrifugation at 4°C the supernatant was removed and replaced by 70% 
ethanol prepared in RNase free to wash RNA. After centrifugation at 4°C the 
ethanol was removed and the pellet was dissolved in 45µl of RNase free H2O. 
At this step RNA could be stored at -80°C. 
2.6.2 For Xenopus embryos from stage 57 to stage 66 
Tissue of interest was dissected and RNA was extracted using RNeasy Plus 
Mini Handbook kit (Qiagen) according to manufacturer’s instructions. 
TissueLyser II (Qiagen) was used to disrupt and homogenise the tissue and an 
additional step using QIAshredder (Qiagen) was added to the protocol before 
the removal of the genomic DNA. RNA was quantified using Qubit (Invitrogen) 
according to manufacturer’s instructions. the RNA was then quantified and 
quality controlled using Qubit (Thermo Fisher Scientific) and 2100 Bioanalyzer 
(Agilent Technologies) respectively. Samples with RNA integrity (RIN) of ≥7 
were used for cDNA synthesis. 
2.7 DNase treatment 
10x DNase buffer (to a final concentration of 1x) and 1µl of DNase I (Roche) 
were added to each RNA sample. Samples were then incubated at 37°C for 30 
minutes to remove residual genomic DNA. To this, 50µl of RNase free H2O was 
added. Sample final volume was 100µl. To extract RNA 100µl (1 volume) of 
acidic phenol/chloroform was then added. After centrifugation at 4°C the 
aqueous upper phase was put into a new 1.5ml microcentrifuge tube. To 
precipitate RNA 70µl of isopropanol, 7µl of 5M NaCl and 1µl of glycogen were 
added. This was centrifuged at 4°C. Then the supernatant was removed and 
replaced by 70% ethanol prepared RNase free to wash RNA. After 
centrifugation at 4°C the ethanol was removed and the pellet was resuspended 
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in 20µl of RNase free H2O. The concentration was determined by 
spectrophotometry (Nanodrop) and sample was stored at -80°C. 
2.8 cDNA synthesis 
2.8.1 For Xenopus embryos from unfertilised egg to stage 45 
To denature RNA structure, 1µg of RNA, 1µl of oligo-dT made up to 11µl 
with RNase free H2O were left at 70°C for 10 minutes. Then to synthesise 
cDNA, 4µl of 5x First Stand Buffer (Promega), 0.5µl RNase inhibitor (Promega), 
2.5µl of 10mM dNTPs, 0.5µl of Reverse Transcriptase (Promega) and 1µl 
Superscript II (Invitrogen) were added and left for 1hour at 42°C. cDNA was 
diluted 1:20 with RNase free H2O to give a final concentration of 10ng/ml. 
2.8.2 For Xenopus embryos from stage 57 to stage 66 
125ng/µl of RNA was added to the 5x Reverse Transcription Master Mix 
(Fluidigm) in a final volume of 5µl. The reaction was performed using a 
thermocycler. Samples were incubated 5 minutes at 25°C, 30 minutes at 42°C 
and 5 minutes at 85°C. cDNA prepared using the Reverse Transcription Master 
Mix is suitable for preamplification using the Fluidigm PreAmp Master Mix. 
2.9 Pre-amplification of cDNA 
1.25µl of cDNA prepared with the Fluidigm Master Mix was added to a mix 
containing primers for genes of interest at a final concentration of 50nM and 1x 
of the 5x Preamp Master Mix (Fluidigm). The reaction was performed using a 
thermocycler. Samples were incubated 2 minutes at 95°C, 15 seconds at 95°C 
and 4 minutes at 60°C for 18 cycles. 
2.10 Polymerase Chain Reaction (PCR) 
The amplification of templates was performed using a thermocycler. Total 
PCR reaction was 25µl containing 10-50ng of template cDNA or small amount 
of bacterial colony, 0.2µM of each forward and reverse primer (see table 1), 1x 
of BioMix™ (2x reaction mix containing ultra-stableTaq DNA polymerase, 
Bioline). An initial denaturation step of 95°C for 3 minutes was followed by a 
denaturation of 1 minute at 95°C. The annealing step was carried out at an 
annealing temperature calculated by subtracting 5°C from the primer melting 
temperature, for 1 minute. This was followed by 1 minute of extension step at 
72°C (according to the expected size of the PCR product, 30s/500bp) (see 
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appendix 1).  25-35 cycles (depending on the level of expression of the gene of 
interest) of denaturation, annealing and extension were carried out. Amplified 
products were fractionated in 1% (w/v) agarose Tris/Borate/EDTA (TBE 1x: 
45nM Tris-Borate, 1mM EDTA, pH8.0) gel electrophoresis with 0.0001% (v/v) of 
10mg/ml ethidium bromide and visualised under UV light using a UV trans-
illuminator (BIO-RAD). 
2.11 Quantitative PCR  
2.11.1 96 well plate 
The reaction was performed in MicroAmp optical 96 well plate (Applied 
Biosystems). The final volume was 15µl containing 5µl of cDNA (diluted at the 
optimised concentration for the experiment), 10µM of each primer (forward and 
reverse), 7.5µl of 2x SYBR® Green PCR Master Mix (Applied Biosystems) and 
1.7µl of RNase free water. A 7500 real-time PCR instrument (Applied 
Biosystems) was used under the following conditions: 50°C for 2 minutes, 95°C 
for 10 minutes, 95°C for 15 seconds cycles 40 times and 60°C for 1 minute. 
2.11.2 384 well plate 
The reaction was performed in a final volume of 6µl (1µl of pre-
amplification product diluted at 1/20, 6µM of each primer, 3µl of 2x SYBR® 
Green PCR Master Mix (Applied Biosystems) and 1,70µl of RNase free water) 
using a QuantStudion 6 Flex system (Applied Biosystems) under the following 
conditions: 50°C for 2 minutes, 95°C for 10 minutes, 95°C for 15 seconds 
cycles 40 times and 60°C for 1 minute. 
2.12 Microfluidics 
2.12.1 Primers validation 
To do the microfluidic experiments all primers had to be validated with a 
good specificity showed by the melt curve and a good efficiency calculated 
using the slope of the standard curve established with five duplicates of 10-fold 
serial dilutions of cDNA template known to express the gene of interest 
(appendix 1 and 2). The formulas to established the percentage of efficiency 
were E = 10^(-1/slope) with E being the amplification efficiency and slope being 
the one obtained with the standard curve, then E was converted to percentage 
by E=-100*(1-10^(-1/slope)). The cDNA was synthetised from 250ng/µl mix of 
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RNA from stage 42, juvenile brain and and skin Xenopus laevis using the 5x 
Reverse Transcription Master Mix (Fluidigm) (see section 2.7.2). The cDNA was 
then pre-amplified with a mix of all primers used for the microfluidic experiment 
at 50nM final concentration using the 5x Preamp Master Mix (Fluidigm) (see 
section 2.8) and diluted at 1/20. The quantitative PCR was performed in 384 
well plates (see section 2.10.2). Only the primers with efficiency between 90 
and 116% and a melt curve showing one specific amplification peak at the right 
melting temperature and none in the negative controls (No Template Control 
(NTC) and a negative control of cDNA synthesis reaction made without adding 
the Reverse Transcriptase enzyme (RT-)) were selected. For some of the 
primers amplification peaks were found in the negative controls but not at low 
melting temperatures due to the creation of primer dimers. To calculated the 
efficiency from the standard curve some points were removed due to bad 
amplification or bad duplicate. 
2.12.2 Reaction 
The microfluidic experiment was performed at the microfluidic platform at 
l’Ecole Normale Superieur in Paris. The reaction was performed on a 9,216 
reaction chambers chip containing 96 different sets of primers and 96 different 
samples (96.96 Dynamic Array™ integrated fluidic circuits (IFCs) (Fluidigm)) 
(figure 2-1). The 96 samples inlets contained diluted at 1/20 cDNA made with 
10ng of RNA (prepared by Dr.Laurent Coen laboratory) using the 5x Reverse 
Transcription Master Mix (Fluidigm) (see section 2.7.2). The 96 primers inlets 
contained 10µM of each set of primers. The chip was then placed into the IFC 
Controller HX (Fluidigm) to prime the control line fluid into the chip according to 
manufacturers instructions. The samples and the primers were loaded into the 
inlets on the chip and loading reagent, containing components necessary for 
quantitative PCR reaction and EvaGreen® dye (Fluidigm), was added to each 
inlets. The chip was then placed into the IFC Controller HX (Fluidigm) where the 
air pressure forces samples and assays into the middle of the chip where they 
mix according to manufacturers instructions. Each sample was mixed with each 
set of primers at a final concentration of 0.04µM in 6nl final volume. After that 
the chip was placed into the BioMark™ HD System (Fluidigm) to perform real-
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time quantitative PCR gene expression. Results were analysed using the Real-
Time PCR Analysis v4.1.3 software (Fluidigm). 
 
Figure 2-1: 96.96 Dynamic Array™ integrated fluidic circuits (IFCs) chip 
used to perform the microfluidic experiment. 
2.13 Statistical analysis 
All statistical tests were carried out using Graph Pad Prism 6 software. 
Suitable statistical tests were chosen for each data set to suit the type of data 
analysed. Tests used include D’Agostino-Pearson omnibus normality test, 
Ordinary one-way ANOVA test, Kruskall Wallis test, unpaired Welch's t-test and 
Mann–Whitney U test. 
2.14 Cloning into pGEM®-T Easy Vector 
The pGEM®-T Easy (Promega) was a linearized vectors with a single 3´-
terminal thymidine at both ends. The T-overhangs at the insertion site greatly 
improved the efficiency of ligation of PCR products by preventing 
recircularization of the vector. Taq DNA polymerase (Bioline) left 'A' overhang 
so there was no need to add A residues at the 3’ and 5’ ends of the PCR 
products. PCR products were purified using the QIAquick PCR Purification Kit 
(QIAGEN) according to manufacturers instructions. The concentration was 
determined by spectrophotometry (Nanodrop). Ligation reactions were carried 
out according to the ratio of vector and insert.  
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This ratio was calculated as follows;  
 
Ligation reactions were carried out according to two conditions of ratio 3:1 
and 1:1. The reaction mixture was as follows; 10-100ng of PCR products, 0.5µl 
of pGEM®-T Easy Vector, 5µl of 2x ligase buffer (Promega), 1µl of Ligase T4 
DNA (3U/µl, Promega) made up to 10µl with RNase free H2O. The reaction was 
then incubated for 2-3 hours at room temperature. Ligation reaction was then 
transformed into competent bacteria by the method outlined in section 2.10. 
2.15 Gateway cloning 
The first step of a gateway cloning was to clone the gene of interest into an 
entry vector. The one used was pENTRTM/D-TOPO® (life technologies). The 
gene of interest was obtained by PCR. To enable directional cloning, the 
forward PCR primer had to contain the sequence, CACC, at the 5′ end. The 4 
nucleotides, CACC, will pair with the overhang sequence, GTGG, in 
pENTRTM/D-TOPO®. The reverse PCR primer did not have to be 
complementary to the overhang sequence GTGG at the 5′ end at 1 base pair 
mismatch. The PCR product had to be blunt-end.  Total PCR reaction was 25µl 
containing 0.5µl of cDNA (cDNA synthesis reaction mixture as a source of 
template, the volume should not exceed 10% of the final PCR reaction volume), 
0.5µM of each forward and reverse primer (see appendix 1), 1x of 5x Phusion 
HF Buffer, 0.02 U/μl of Phusion DNA Polymerase (2 U/μl stock solution) and 
200 μM each dNTPs. An initial denaturation step of 98°C for 30 seconds was 
followed by a denaturation of 10 seconds at 98°C. The annealing step was 
carried out at an annealing temperature calculated by substracting 5°C from the 
primer melting temperature (see appendix 1), for 45 seconds. This was followed 
by 1 minute of extension step at 72°C (according to the expected size of the 
PCR product, 15–30 s/kb, see table 1).  25-35 cycles (specific for each primer 
set, see table 1) of denaturation, annealing and extension were carried out. 
Amplified products were fractionated in 1% (w/v) agarose Tris/Borate/EDTA 
(TBE 1x: 45nM Tris-Borate, 1mM EDTA, pH8.0) gel electrophoresis with 
0.0001% (v/v) of 10mg/ml ethidium bromide and visualised under UV light using 
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a UV trans-illuminator (BIO-RAD). PCR products were purified using the 
QIAquick PCR Purification Kit (QIAGEN) according to manufacturer’s 
instructions. The concentration was determined by spectrophotometry 
(Nanodrop). The TOPO® Cloning reaction was then set up with a 0.5:1 to 2:1 
molar ratio of PCR product: TOPO® vector. For chemical transformation, 1 to 
5ng of PCR product of 1kb or 5 to 10ng of PCR product of 2kb were added to 
1µl of salt solution and 1µl of TOPO® vector. The mixture was incubate for 5 
minutes at room temperature. DH5 alpha competent E.coli bacteria were 
transformed with the plasmid. A positive colony containing the gene of interest 
into the TOPO® vector was identified by colony PCR with specific primers used 
to amplify the gene of interest. After mini-prep, the sequence of the gene of 
interest was confirmed by sequencing with M13 forward and reverse primers 
(Sanger Sequencing Service, Source BioScience). The LR reaction mixture was 
composed of 50 to 150ng of entry clone (TOPO® vector containing the gene of 
interest), 150ng of destination vector (adapted pCS2+ plasmid with a HA tag at 
the C-terminal position, contain the ccdB lethal gene which is disrupted after LR 
reaction, this plasmid was from Jim Smith lab). The final volume was 8μl 
completed with TE buffer pH8 (10mM Tris and 1mM EDTA). 2μ l of LR 
ClonaseTM II enzyme mix (Invitrogen) was added to the mixture and incubated 
at 25°C for 1 hour.  To terminate the reaction, 1μl of the Proteinase K solution 
(Invitrogen) was added and the samples were incubated at 37°C for 10 
minutes. DH5 alpha competent E.coli bacteria were transformed with the 
plasmid. A positive colony containing the gene of interest into the TOPO® vector 
was identified by colony PCR with specific primers used to amplify the gene of 
interest. After mini-prep, the sequence of the gene of interest was confirmed by 
sequencing with SP6 and T7 primers (Sanger Sequencing Service, Source 
BioScience). 
2.16 Transformation 
100µl of DH5 alpha competent E.coli bacteria were added to 5µl of plasmid 
DNA and left on ice for 30 minutes. These were heat shocked at 42°C for 90 
seconds to open cells and then returned to ice for a further incubation of 5 
minutes. 300µl of Lysogeny broth (LB: 5g tryptone, 2.5g yeast extract, 5g NaCl, 
pH7 made up to 500ml with distilled H2O) media was added and cells were left 
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for 1 hour at 37°C with continuous shaking (200rpm) to allow growth. 100µl of 
culture was then plated on pre-warmed (37°C) LB and agar plates with the 
appropriate antibiotics. These were incubated overnight at 37°C. 
2.17 Mini and Midi Extraction of Plasmid DNA 
Single colonies of bacteria were used to inoculate either 10ml or 50ml 
LB/antibiotic liquid media, for mini and midi preparation, respectively. The 
cultures were grown at 37°C overnight with continuous shaking (200rpm). The 
DNA plasmid was isolated using the Plasmid Mini Kit (reSource) and 
NucleoBond® Xtra Midi Kit (MACHEREY-NAGEL) according to manufacturers 
instructions.  
2.18 Probe synthesis 
2.18.1 Template 
2.18.1.1  Linearized plasmid 
Plasmids containing gene of interest were first linearised by restriction 
enzyme digestion using an appropriate restriction enzyme site to give antisense 
and sense RNA probes (see table 2-1). 2-10µg of plasmid was added to 2µl of 
the appropriate enzyme, 5µl of the optimal buffer for the enzyme and then made 
up to 50µl with RNase free water. This was left at 37°C for a minimum of 2 
hours or a maximum of overnight.  The cut plasmid could be visualised on an 
agarose gel. To precipitate DNA 1/10 NaOH pH5.2, 250µl ethanol 100%, and 
1µl of glycogen were added and incubated overnight at -20°C. After 
centrifugation, the supernate was removed and replaced by 70% ethanol to 
wash DNA. After centrifugation the ethanol was removed and the pellet was 
resuspended in 20µl of RNase free H2O. The concentration was determined by 
spectrophotometry (Nanodrop). 
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Table 2-1: Terms of use of the plasmids used to make probes. 
plasmid antisense linearisation 
antisense 
polymerase source 
XADAMTS-1 SalI T7 EST Image Clone 4408215 
xWt1-pGEM7-
s52S0304 Sac1 T7 
European Xenopus 
Resource Centre 
Pax8 
9pBS.KLPax8.1 EcoRI T7 
European Xenopus 
Resource Centre 
Xlim1 pBSKS XhoI T7 European Xenopus Resource Centre 
Pax2 EcoRI T3 European Xenopus Resource Centre 
Atp1b1a (5570138) SalI or SmaI or EcoRI T7 
European Xenopus 
Resource Centre 
2.18.1.2 PCR product 
The gene of interest was cloned into pGEM®-T Easy vector and used as 
a template for a PCR reaction using M13 forward and reverse primers at a 
concentration of 0.1µM (appendix 1). The Mini or Midi preparation of the 
plasmid was diluted ten times and 1µl was used for the PCR reaction, 1x of 
BioMix™ (2x reaction mix containing ultra-stableTaq DNA polymerase, Bioline) 
was added for a total volume of 10µl. A thermocycler was used to perform the 
reaction under the following conditions; an initial denaturation step of 95°C for 3 
minutes was followed by a denaturation of 1 minute at 95°C. The annealing 
step was carried out at an annealing temperature of 55°C for 1 minute. This 
was followed by 1 minute of extension step at 72°C. 25 cycles denaturation, 
annealing and extension were carried out. Amplified products were fractionated 
in 1% (w/v) agarose Tris/Borate/EDTA (TBE 1x: 45nM Tris-Borate, 1mM EDTA, 
pH8.0) gel electrophoresis with 0.0001% (v/v) of 10mg/ml ethidium bromide and 
visualised under UV light using a UV trans-illuminator (BIO-RAD).  
2.18.2 Reaction 
Probe was synthetised with a promoter specific RNA polymerase (see table 
2), the following reaction conditions were used; 1µl linearised plasmid or PCR 
template, 2µl dithiothréitol (DTT, Promega), 1µl Digoxigenin (DIG) labeled UTPs 
(Roche), 1µl RNase inhibitor (Promega), 2µl (40U) RNA polymerase (Promega, 
see table 2), 4µl 5x transcription buffer (Promega) made to a final volume of 
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20µl with RNase free H2O. The reaction was incubated at 37°C for 3 hours. Any 
remaining DNA template was removed by adding 1µl of DNase I (Roche) and 
incubating for 30 minutes at 37°C. 30µl of RNase free H2O were then added to 
purify the probe using G50 column probe purification (GE Healthcare) according 
to manufacturers protocol. Probe quality and transcription efficiency was 
checked by agarose TBE gel electrophoresis. They were then diluted at 1/200 
to be used for in situ hybridisation. 
2.19 Capped RNA synthesis 
Plasmids containing gene of interest were first linearised by restriction 
enzyme digestion using an appropriate restriction enzyme site (see table 2-2). 
2-10µg of plasmid was added to 2µl of the appropriate enzyme, 5µl of the 
optimal buffer for the enzyme and then made up to 50µl with RNase free water. 
This was left at 37°C for a minimum of 2 hours or a maximum of overnight.  The 
cut plasmid could be visualised on an agarose gel and purified using a Qiagen 
PCR purification kit according to kit instructions. The concentration was 
determined by spectrophotometry (Nanodrop). For capped RNA synthesis 0.1 
to 1µg of linearised plasmid, 1X of 2X NTP/CAP (Ambion), 1X of 10X Reaction 
Buffer (Ambion), 2µl of Enzyme Mix (SP6, T7, or T3, Ambion or Promega) and 
made up to 20µl with RNase free H2O. This was left for 2 hours at 37°C. 1µl of 
TURBO™ DNase (2 U/µL) was added for 15 minutes at 37°C. The RNA was 
precipitated by adding 30μl of RNase free H2O and 30μl of lithium chloride 
precipitation solution (Ambion). This was left at -20°C for minimum 30 minutes 
and maximum overnight. The sample was then centrifuged at 4°C for 15 min 
at maximum speed to pellet the RNA. The supernatant was removed and the 
pellet washed with 1ml of 70% ethanol. After centrifugation at 4°C the ethanol 
was removed and the pellet was dissolved in 20µl of RNase free H2O. At this 
step RNA could be stored at -80°C. 
Table 2-2: Terms of use of the plasmids used to make capped RNA.  
plasmid linearisation polymerase 
pCS2-adamts9S-HA ApaI (Promega) sp6 
pCS2-adamts9L-HA ApaI (Promega) sp6 
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2.20 Microinjection, morpholinos and mRNA used, GFP detection 
Embryos undergoing microinjection were placed in 3% Ficoll (6g Ficoll 
PM400, 60ml 1xMMR, 140ml distilled H2O). Targeted injections were performed 
at one cell stage, two-cell stage or at 8-cell stage into the V2 blastomere 
(according to (Nieuwkoop and Faber, 1994)) using a 10nl calibrated needle. 
Oxygen free nitrogen was used with a Harvard apparatus injector (Medical 
Systems Research products). The injector was set up at Pout =90, Pbalance = 0.6 
and Pinject =16. 2hours after injection the Ficoll was removed from the embryos 
and replaced with 0.1xMMR and left to develop at 18°C or 23°C depending on 
the purpose of the experiment. Antisense morpholino oligonucleotides (MOs) 
used were designed and synthetised by Gene Tools (table 2-3). Morpholino 
were stored at room temperature. They were stocked at -20°C when combined 
with GFP capped RNA for lineage tracing. They were then heated at 65°C 
before use for 5 minutes. The optimal concentration of morpholino for injection 
was defined by doing dose-response experiment. Morpholinos were coinjected 
with 300pg of GFP capped RNA as a control of injection and good location of 
the injection.  
Table 2-3: Sequences of the morpholinos used in this study. 
Morpholino name Target sequence 
Standard control (cMO) 5’-CCTCTTACCTCAGTTACAATTTATA-3’ 
ADAMTS9 (tropicalis) 5’-GAGGCAAGATGCATGTTTGTCCCCT-3’ 
ADAMTS9-L (laevis) 5’-TTCATGTTTGTCCGCAGGAAGCCCC-3’ 
ADAMTS9-S (laevis) 5’-TCCTCGTCCTCTTGAAGTGCATGTC-3’ 
2.21 Wholemount in situ hybridization 
Embryos were re-hydrated after fixation in 100%, 75%, 50% methanol, 25% 
methanol/1x phosphate buffer saline (PBS 10x: 2.5g NaH2PO4.H2O, 11.94g 
NaHPO4.H2O, 102.2g NaCl, 400ml distilled H2O, pH 7.4 and total volume of 1L) 
with 0.1% Tween 20 (PBST).  Embryos were bleached to effectively observe in 
situ staining. For this embryos were incubated in a solution of 1.5ml 30% H2O2, 
2.5ml formamide, 1.25ml 20x Sodium Chloride and sodium Citrate (SSC 20x: 
175.3g NaCl, 88.2g Sodium citrate, pH7 and total volume of 1L with distilled 
H2O) for 2 hours on a light box. Then embryos were washed in PBST and 
incubated in hybridisation buffer (50% formamide, 5xSSC, 1mg/ml Torula RNA, 
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100µg/ml heparin, 1x Denharts solution, 0.1% Tween 20, 0.1% CHAPS, 10mM 
EDTA) at 65°C for 2-6 hours. After that the embryos were incubated into fresh 
hybridisation buffer and the appropriate probe overnight at 65°C. Probe was 
replaced by 2xSSC and then by 0.2xSSC all at 65°C. The embryos were 
washed in 1xMaleic acid buffer (MAB: 100mM Maleic acid, 150mM NaCl, 
pH7.5) with 0.1% Tween 20 (MABT) and blocked in a 1xMABT and 2% 
Boerhinger Mannhein Blocking (BMB) solution for 1 hour at room temperature.  
BMB solution was then replaced by anti-digoxigenin (1:2000), 2% BMB, 20% 
Goat serum and 1x MABT solution and embryos were incubated overnight at 
4°C. The antibody solution was removed and embryos were washed five times 
with MABT at room temperature. They were kept overnight at 4°C in the final 
wash. The colour reaction was performed after washing the embryos in alkaline 
phosphate buffer (100mM Tris pH9.5, 50mM MgCl2, 1mM NaCl, 0.1% Tween 
20, 2mM levamisol) at room temperature. Detection of the probe was performed 
by using nitro-blue tetrazolium chloride (NBT: 75mg/ml in 70% 
dimethylformamide) at 4.5µl/ml and 5-bromo-4-chloro-3'-indolyphosphate p-
toluidine salt (BCIP: 50mg/ml in 100% dimethylformamide) at 3.5µl/ml in 
alkaline phosphate buffer. Embryos were then put in 5xTris-buffered saline 
(TBS 10x: 40g NaCl, 1g KCl, 125ml Tris pH7.5 and total volume of 500ml) with 
5% Tween 20 to remove background and photographed. 
2.22 Wholemount antibody staining 
Embryos were re-hydrated after fixation in 100%, 75%, 50% methanol, 25% 
methanol/1x PBS. Embryos were bleached to effectively observe the staining 
(see section 2.20). The bleaching solution was removed and the embryos were 
washed three times with PBT (PBS, 2mg/ml BSA, 0.1% Triton X-100) for 5 
minutes. They were then incubated with fresh PBT for 2 hours at 4°C. PBT was 
then removed, replaced with primary antibodies diluted in PBT (see table 2-4) 
and incubated overnight at 4°C. The primary antibody was then removed and 
replaced by PBT for 1 hour at 4°C. This step was repeated four times. Embryos 
were then incubated with secondary antibody diluted in PBT (see table 2-4) 
overnight at 4°C. The secondary antibody was then removed and replaced by 
PBT for 1 hour at 4°C. This step was repeated three times. Embryos were then 
washed with alkaline phosphate buffer (see section 2.20) for 1 hour at room 
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temperature.  The colour reaction was performed using NBT/BCIP (see section 
2.20) or Fast Red (Sigma). One Fast Red TR/Naphthol AS-MX Phosphate (4-
Chloro-2-methylbenzenediazonium/3-Hydroxy-2-naphthoic acid 2,4-
dimethylanilide phosphate) tablet and one Tris buffer tablet were dissolved in 10 
ml of distilled water providing 10ml of ready-to-use substrate. When the colour 
reaction was completed the substrate was removed and replaced by PBS to 
stop the reaction. Embryos were then fixed with MEMFA for 1 hour at 4°C. They 
could be stored in methanol at -20°C or in MEMFA if stained with fast red, 
alcohol soluble substrate. 
Table 2-4: Term of use of the antibodies used for wholemount antibody 
staining in Xenopus. 
antibody dilution source 
3G8 1/10 European Xenopus Resource Centre 
4A6 1/10 European Xenopus Resource Centre 
Anti-Mouse IgG-Alkaline 
Phosphatase 1/500 Sigma 
2.23 Cryosectioning 
Embryos were re-hydrated after fixation in 100%, 75%, 50% methanol, 25% 
methanol/1xPBST, PBST and incubated in 30% sucrose solution overnight at 
4°C. Embryos were then transferred to cryomolds filled with optimal cutting 
temperature compound (OCT) and left at room temperature. When embryos 
were at the bottom of cryomolds filled they could be positioned appropriately for 
sectioning. Embryos were then incubated 20 minutes in isopentane inside dry 
ice and left at -20°C.  
Embryos were sectioned using the LEICA CM 1950 Cryostat and sections 
were placed on 5% TESPA slides overnight at 4°C. Slides were washed in 
PBST and covered with a coverslip using mounting media. Images were taken 
using a Zeiss Axioplan 2ie microscope with colour camera (HRc). 
2.24 Western-blot 
2.24.1 Protein extraction 
Ten embryos were collected at stage 8 and solubilised in 50µl NP40 
(150mM NaCl, 1% NP-40, 50mM pH8.0, one proteinase inhibitors cocktail tablet 
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(Roche)) lysis buffer, at this step embryos can be stored at -20°C. To extract 
the proteins 500µl of Freon (1,1,2, trichlorotrifluroethane 99.9%) were added to 
the embryos in NP40 buffer, vortexed, left on ice for 5 minutes and centrifuged 
at maximum speed for 15 minutes at 4°C. The top phase was then transferred 
to a new clean tube and stored at -20°C. 
2.24.2 Sample preparation 
To quantify the amount of proteins in the samples the BSA quantification 
method was used with a stock solution at 4mg/ml. This stock solution was 
diluted with the NP40 lysis buffer at nine different concentrations of 0, 0.1, 0.2, 
0.4, 0.8, 1.2, 1.6, 2 and 4µg/µl to establish the standard curve. In a 96 well 
plate, 5µl of each dilution point (in triplicate) and 5µl of sample was used. To 
these was added 25µl of mix A, composed of 1ml of Reagent A and 20µl of 
Reagent S (from DCTM Protein Assay (BIO-RAD)), and 200µl of Reagent B 
(from DCTM Protein Assay (BIO-RAD)). The absorbance (λ) was read in the 
VersaMax™ ELISA Microplate Reader (Molecular Devices) at 750nm and the 
concentration of proteins was calculated from the standard curve using the 
y=A+Bx where y is the absorbance, x the concentration in µg/µl and A and B 
specific parameters to each standard curve. The samples were then diluted to 
have the right amount of proteins to load on a gel, corresponding to 20µg for 
this study, an equal volume of 2X Laemmli sample buffer (65.8 mM Tris-HCl, pH 
6.8 26.3% (w/v) glycerol, 2.1% SDS and 0.01% bromophenol blue (BIO-RAD)) 
completed with 5% of 2-mercaptoethanol was the added and the samples were 
incubated at 95°C for 5 minutes.  
2.24.3 Protein electrophoresis 
The protein electrophoresis was realised using the Mini-PROTEAN® 
Tetra Handcast Systems (BIO-RAD). The electrophoresis gel was composed of 
two different gels called the stacking gel (table 2-5), to concentrate all the 
proteins in one band, and the resolving gel (table 2-6) to separate the proteins 
based on their molecular weight. The gels were placed in the tank filled with 1X 
running buffer (table 2-7) and when the samples were loaded the migration was 
carried out using an electrophoresis power supply (BIO-RAD) at 100 volts for 2 
hours. To transfer the proteins from the gel to a polyvinylidene difluoride (PVDF) 
membrane they were placed between pieces of Whatman filter papers and 
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foam pads (BIO-RAD) (figure 2-2). Before to be used the PVDF membrane had 
to be incubated in 100% methanol. The assembly of this sandwich was done in 
the 1X transfer buffer composed of 70% of water, 20% of methanol and 10% of 
transfer buffer 1X (table 2-8) kept at 4°C and placed in a cassette. The 
electroblotting was carried out using a Mini Trans-Blot® Cell (BIO-RAD) and an 
electrophoresis power supply (BIO-RAD) at 115 volts for 75 minutes. When the 
transfer finished, the membrane was washed in 1X TBS 0.1% Tween 20 (TBST) 
(TBS 10X: 24.23g Tris Base, 80.06g NaCl) for 5 minutes and then stained with 
Ponceau solution (0.5% Ponceau S (w/v) and 1% acetic acid) to colour the 
proteins and validate the transfer. The membrane was then washed with water 
and blocked in 5% milk solution diluted in 1X TBST for two hours at room 
temperature. The membrane was incubated overnight at 4°C with the primary 
antibody (table 2-9) diluted in 5% milk solution in 1X TBST. After being washed 
with 5% milk solution in 1X TBST the membrane was incubated with the 
secondary antibody (table 2-9) for two hours at room temperature. The 
membrane was then washed in 1X TBST and incubated with the ECL solution, 
composed of equals volume of detection reagent 1 and detection reagent 2 
(Pierce™ ECL Plus Western Blotting Substrate, Thermo scientific), for 5 
minutes in the dark. This solution is a chemiluminescent substrate for the 
detection of horseradish peroxidase (HRP) on immunoblots, the 
chemiluminescent signal was detected using the Image Analyzer LAS-3000 
(Fujifilm Life Science).  
Table 2-5: Composition of the stacking gel. APS and TEMED were added 
last and water was added to complete the final volume needed. TEMED: 
Tetramethylethylenediamine, SDS: Sodium dodecyl sulfate, APS: Ammonium 
persulfate. 
Components Initial concentration 
Final 
concentration 
Acrilamide/bis 30% 5% 
Tris HCl pH= 6,8 1,5M 126mM 
SDS 10% 0,1% 
APS 10% 0,1% 
TEMED  0,1% 
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Table 2-6: Composition of the resolving gel. APS and TEMED were added 
last and water was added to complete the final volume needed. TEMED: 
Tetramethylethylenediamine, SDS: Sodium dodecyl sulfate, APS: Ammonium 
persulfate. 
Components Initial concentration 
Final 
concentration 
Acrilamide/bis 30% 10% 
Tris HCl pH= 8,8 1,5M 375mM 
SDS 10% 0,1% 
APS 10% 0,1% 
TEMED  0,1% 
 
Table 2-7:Composition of the running buffer at 10X. Water was added to 
complete the final volume. SDS: Sodium dodecyl sulfate. 
Components Final concentration 
Tris base 30g/l 
Glycine 144g/l 
10% SDS 1% 
pH=8.3 
 
 
 
Figure 2-2:Transfer sandwich containing the electrophoresis gel, the 
PVDF membrane, filer papers and foam pads (sponge). 
 
Table 2-8:Composition of the running buffer at 10X. Water was added to 
complete the final volume.	  
Components Final concentration 
Tris base 30g/l 
Glycine 144g/l 
pH=8.3 
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Table 2-9:Term of use of the antibodies used for western-blot in Xenopus. 
antibody dilution source 
anti-HA 
Rat monoclonal 3F10 
1/250 
Roche 
#11867423001 
anti-HSC70 (B-6) 
Mouse monoclonal 
1/2500 
Santa Cruz 
sc-7298 
HRP-conjugated polyclonal goat 
anti-mouse immunoglobulins 1/1000 
Dako Cytomation 
P0447 
anti-Rat IgG (whole 
molecule)−Peroxidase 
Goat polyclonal 
1/10000 
Sigma 
A5795 
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3 Chapter III: Evolutionary history of the ADAMTS 
family in Xenopus laevis and Xenopus tropicalis  
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3.1 Introduction 
Before this project started very little was known about the ADAMTS 
family in Xenopus. The 19 ADAMTS genes were identified in Xenopus tropicalis 
(Suga et al., 2006). During this project a new version of the X. laevis version 9.1 
was published in open access (Session et al., 2016). The X. laevis genome is 
composed of two homoeologous subgenomes called L and S for long and short, 
respectively (Session et al., 2016). The subgenome S is shorter due to more 
deletions than L. They have similar chromosomes sizes to the X. tropicalis 
genome, suggesting they have ancestral chromosome organisation. In X. laevis 
eight out of the nine pairs of homoeologous (one copy on each set of 
chromosomes pairs different of homologous that defines copies on the same 
pair of chromosomes) have an orthologous chromosome in X. tropicalis and the 
ninth pair is the result of a fusion of chromosomes 9 and 10 found in X. 
tropicalis. No inter-chromosomal rearrangements are observed in these two 
amphibian species (Session et al., 2016). 
X. laevis and X. tropicalis diverged from each other around 48 million 
years ago (Ma) before the divergence of the two diploid species that gave rise 
to the X. laevis subgenomes L and S, which occurred around 34 Ma. Analysis 
of transposable elements (TE) or ‘jumping genes’ specific for each subgenomes 
provided an evolutionary view of the two diploid ancestral species. These two 
species are still unknown. Specific TEs on each subgenome were active until 
18 Ma suggesting that the allotetraploidization happened around 17 Ma 
(Session et al., 2016) (figure 3-1). X. laevis and X. tropicalis ADAMTSs will be 
compared to ADAMTSs in Drosophila melanogaster, Caenorhabditis elegans, 
Ciona intestinalis, Mus Musculus and Homo sapiens by phylogenetic study to 
determine the evolutionary history and which X. laevis ADAMTS homoeologous 
are closely related to X. tropicalis. 
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Figure 3-1: Phylogenetic tree illustrating the evolutionary history of Xenopus 
laevis and Xenopus tropicalis. Divergence between the allotetraploid X. laevis 
(2n=36) and the diploid X. tropicalis (2n=20) occurred at 48 millions years ago (Ma), 
divergence between the two ancestral diploid species of subgenome L and S 
happened at 34 Ma and the hybridisation of these two subgenomes in X. laevis was 17 
Ma.  
Comparisons between gene positions provide an overview of the 
possible deletions and intra-chromosomal rearrangements. These events occur 
more in the S subgenome. Around 50% of proteins coding genes are present in 
two copies in X. laevis (Session et al., 2016). The loss of one copy is likely to 
happen if their function is redundant and if there is no mutations leading to a 
new function. Mutations can give rise to new (neofunctionalisation) or different 
(subfunctionalisation) functions of one of the copies depending on where and 
when the gene expression is necessary but mutations lead mostly to a loss of 
function of one of the copies. Duplicated genes can be maintained due to gene 
dosage (Otto, 2007). It has been shown than the evolution of keratin gene 
family in X. laevis is marked by subfunctionalisation and loss of homoeologous 
on the subgenomes L and S. This could be due to their different level of 
expression required during development in a stage and tissue dependant 
manner to adapt to environmental changes (Suzuki et al., 2016). 
 In this chapter the evolutionary history of the ADAMTS family will be 
assessed in Xenopus laevis. The 19 Xenopus tropicalis ADAMTS followed the 
same evolutionary history as the mammalian 19 ADAMTS from protostomes 
ancestral genes (Kelwick et al., 2015a). The synteny, the conservation of the 
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chromosomal position, will be assessed for the ADAMTS genes present in X. 
laevis subgenomes and X. tropicalis. A comparison between the two X. laevis 
ADAMTS copies, on the L and S chromosomes, and the X. tropicalis copy will 
show the conservation of the chromosomal organisation between these two 
species. 
3.2 Results 
3.2.1 Gene identification in Xenopus laevis and Xenopus tropicalis 
Protein sequences of the 19 human and mouse ADAMTSs were used as 
a reference to identify the ADAMTS genes in X. laevis (version 9.1 from 2015) 
and X. tropicalis (version 9.0 from 2015) using the UCSC Genome Browser. 
Genes with the highest percentage of similarity were selected. ADAMTS8 is not 
annotated in the X. laevis genome but its chromosomal position was identified 
using human ADAMTS8 as reference. All 19 ADAMTS genes are present in 
both X. tropicalis and X. laevis genomes including seven singletons. ADAMTS7, 
ADAMTS8, ADAMTS12, ADAMTS13, ADAMTS16, ADAMTS19 and 
ADAMTS20 have only one copy in the X. laevis genome located on the L 
chromosome. The chromosomal position of ADAMTS genes is conserved 
between X. tropicalis and X. laevis. X. tropicalis ADAMTS3 and ADAMTS13 are 
located on scaffold due to a lack of chromosomal position in the genome 
assembly (table 3-1). 
3.2.2 Phylogenetic study of Xenopus laevis and Xenopus tropicalis 
ADAMTS  
ADAMTS evolutionary history from protostomes to vertebrates is marked 
by duplication and retrotransposition events leading to the 19 members found in 
mammals. The degree of conservation of the protein ADAMTS family between 
mammals (Homo sapiens and Mus musculus) and amphibians (Xenopus laevis 
and Xenopus tropicalis) was assessed by phylogenetic study using the 
Neighbor-Joining method (figure 3-2).  
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Table 3-1: Chromosomal location of ADAMTS genes in Xenopus laevis and 
Xenopus tropicalis. Chromosome number followed by an L for the longer and an S for 
the shorter indicate X. laevis gene location on the two subgenomes. Scaffold number is 
indicated for the genes without a chromosomal location. 
 
X.tropicalis 
(v9.0) 
X.laevis  
(v9.1) 
genes chromosome number of copy chromosome 
ADAMTS1 2 2 2S & L 
ADAMTS2 3 2 3S & L 
ADAMTS3 scaffold_51 2 1S & L 
ADAMTS4 8 2 8S & L 
ADAMTS5 2 2 2S & L 
ADAMTS6 1 2 scaffold53 & 1L 
ADAMTS7 3 1 3L 
ADAMTS8 7 1 7L 
ADAMTS9 4 2 4S & L 
ADAMTS10 1 2 1S & L 
ADAMTS12 1 1 1L 
ADAMTS13 scaffold_620 1 8L 
ADAMTS14 7 2 7S & L 
ADAMTS15 7 2 7S & L 
ADAMTS16 6 1 6L 
ADAMTS17 3 2 3S & L 
ADAMTS18 4 2 4S & L 
ADAMTS19 1 1 1L 
ADAMTS20 3 1 3L 
 
Each X. laevis and X. tropicalis ADAMTS form a cluster on the same 
branch of the phylogenetic tree as the ADAMTS orthologous in H. sapiens and 
M. musculus (figure 3-2). They are all on the same evolutionary branch rooted 
by an ancestral gene of protostome (Drosophila melanogaster and 
Caenorhabditis elegans) and chordates (Ciona intestinalis) except for 
ADAMTS17, 19 and 13 which do not have an ancestral gene in C. intestinalis 
(figure 3-2). 
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Figure 3-2:	   Evolutionary relationships of the ADAMTS protein. The phylogenetic 
tree was inferred using the Neighbor-Joining method. The different clades of ADAMTS 
are shown with a coloured line, purple for the vWFCP, green for the procollagen N-
propeptidase, yellow for the orphan, blue for COMP proteinases and red for 
aggrecanases. The vertebrate ADAMTS genes are indicated by a number followed by 
a single letter code indicating the species: for example, ADAMTS1 t represents 1 from 
Xenopus tropicalis; 2 l represents ADAMTS2 from Xenopus laevis; 15 h is ADAMTS15 
from Homo sapiens; 8 m is ADAMTS8 from Mus musculus. For Drosophila 
melanogaster (dro), Caenorhabditis elegans (cel) and Ciona intestinalis (cio), the 
annotation is the specie followed by the gene number; for example, cio 6 is ADAMTS6 
from C. elegans. Adapted from (Kelwick et al., 2015a).	  	  
The relation between homoeologous ADAMTS in X. laevis subgenome L 
and S and orthologous ADAMTS in X. tropicalis analysed by the phylogenetic 
study using protein sequences, as previously described, was looked in more 
details in order to establish which ones were more conserved between these 
two species. Homoeologous X. laevis ADAMTS2, 3, 4, 6, 9 and 14 are highly 
conserved when compared with their orthologous in X. tropicalis. Whereas other 
X. laevis ADAMTSs have one of their copies on a subgenome more similar to X. 
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tropicalis than to their other copy. X. laevis ADAMTS1 L, 15 L and 18 L are 
more related to their orthologous in X. tropicalis than their homoeologous on 
subgenome S. Whereas X. laevis ADAMTS5 S, 10 S and 17 S are more close 
to X. tropicalis than their other copy on subgenome L (figure 3-3).  
	  
Figure 3-3:	  Phylogeny of ADAMTS in both X. laevis subgenomes L and S and X. 
tropicalis. Coloured boxes show the different relationship between orthologous 
ADAMTS, pink for ADAMTS more conserved between X. laevis L and X. tropicalis, 
blue for ADAMTS more conserved between both X. laevis L and S and green for 
ADAMTS more conserved between X. laevis S and X. tropicalis. 	  
3.2.3 Synteny analysis of ADAMTS genes between Xenopus laevis 
subgenomes L and S and Xenopus tropicalis 
It has been shown that more gene deletions occurred on the subgenome 
S than on the subgenome L, explaining the shorter size of the S subgenome 
compare to L and the X. tropicalis genome (Session et al., 2016). Synteny 
analysis was used to look at these events in the ADAMTS gene family. 
Locations and orientations of neighbour genes to one of the seven singleton 
ADAMTS genes in subgenome S were compared to their positions on the same 
chromosome in subgenome L and in X. tropicalis. 
In order to carry out the synteny analysis, genes close to the gene of 
interest were selected. Due to the lack of annotation and/or assembly of 
scaffolds into chromosomes in the X. laevis (v9.1) and X. tropicalis (v9.0) 
genomes, neighbour genes were selected based on the criteria that they had to 
be annotated on the three genomes, even though they might not be the closest 
gene to the ADAMTS gene of interest. 
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A comparison of chromosomal location between the two X. laevis 
subgenomes L and S revealed that ADAMTS19 is the only gene deleted on the 
S chromosome whereas their neighbour genes were present on both L and S 
chromosomes in the same location and orientation (figure 3-4F). Intra-
chromosomal arrangements were observed between the homoeologous 
subgenomes for the chromosomes 3, 6 and 7. Conserved genes on L and S 
around ADAMTS7, ADAMTS8, ADAMTS16 and ADAMTS20 have their position 
and/or their orientation inverted on the S chromosome compared to the L 
chromosome (figure 3-4A, B, E, G). Loss of one copy is observed for several 
closely located genes including ADAMTS genes such as ADAMTS7, 
ADAMTS8, ADAMTS12, ADAMTS13, ADAMTS16 and ADAMTS20 (figure 3-
4A, B, C, D, E and G).  The chromosomal organisation on the Xenopus 
tropicalis genome shows more similarities to the subgenome L (figure 3-4C, E, 
F and G). As the assembly of the X. tropicalis is not yet complete, some genes 
are found on scaffolds and not yet allocated to a chromosome (figure 3-4D).  
X. laevis subgenome L and X. tropicalis genomes have been shown to 
be more similar than with the X. laevis subgenome S. The synteny studies of 
the three copies of ADAMTS genes on these genomes show that six out of 
twelve; ADAMTS1, ADAMTS2, ADAMTS3, ADAMTS9, ADAMTS10 and 
ADAMTS17, have their chromosomal organisation conserved between X. 
tropicalis and X. laevis subgenome L but not with subgenome S (figure 3-5). 
Intra-chromosomal rearrangement (figure 3-5A, B and C) or loss of genes 
(figure 3-5D, E and F) are observed in the subgenomes S around these genes. 
Conservation of the synteny between the two X. laevis subgenomes and 
X. tropicalis genomes is observed for ADAMTS14 and ADAMTS18 (figure 3-6) 
whereas it is not conserved for ADAMTS4, ADAMTS6 and ADAMTS15 (figure 
3-7). 
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Figure 3-4: Synteny of single copy ADAMTS genes in subgenomes S and L of 
Xenopus laevis and Xenopus tropicalis. Chromosome number is indicated on the 
left followed by an l with L and S for the longer and shorter X. laevis subgenomes, 
respectively, and a t for X. tropicalis. The red star (D) indicates the location of 
scaffolds; nelfb on scaffold75; zbtb43 on scaffold363; zbtb34 on scaffold92; 
ADAMTS13 on scaffold620; slc2a6 on scaffold285; fam163b and ADAMTSL2 on 
scaffold 353. The arrows show the orientation of the genes syntenic to (A) ADAMTS7; 
(B) ADAMTS8; (C) ADAMTS12; (D) ADAMTS13; (E) ADAMTS16; (F) ADAMTS19; (G) 
ADAMTS20. 
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Figure 3-5: Synteny of X. laevis ADAMTS genes with similar organisation in 
subgenome L and X. tropicalis genome but different to X. laevis subgenome S. 
Chromosome number is indicated on the left followed by an l with L and S for the 
longer and shorter X. laevis subgenomes, respectively, and a t for X. tropicalis. The red 
stars and lines represent the location of a scaffold, scaffold89 (B) and scaffold 51 (D). 
The arrows show the orientation of the genes syntenic to (A) ADAMTS1/5; (B) 
ADAMTS2; (C) ADAMTS17; (D) ADAMTS3; (E) ADAMTS9 and (F) ADAMTS10. 
 
Figure 3-6: Synteny of X. laevis ADAMTS genes in subgenomes L and S with 
similar chromosomal organisation as X. tropicalis ADAMTS genes. Chromosome 
number is indicated on the left followed by an l with L and S for the longer and shorter 
X. laevis subgenomes, respectively, and a t for X. tropicalis. The arrows show the 
orientation of the genes syntenic to (A) ADAMTS14 and (B) ADAMTS18. 
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Figure 3-7:	  Synteny of X. laevis ADAMTS genes in subgenomes L and S and with 
different chromosomal position compare to X. tropicalis ADAMTS genes. 
Chromosome number is indicated on the left followed by an l with L and S for the 
longer and shorter X. laevis subgenomes, respectively, and a t for X. tropicalis. The red 
star and line represent the location of scaffold 53 (B). The arrows show the orientation 
of the genes syntenic to (A) ADAMTS4, (B) ADAMTS6 and (C) ADAMTS15. 	  
3.2.4 Conservation of the Xenopus ADAMTS genes between Xenopus 
laevis subgenomes L and S 
 Mutations within copies of the same gene can occur in polyploid cells 
creating loss or new/different functions (Otto, 2007). The percentage of 
similarities between the two copies on the L and S X. laevis subgenomes of 
ADAMTS genes is around 95%. The lowest percentage of similarity is 
ADAMTS2 and the highest is ADAMTS6 (table 3-2).  
The comparison by alignment of ADAMTS amino acid sequences 
showed that most of the differences were located at the C and N-terminal of the 
protein and not in the different domains. This suggests that the structure of the 
protein might be conserved between the L and S subgenomes as well as the 
function. During this analysis a missing domain for the ADAMTS9 coded by the 
subgenome L copy (figure 3-8) were observed. However this missing domain 
was due to a lack of genome sequencing in the subgenome L leading to a 
wrong protein sequence. Sequencing of the missing area by PCR would allow 
completing the ADAMTS9 gene sequence on the subgenome L.  
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Table 3-2: Percentage similarity between homoeologous X. laevis ADAMTS 
genes on the two subgenomes L and S. 
 
 	  
	  
Figure 3-8: Xenopus laevis ADAMTS9L and ADAMTS9S structure. The name of 
the protein is on the left gollowed by an L for the subgenome L copy and a S for the 
subgenome S copy. The pink star indicates the missing Thrombospondin type 1 motif 
(TSR) in ADAMTS9L. 
3.3 Discussion 
 The aim of this chapter was to identify the Xenopus ADAMTS genes, 
assess their degree of conservation to mammalian ADAMTS genes and their 
place in evolutionary history form protostomes to the 19 ADAMTS genes in 
mammals, analyse their chromosomal organisation on the X. laevis 
subgenomes L and S and the X.tropicalis genome. 
 19 ADAMTS genes are found in the Xenopus laevis subgenome L and 
Xenopus tropicalis, the same as in mammals, whereas only twelve are present 
in the subgenome S due to a loss of copy for seven ADAMTSs (ADAMTS7, 
ADAMTS8, ADAMTS12, ADAMTS13, ADAMTS16, ADAMTS19 and 
genes % of similarity between subgenomes L and S 
ADAMTS1 95.15 
ADAMTS2 86.32 
ADAMTS3 94.57 
ADAMTS4 92.92 
ADAMTS5 96.70 
ADAMTS6 98.12 
ADAMTS9 92.74 
ADAMTS10 95.13 
ADAMTS14 94.97 
ADAMTS15 94.9 
ADAMTS17 95.58 
ADAMTS18 93.16 
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ADAMTS20). Loss of these copies can be explained by neofunctionalization 
and/or regulation of the level of expression. X. tropicalis and X. laevis ADAMTS 
chromosomal position is conserved, thus confirming the absence of inter-
chromosomal rearrangements. It is known that 92% of the genes are conserved 
between X. tropicalis and the subgenome L of X. laevis when only 68% are 
conserved between X. tropicalis and the subgenome S of X. laevis (Session et 
al., 2016). The Xenopus ADAMTS gene family have the following proportions: 
100% are present in X. tropicalis and X. laevis subgenome L but only 63% are 
present in X. laevis subgenome S. 
First phylogenetic analysis showed that the evolutionary history of the 19 
ADAMTS proteins present in X. tropicalis is similar to the 19 mammalian 
ADAMTS (Kelwick et al., 2015a). The new version of the annotated X. laevis, 
released in 2015, allowed me to look at the conservation of ADAMTS in X. 
laevis compare to ADAMTSs in Drosophila melanogaster, Caenorhabditis 
elegans, Ciona intestinalis, Xenopus tropicalis, Mus Musculus and Homo 
sapiens. It showed that they are strongly conserved suggesting that they 
followed the same evolutionary history starting with a duplication of an ancestral 
gene prior the divergence of protostomes and deuterostomes around 650 Ma. 
Duplications and retrotransposition events lead to the 19 ADAMTS genes found 
in mammals and in X. laevis and X. tropicalis. These data suggest that the 
study of the function of ADAMTS in Xenopus could provide valuable information 
in relation to their function in humans. 
Homoeologous X. laevis ADAMTS proteins are more closely related to 
each other than to orthologous X. tropicalis ADAMTS proteins. For some cases 
one of the X. laevis copy on the L or S subgenomes is more closely related to 
X. tropicalis suggesting that a homoeologous gene is more related to an 
ancestral gene (figure 3-3). A similar phylogenetic analysis could be done using 
the ADAMTS genes sequences to confirm the relation between homoeologous 
and orthologous observed at the protein level. It has been shown that 
homoeologous pairs can have different expression levels and profiles. Such as 
one X. laevis copy can show an expression profile more similar to X. tropicalis 
copy than to the other X. laevis copy. The keratin gene family shows these 
different expression profiles between homoeologous due to neofunctionalisation 
to adapt to environmental changes (Suzuki et al., 2016). Whereas (Watanabe et 
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al., 2016) found that for most families of transcription factors, such as 
homeobox genes family, sox and pax gene families, homoelogous have the 
same level and profile of expression suggesting that they are conserved due to 
the need of high expression of these genes.   
 The synteny of the ADAMTS gene family is more conserved between X. 
tropicalis and X. laevis subgenome L than with the subgenome S, indicating the 
ancestral synteny is the one found on these two genomes. Intra-chromosomal 
rearrangements occurred creating inverted chromosomal organisation on a 
group of genes or on an individual gene, between the three chromosomes. 
Some of the genes used in this study are located on scaffolds but with the same 
synteny found on annotated chromosomes. These data can help improve the 
genome assembly by allocating scaffolds into the correct chromosome 
(Watanabe et al., 2016). 
 ADAMTS gene copies on X. laevis subgenome L and S are not identical. 
This suggests that mutations occurred before and/or after the hybridisation of 
the two different subgenomes. It could lead to loss of function, 
neofunctionalisation or subfunctionalisation in function of the gene dosage 
(Watanabe et al., 2016) or on the specific need at specific time and place during 
development (Suzuki et al., 2016). It is not known if these differences disrupt 
the structure and/or the function of the ADAMTS proteins. 
 In order to investigate the role of the ADAMTSs in more detail, their 
expression profiles during development have to be defined, which will be 
describe in the next two chapters along with functional studies on one of the 
ADAMTSs, ADAMTS9.  
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4 Chapter IV: Characterisation of the ADAMTS family 
in Xenopus during organogenesis  
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4.1 Introduction 
4.1.1 ECM remodeling during neural crest cell migration in Xenopus 
In this chapter the expression profiles of the ADAMTS family will be 
looked at in early development and the function of ADAMTS9 will be 
investigated in neural crest (NC) and in kidney development. 
Neural crest (NC) development starts with a complex interplay of signals 
between the neural and non-neural ectoderm during gastrulation leading to the 
formation of a broad progenitor domain named the “neural plate border”. 
Transcription factors named “neural plate border specifiers” activate NC-specific 
markers in a subset of neural plate border cells at the end of gastrulation. The 
epithelium-to-mesenchyme transition (EMT), which is characterising by the loss 
of tight and adherent junctions, modifications of the apical-basal cell polarity 
and rearrangements of the cytoskeleton, is then activated and initiates NC 
migration during neurulation. The NC emerge along the anterior-posterior axis 
of the embryo, posterior to the mid-diencephalon and during organogenesis NC 
migrate along defined routes, proliferate, and populate their target tissues and 
organs where they differentiate (Pegoraro and Monsoro-Burq, 2013) (Thiery et 
al., 2009) (Theveneau and Mayor, 2012). The NC migrate in four main streams 
in a solitary or collective way. The enteric NC migrate into the gut, the cardiac 
NC migrate to the heart loops, the cephalic NC migrate anteriorly (through the 
branchial arches) into the head and the trunk NC migrate down the trunk of the 
embryo. Trunk NC pass in-between the neural tube and the somites and some 
NC migrate straight up where they will give rise to mesenchymal and pigment 
cells in the dorsal fin (figure 4-1) (Theveneau and Mayor, 2013). 
In vivo and in vitro studies show that versican is a nonpermissive matrix 
for NC migration leading them along the correct migratory direction by creating 
restrictive boundaries. Confinement is essential for collective NC migration 
(Szabo et al., 2016). ADAMs play a role in NC migration (Alfandari et al., 2001). 
ADAM9, 13 and 19 have been shown to play a role in NC migration. ADAM9 
and 13 can cleave cadherin-11, which stimulates NC migration (McCusker et 
al., 2009). The cleavage of ADAM13 releases a cytoplasmic domain that 
translocates to the nucleus and activates gene transcription promoting NC 
migration (Cousin et al., 2011). Loss of function experiments for ADAM9 lead to 
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a reduction of NC markers and NC migration (Neuner et al., 2009). The 
membrane-bound MMP14 is expressed in cephalic and trunk migrating NC and 
may play a role in the remodeling of the ECM (Harrison et al., 2004) (Tomlinson 
et al., 2009). 
 
 
Figure 4-1: Xenopus neural crest cells migration pathways. Migratory routes for the 
cephalic, enteric and cardiac NC are indicated in red and routes for the trunk NC is 
indicated in green. (A) Migratory NCC in a stage 24 embryo, (B) transversal section of 
a Xenopus embryo stage 23 showing the migrating trunk NC between the neural tube 
and the somites and straight up to the dorsal fin. The developmental stage 
representations are from (Nieuwkoop and Faber, 1994). 	  
4.1.2 Remodeling during pronephros development in Xenopus 
In Xenopus kidney development starts at late gastrulation (stage 12.5) 
when renal precursor cell lineage is specified. In early neurula embryos the 
kidney fields are formed in the intermediate mesoderm. At tailbud stage the 
specified intermediate mesoderm condenses to form the pronephric primordium 
that by a medio-lateral patterning, regulated by notch signaling, gives rise to 
tubules, nephrostomes and glomus. The glomus is the equivalent of the 
mammalian glomerulus but directly filters into the coelomic cavity that surrounds 
embryonic organs and not into the Bowman’s capsule. Major morphological 
changes occur at tadpole stage (stage 36) characterised by cell movements. 
Distal cells of the tubule move in the proximal direction leading to the curvature 
of the tubule that becomes the intermediate tubule. At the same time the 
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diameter of the proximal tubule decreases and convergent extension 
movements lead to its elongation. At stage 38 the tubule of the pronephros 
forms a stereotypic S-shape loop segmented along its proximal-distal axis, in 
proximal, intermediate and distal tubule, and urine flow starts (Lienkamp, 2016) 
(figure 4-2A). The Xenopus pronephros is structurally and functionally similar to 
the mammalian nephron. The pronephros is composed of three domains: the 
glomus, where the blood is filtrated into the coelomic cavity; the tubule where 
selective re-absorption and secretion takes place, and the duct that transports 
waste to the cloaca. Nephrostomes are thin ciliated funnels that transfer the 
fluids from the coelom to the tubule (figure 4-2B). At metamorphosis the 
pronephros is replaced by the mesonephros with a more complex structure; the 
adult kidney (Lienkamp, 2016). 
 
Figure 4-2: Pronephros development in Xenopus. (A) Localisation of the 
pronephros at different stages of development indicated in the grey box corresponding 
to different steps of the pronephros organogenesis indicated in the orange box. (B) 
Morphology of the pronephros at tadpole stage (stage 38). The developmental stage 
representations are from (Nieuwkoop and Faber, 1994). 	  
The globular basement membrane (GBM) is the thickest basement 
membrane in the kidney and is composed of laminin, type IV collagen and 
heparan sulfate proteoglycans. The main function of this pericellular ECM is to 
act as a filter between the vascular system and the urinary space. This is 
dependant upon the charge of the basement membrane, which is negatively 
charged due to the presence of GAGs chains linked to the heparan sulfate 
proteoglycans. Mutations in these components lead to kidney diseases in 
human and mouse. The interstitial ECM in the kidney is mostly composed of 
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different types of collagens, fibronectin, thrombospondin, proteoglycans such as 
versican and hyaluronan. In renal fibrosis the scar tissue is caused by the 
accumulation of ECM components in the interstitial ECM due to decreased 
degradation and elevated synthesis making them good markers of renal 
fibrosis. Dysregulation of the interstitial ECM components are seen in most 
kidney diseases. Interstitial renal ECM has different functions such as hydration, 
force-resistance and as a growth factor reservoir. ADAM19 mRNA is expressed 
in human kidney in distal tubules but not in proximal tubules or glomerulus, 
whereas in renal disease it is expressed in proximal tubules and the glomerulus 
and it is up regulated in distal tubules. These profiles of expression suggest a 
role for ADAM19 in kidney development and in renal diseases (Melenhorst et 
al., 2006). A similar observation has been reported for ADAM family member 
ADAM17 found weakly expressed in human proximal tubules, peritubular 
capillaries, glomerular endothelium and parietal epithelium. ADAM17 was up 
regulated after interstitial fibrosis and tubular atrophy and found expressed in 
the mesangium suggesting a role in kidney disease fibrosis (Mulder et al., 
2012). MMP-1, -2, -3, -9, -13, -14, -24, -25, -27 and -28 are expressed in the 
kidney and have been shown to be involved in ECM remodeling, degradation of 
basement membrane, angiogenesis, cell migration and cell apoptosis. They are 
implicated in renal diseases such as fibrosis, especially MMP-2, -7 and -9. 
TIMP1, 2 and 3 are expressed in the kidney and TIMP1 and 2 are increased in 
renal diseases (Genovese et al., 2014). 
Little is known about the role of the ADAMTS family in the neural crest 
migration and in the pronephros development. The ECM remodeling is 
important for these two developmental processes. The ADAMTSs function in 
neural crest cells and pronephros development using Xenopus as an animal 
model will be investigated in this chapter. 
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4.2 Results 
4.2.1 ADAMTSs expression and function in Xenopus tropicalis 
4.2.1.1 Expression profiles of the ADAMTS family in Xenopus tropicalis 
To look at the expression profiles of the ADAMTS family in Xenopus 
tropicalis during development the RNA of different all embryos (n=10) at key 
stages of development such as unfertilised egg, blastula (stage 9), neurula 
(stage 15), organogenesis at early tailbud (stage 22), tailbud (stage 27) and late 
tailbud (stage 33), and organogenesis at tadpole (stages 40, 42 and 45) was 
extracted (figure 4-3). cDNA synthesis was then carried out and the expression 
profiles established by RT-PCR. The same number of PCR cycles (35 cycles) 
was used for all ADAMTSs genes; p300 was used as a loading control and H20 
as a negative control. The signal intensity was different for the members of the 
ADAMTS family. ADAMTS1, ADAMTS6 and ADAMTS10 were the most 
strongly expressed whereas ADAMTS2 and ADAMTS13 (figure 4-3). The 
maternal expression was measured at the unfertilised egg stage as the 
embryonic transcription only begins the mid blastula transition (stage 8). Only 
ADAMTS17, ADAMTS6, ADAMTS7, ADAMTS2, ADAMTS3, ADAMTS5 and 
ADAMTS1 had a maternal expression (figure 4-3). The expression of the 
ADAMTSs is dynamic across Xenopus tropicalis developmental stages (figure 
4-3).  
4.2.1.2 Expression pattern of ADAMTS9 in Xenopus tropicalis 
PCR only gives temporal expression. Wholemount in situ hybridisation 
(WISH) provides spatial as well as temporal information. In situ probes were 
generated for a number of ADAMTSs. 
WISH were carried out, with probes generated from PCR products, for all 
the ADAMTSs in Xenopus tropicalis but with the exception of ADAMTS9 (figure 
4-4), they did not show any specific signals.  
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Figure 4-3: Expression of the ADAMTS genes family during Xenopus tropicalis 
development. Analysis by RT-PCR of mRNA from egg to stage 45. Xenopus stages 
are indicated at the top according to (Nieuwkoop and Faber, 1994) (NF) and gene 
names are indicated on the left. W: water (H20), is a negative control and p300 is a 
loading control. ADAMTS genes are organised by clade as follow, (A) orphan, (B) 
COMP proteinases, (C) vWFCP, (D) Procollagen N-propeptidase and (E) 
Hyalectanases. 
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WISH for ADAMTS9 did not show any specific signal in early stages 
before tailbud stages in X.tropicalis which confirm RT-PCR results showing that 
ADAMTS9 was not expressed before neurula and early tailbud stages (figure 4-
3). At early tailbud stages (stages 24) ADAMTS9 expression was mostly found 
in the developing eye and in the cloaca (figure 4-4A). At tailbud stages (stages 
27), the expression was observed in the eye, in the midbrain hindbrain 
boundary, in the pronephros and in the pronephric duct and in the cloaca (figure 
4-4B). At stage 33 the ADAMTS9 expression was found in numbers of 
developing organs and structures such as the pronephros, the pronephric duct, 
the olfactory placode, the optic cup, the otic vesicle, the branchial arches and 
the cloaca (figure 4-4C). At tadpole stages (stages 41) the eye structure was 
more defined and the ADAMTS9 expression was specific to the lens and the 
retinal pigment epithelium, the expression was also found in the pancreas and 
in the fin (figure 4-4D).  
4.2.1.3 ADAMTS9 knockdown in Xenopus tropicalis 
To study the function of ADAMTS9 in Xenopus tropicalis development, a 
morpholino was designed to block the translation of the ADAMTS9 protein. 
ADAMTS9 morpholino was injected into both cells of a two-cell stage embryo at 
varying concentrations (30 and 60ng) to determine a concentration, which 
would give a consistent phenotype. At the same time a control morpholino 
(morpholino that targeted a human beta-globin intron mutation that causes 
beta-thalassemia and is known to not cause phenotypes in Xenopus) was 
injected in the same way at the highest concentration of ADAMTS9 morpholino 
(60ng) (figure 4-5). This morpholino was used as a negative control to assess 
the specificity of the observed phenotypes to ADAMTS9 morpholinos. 
This experiment showed that the injection of 30ng and 60ng of 
ADAMTS9 morpholino did not appear to have an effect on Xenopus tropicalis 
development. Injected embryos with 30ng and 60ng of ADAMTS9 morpholino 
appeared wild type, as demonstrated in the two group images (figure 4-5A and 
B) compared to the injected embryos with the control morpholino, as 
demonstrated in the group image (figure 4-5C). 
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Figure 4-4 The expression pattern of ADAMTS9 in Xenopus tropicalis embryos. 
Developmental stages are according to (Nieuwkoop and Faber, 1994). Lateral views of 
embryos with anterior on the left and posterior on the right. (A) At stage 24 the 
expression is in the eye (e) and in the cloaca (c) (e). (B) At stage 27 the expression is 
in the eye, in the midbrain hindbrain boundary (mh), in the pronephros (pn) and in the 
pronephric duct and in the cloaca (pd). (C) At stage 33 the expression is in the 
olfactory placode (op), in the optic cup (oc), in the midbrain hindbrain boundary, in the 
otic vesicle (ov), in the pronephros (pn), in the branchial arches (ba) and in the cloaca. 
(D) At stage 41 the expression is also in the lens (l), in the retinal pigment epithelium 
(rpe) in the pancreas (p) and in the fin (f).	   	   	  
	   78 
	  
Figure 4-5: The phenotype obtained after ADAMTS9 knockdown in Xenopus 
tropicalis. At the top is represented a 2 cell stage embryo injected with ADAMTS9 
morpholino and GFP mRNA (600pg). In the middle is shown the GFP signal in injected 
embryos. At the bottom are the group pictures of stage 41 injected embryos with (A) 
30ng of ADAMTS9 morpholino (n=33), (B) 60ng of ADAMTS9 morpholino (n=36) and 
(C) 60ng of control morpholino (n=42). Co: control and MO: morpholino. 
Developmental stages are according to (Nieuwkoop and Faber, 1994).	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4.2.2 ADAMTSs expression and function in Xenopus laevis 
4.2.2.1 Expression profile of the hyalectanases family in Xenopus laevis 
Xenopus laevis was chosen as model organism rather than Xenopus 
tropicalis for the rest of the study due to the larger size of the embryos to realise 
targeted injections and to observe phenotypes.  
The focus for the rest of this study will be on the hyalectanases family 
composed of ADAMTS1, ADAMTS4, ADAMTS5, ADAMTS8, ADAMTS9, 
ADAMTS15 and ADAMTS20, during Xenopus development. Hyalectans, 
subfamily of proteoglycans, have been shown to be essential for development 
(Brunet et al., 2012) and the different members of this family, aggrecan, 
versican, neurocan and brevican, can be cleaved by the hyalectanases family 
of ADAMTSs (Stanton et al., 2011).  
As RT-PCR is only a semi quantitative method, quantitative RT-PCR 
(qRT-PCR) was used in order to look at the hyalectanases quantitative 
expression profiles during Xenopus laevis development. RNA from key 
developmental stages such as blastula (stage 6), gastrula (stage 11), neurula 
(stage 16), organogenesis at early tailbud (stage 24), late tailbud (stage 33) and 
tadpole (stage 42) was extracted. cDNAs synthesised from the RNA of these 
samples were used for qRT-PCR (figure 4-4) for the hyalectanases gene family 
and for versican (VCAN) one of their substrates. Ct data from qRT-PCR were 
collected using 7500 Software v2.3 (Applied Biosystems) and analysed using 
Excel (Microsoft). ΔCt (gene Ct—odc Ct) were obtained from Ct values of each 
gene for normalization and then ΔCt values were converted to relative gene 
expression using the 2-ΔCt method.  
The ΔCt values were used to create a heat-map showing the level of 
expression of the hyalectanases family compare to each other at the different 
stages of development (figure 4-6A). The analysis of the heat map suggested 
that all ADAMTSs and VCAN were expressed higher at organogenesis stages 
(stages 33 and 42) than at early developmental stages (stages 6, 11 and 16) 
and that ADAMTS20 was the least expressed and VCAN the most expressed. 
Only ADAMTS8 showed a high expression at stage 6 (figure 4-6A).  
 The 2-ΔCt method was used to determine the individuals expression 
profiles using Graph Pad Prism 6 software (figure 4-6B). The expression was 
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low at early stages and high at late organogenesis stages (stage 42) for nearly 
all hyalectanases family members with the exception of ADAMTS1 that showed 
a peak of higher expression at stage 11 (gastrula) and ADAMTS8 that showed 
a peak of expression at stage 6 (blastula) suggesting a maternal expression 
(figure 4-6B). ADAMTS9 and its substrate, VCAN, showed the same expression 
profile with an expression increase at neurula (stage 16) to late organogenesis 
(stage 42) (figure 4-6B). The gene expression results for the hyalectanases 
gene family obtained by RT-PCR in Xenopus tropicalis (figure 4-3) showed 
similar higher expression at late stages of development compared to early 
stages as observed by qRT-PCR in Xenopus laevis (figure 4-6). 
PCR only gives temporal expression. Wholemount in situ hybridisation 
(WISH) provides spatial as well as temporal information. In situs probes were 
generated for a number of ADAMTSs. 
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Figure 4-6: Expression profiles of the hyalectanases family and VCAN during 
Xenopus laevis development. Analysis by qRT-PCR of mRNA from stage 6 to stage 
42 embryos normalized to odc as a loading control. The experiment was done three 
independent times. Expression profiles are represented as, (A) a heatmap where 
genes names are on the vertical axis and developmental stages on the horizontal axis 
according to (Nieuwkoop and Faber, 1994) (NF). (B) Each graph represents the 
expression profile of a single gene; the numbers on the vertical axis represents the 
normalized expression value and on the horizontal axis represents stages of 
development (mean with SEM), n=3. 
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4.2.2.2 Expression pattern of ADAMTS9 in Xenopus laevis 
WISH were carried out, with probes generated from PCR products, for 
the hyalectanases family in Xenopus laevis but with the exception of ADAMTS9 
(figure 4-8), they did not show any specific signals. An ADAMTS1 probe was 
generated from a plasmid containing an image clone sequence of ADAMTS1 
gene in Xenopus laevis. The expression of ADAMTS1 obtained by WISH in 
Xenopus laevis using this probe was found in the posterior part of the embryo at 
neurula stage (stage 15) and in the branchial arches, the somites and the heart 
anlage at tailbud stage (stage 26) (figure 4-7). These results were similar to the 
one previously observed for ADAMTS1 in Xenopus laevis (Suga et al., 2006). 
 
	  
Figure 4-7: The expression pattern of ADAMTS1 in Xenopus laevis. 
Developmental stages are according to (Nieuwkoop and Faber, 1994). (A) At stage 15 
the expression is in the posterior part of the embryo. (B) Lateral view of an embryo at 
stage 26 with anterior on the left and posterior on the right, the expression is in the 
branchial arches (ba), in the somites (s) and in the heart anlage (ha). 	  
WISH for ADAMTS9 did not show any specific signal in early stages 
before tailbud stages,, which confirm qRT-PCR results in X.laevis showing that 
ADAMTS9 was not expressed before neurula and early tailbud stages (figure 4-
6). At early tailbud stages (stages 22) ADAMTS9 expression was mostly found 
in the developing eye, in migrating cells localised on the anterior side of the 
embryo and in the pronephric anlage (figure 4-8A). At tailbud stages (stages 25 
and 26), the expression was observed in the eye, in the midbrain hindbrain 
boundary, in migrating cells localised on the anterior side of the embryo (figure 
4-8B and C). At stage 35 the ADAMTS9 expression was found in numbers of 
developing organs and structures such as the pronephros, the pronephric duct, 
the olfactory placode, the optic cup, the otic vesicle, the branchial arches, the 
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fin and the cloaca (figure 4-8D). At tadpole stages (stages 38) the eye structure 
was more defined and the ADAMTS9 expression was specific to the lens and 
the retinal pigment epithelium, the expression was also found in the pancreas, 
in the fin and in the cloaca (figure 4-8E).  
ADAMTS9 expression was found in the developing pancreas. The 
expression was observed in the dorsal pancreatic anlage on the dorsal surface 
of the endoderm at the level of the pronephros (red arrows figure 4-9A’ and A’’) 
and in the ventral pancreas formed of two symmetrical (left and right) anlagen 
at stage 37/38 (black arrows figure 4-9A’ and A’’). At stage 40 ADAMTS9 
expression was seen in the dorsal and ventral pancreatic anlagen that have 
fused. The fusion occurs at the junction of the right side of the dorsal pancreatic 
bud with the dorsal aspect of the fused ventral buds (black and red arrows 
figure 4-9B’ and B’’) (Kelly and Melton, 2000). 
To look in more detail at the ADAMTS9 expression profiles the head and 
the trunk of late tailbud and tadpole stages (stages 35 and 38) embryos were 
sectioned (figure 4-10A and B). In the head the expression was found in the 
optic cup, midbrain hindbrain boundary, in the otic vesicle at stage 35 (figure 4-
10 1, 2, 3 and 4), in the lens and the retinal pigment epithelium at stage 38 
(figure 4-10 6). In the trunk the expression was mostly found in the pronephric 
anlage at stage 35 and in the pronephros (figure 4-10 5 and 7) (Lienkamp et al., 
2012). 
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Figure 4-8: The expression pattern of ADAMTS9 in Xenopus laevis embryos. 
Developmental stages are according to (Nieuwkoop and Faber, 1994). Lateral views of 
embryos with anterior on the left and posterior on the right. (A) At stage 22 the 
expression is in the eye (e), in migrating cells (mc) and in the pronephric anlage (pn). 
(B, C) At stage 25 and 26 the expression is in the eye, in migrating cells (mc) and in 
the midbrain hindbrain boundary (mh). (D,E) At stage 35 and 38 the expression is in 
the olfactory placode (op), in the optic cup (oc), in the midbrain hindbrain boundary, in 
the otic vesicle (ov), in the pronephros (pn), in the pronephric duct (pd), in the branchial 
arches (ba), in the fin (f) and cloaca (c). (E) At stage 38 the expression is also in the 
lens (l), in the retinal pigment epithelium (rpe) and in the pancreas (p). 
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Figure 4-9: The expression pattern of ADAMTS9 in the pancreas of Xenopus 
laevis tadpoles. Lateral view of right and left sides of (A’’ and A’’’) stage 37/38 and (B’’ 
and B’’’) stage 40 embryos, developmental stages are according to (Nieuwkoop and 
Faber, 1994). Red and black arrows indicate ventral and dorsal pancreas respectively 
(A’’, A’’’, B’’ and B’’’). 
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Figure 4-10: Sectioned Xenopus laevis embryos after WISH for ADAMTS9. 
Developmental stages are according to (Nieuwkoop and Faber, 1994). In each panel 
lines and numbers indicate the level of the sections. Embryos are shown with anterior 
on the right and sections with dorsal at the top. (A) At stage 35, (1, 2, 3) in the head the 
expression is in the optic cup (oc), in the midbrain hindbrain boundary (mh) and (4) in 
the otic vesicle (ov); in the trunk (5) the expression is in the pronephros (pn). (B) At 
stage 38, (6) in the head the expression is in the lens (l) and in the retinal pigment 
epithelium (rpe); in the trunk (7) the expression is in the pronephros (pn).	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4.2.2.3 ADAMTS9 knockdown in Xenopus laevis 
 The Xenopus laevis genome is allotetraploid and is composed of two 
subgenomes, L and S (see chapter III). The expression profile of the two 
ADAMTS9 copies, ADAMTS9L and ADAMTS9S, was assessed by RT-PCR 
during Xenopus laevis development from unfertilised egg to tadpole (stage 45) 
(figure 4-11). ADAMTS9L expression was not detectable in the unfertilised egg 
or at stage 6, suggesting no maternal expression. ADAMTS9L expression was 
detectable from neurula (stage 16) whereas ADAMTS9S expression was found 
from stage 6 although the expression appeared low. Both ADAMTS9L and 
ADAMTS9S were found at the tailbud and tadpole stages corresponding to 
neural crest cells migration and organogenesis (figure 4-11).  
To study the function of ADAMTS9 in Xenopus laevis development, two 
morpholinos were designed to block the translation of ADAMTS9L and 
ADAMTS9S proteins. Morpholinos were injected into both cells of a two-cell 
stage embryo at varying concentrations (40 and 60ng) to determine a 
concentration, which would give a consistent phenotype. At the same time a 
control morpholino was injected in the same way at the highest concentration of 
ADAMTS9 morpholinos (60ng) (figure 4-12).  
This experiment showed that the injection of 40ng and 60ng of 
ADAMTS9L or ADAMTS9S morpholinos did not appear to have an effect on 
Xenopus laevis development. In comparison with the injected embryos with the 
control morpholino (group picture figure 4-12E), injected embryos with 40ng and 
60ng of ADAMTS9L morpholino appeared wild type (two group images figure 4-
12A and B) as well as injected embryos with 40ng and 60ng of ADAMTS9S 
morpholino (two group images figure 4-12C and D). 
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Figure 4-11: Expression of ADAMTS9L and ADAMTS9S during Xenopus laevis 
development. Analysis by RT-PCR of mRNA from egg to stage 45. Xenopus laevis 
stages are indicated at the top according to (Nieuwkoop and Faber, 1994) (NF) and 
gene names are indicated on the left.  odc is a loading control. -RT is a negative 
control of cDNA synthesis reaction made without adding the Reverse Transcriptase 
enzyme and W: water (H20), is a negative control of the PCR reaction without cDNA 
template. 
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Figure 4-12: The phenotype obtained after ADAMTS9 knockdown in Xenopus 
laevis. At the top is represented a 2 cell stage embryo injected with ADAMTS9L or 
ADAMTS9S morpholino and GFP mRNA (600pg). In the middle is shown the GFP 
signal in injected embryos. At the bottom are the group pictures of stage 41/42 injected 
embryos with (A) 40ng of ADAMTS9L morpholino (n=46), (B) 60ng of ADAMTS9L 
morpholino (n=44), (C) 40ng of ADAMTS9S morpholino (n=53), (D) 60ng of 
ADAMTS9S morpholino (46) and (E) 60ng of control morpholino (n=43). Co: control 
and MO: morpholino. Developmental stages are according to (Nieuwkoop and Faber, 
1994).	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ADAMTS9 knockdown in Xenopus tropicalis and Xenopus laevis 
embryos experiments did not show phenotypes. The qRT-PCR in Xenopus 
laevis showed that ADAMTS9 and VCAN were expressed at the same 
developmental stages from neurula (stage 16) to organogenesis (stage 42) and 
it has been shown that VCAN was expressed in the same embryonic locations 
than ADAMTS9 such as in the branchial arches, structures where NC migrate, 
and in the pronephros (figure 4-13) (Casini et al., 2008). The co expression of 
VCAN and ADAMTS9 in these structures suggests a role of ADAMTS9 in the 
remodeling of the ECM during development by cleavage of versican. In order to 
assess this hypothesis targeted injections into specific blastomere giving rise to 
neural crest and pronephros were carried out. 
 
	  
Figure 4-13:	  The expression pattern of VCAN in Xenopus laevis embryos. Lateral 
view of embryos with anterior on the left and posterior on the right. Developmental 
stages are according to (Nieuwkoop and Faber, 1994). (A) (B) At stage 28 and 33 the 
expression is in the branchial arches (ba), in the pronephros (pn) and in the pronephric 
duct (pd).  
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4.2.2.4 ADAMTS9 knockdown in neural crest of Xenopus laevis 
 To specifically knockdown ADAMTS9 in the neural crest the injections 
were targeted into one dorsal blastomere at the 4-cell stage. GFP mRNA was 
co-injected in order to trace the injection, to ensure that it was injected at the 
right location and to identify which side of the embryos had been injected. Just 
one side (one blastomere out of two dorsal blastomere) of the embryo was 
injected and the other side was used as a control to evaluate a phenotype due 
to the ADAMTS9 knockdown. Xenopus laevis embryos injected at two-cell 
stage with 60ng of morpholinos did not present toxicity phenotype due to the 
amount of morpholinos (figure 4-12B, D and E). Targeted co-injection of 
ADAMTS9L and ADAMTS9S morpholinos into one blastomere at 4-cell stage 
Xenopus laevis embryos will be carried out at 40ng of each morpholino due to 
the smaller size of a blastomere at 4-cell stage compared to a two-cell stage. 
ADAMTS9L and ADAMTS9S, as well as 600pg of GFP mRNA were injected 
(figure 4-14). After selection of the embryos injected at the right location, the 
analysis of the effect of the ADAMTS9 knockdown on neural crest development 
was carried out using sox10 as a marker for NC migration at tailbud stages 
(figure 4-14A). Sox10 is a transcription factor essential for neural crest cells 
development (Honoré et al., 2003). The experiment demonstrated that the 
embryos displayed a wild type phenotype similar to the non-injected side with 
no perturbation of the NC migration in the anterior part of the embryo (cephalic, 
enteric and heart NC) or in the trunk of the embryo (trunk neural NC) (figure 4-
14A). NC give rise to melanocytes and craniofacial cartilage (Theveneau and 
Mayor, 2013). Injection of the ADAMTS9 morpholinos appeared to have no 
effect on these structures as observed at tadpole stages (stage 41) (figure 4-
14B). 
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Figure 4-14:	  Knockdown of ADAMTS9 in neural crest of Xenopus laevis. On the 
left is represented the schematic of an embryo stage 3 and the injection of ADAMTS9L 
and ADAMTS9S morpholinos (40ng) and GFP mRNA (600pg) into one dorsal 
blastomere to target NC. In the middle is shown the GFP signal of an injected embryo 
localised in the migrating NC (white arrows), the correct localisation. At the bottom (A) 
is a sox10 in situ realised on injected embryo at stage 26 to look at the phenotype of 
migrating NC (white arrows) on the injected side compare to the non-injected side 
(n=15) and (B) is stage 41 injected embryos to look at the pigment cell phenotype 
(white arrows) (n=10). Developmental stages are according to (Nieuwkoop and Faber, 
1994). 
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4.2.2.5 ADAMTS9 knockdown in the pronephros of Xenopus laevis 
4.2.2.5.1 Protocol of injection and analysis 
 ADAMTS9L and ADAMTS9S morpholinos with GFP mRNA were 
injected into the ventral V2 blastomere of an 8-cell stage embryo to target the 
pronephros (figure 4-15). The injection at the correct location, in the 
pronephros, was assessed using GFP signal and embryos with the right 
localisation of the signal were selected to carry out phenotypic analysis using 
several markers of pronephros development (figure 4-15).  
 
 
 
 
 
 
	  
Figure 4-15: Loss of function experiment for ADAMTS9 during pronephros 
development in Xenopus laevis. At the top is represented an 8 cells embryo injected 
in the V2 blastomere with ADAMTS9L and ADAMTS9S morpholinos and GFP mRNA 
(600pg). At the bottom is shown the GFP signal in injected embryos at different stages 
of development located at the right localisation corresponding to the pronephros (white 
arrow). The developmental stage representations are from (Nieuwkoop and Faber, 
1994). 
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4.2.2.5.2 Early markers, wt1 and pax8 
 ADAMTS9 has previously been shown to be expressed in the 
pronephros from early tailbud stages (figure 4-7) suggesting a role of ADAMTS9 
in the pronephros development of Xenopus laevis. To investigate this 
hypothesis, after selection of injected Xenopus laevis embryos with 40ng of 
both ADAMTS9S and ADAMTS9L morpholinos (and 600pg of GFP mRNA) on 
one side in the pronephros wholemount in situ hybridisation were carried out for 
the zinc finger transcription factor Wilms' tumor suppressor (wt1), a marker for 
the pronephric anlage and the glomus (Lienkamp et al., 2012), in order to look 
at the effect of the loss of function of ADAMTS9 on the glomus development 
(figure 4-16). No major effects due to ADAMTS9 knockdown were observed on 
the glomus development on the injected side of the embryo (figure 4-16 left) 
compare to the non injected control side (figure 4-16 right).  
 Next the effect of the loss of function of ADAMTS9 on the pronephric 
tubules and duct development were investigated using the transcription factor 
paired box gene 8 (pax8), a marker for the pronephric anlage, the pronephric 
tubules and pronephric duct (Heller and Brandli, 1999). WISH was carried out 
on injected embryos on one side in the blastomere giving rise to the pronephros 
(figure 4-17). A delay was observed in the development of the tubules (figure 4-
17, black arrows) and the duct (figure 4-17, white arrows) on the injected side 
with 40ng of both ADAMTS9S and ADAMTS9L morpholinos (and 600pg of GFP 
mRNA) when compared to the non injected side from stage 22 to stage 27 
embryos (figure 4-17). The duct structure was not formed at early tailbud stage 
(stage 22) on the injected side (white arrow, figure 4-17A and B). At stage 25 
the tubules and the duct structures were less defined on the injected side (white 
and black arrows, figure 4-17C and D). The same phenotype was seen at stage 
27 where the tubules and duct structures were more similar to that at stage 25 
on the non injected side when compared to a non injected side of the stage 27 
embryo (white and black arrows, figure 4-17C and F).  
The phenotypes observed after knock-down of ADAMTS9 using 
morpholinos were delay of pronephric tubules and duct development at tailbud 
stages, showed by pax8 in situ hybridisation, but no phenotypes in the glomus, 
showed by wt1 in situ hybridisation.  
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Figure 4-16:	  Wholemount	  in situ hybridisation for wt1 in Xenopus laevis injected 
embryos with both ADAMTS9L and ADAMTS9S morpholinos. On the left side are 
non injected embryos and on the right side are injected embryos. Developmental 
stages, according to (Nieuwkoop and Faber, 1994), are indicated at the bottom right of 
the right picture. The black arrow indicates the specific signal in the glomus (n=5 for 
stage 22, n=3 for stage 25 and n=12 for stage 27). 
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Figure 4-17:	   Wholemount in situ hybridisation for pax8 in Xenopus laevis 
injected embryos with both ADAMTS9L and ADAMTS9S morpholinos. On the left 
side are non injected embryos (A,C and E) and on the right side are injected embryos 
(B, D and F). Developmental stages, according to (Nieuwkoop and Faber, 1994), are 
indicated at the bottom right on the right pictures, (A, B) stage 22 (n=6), (C, D) stage 25 
(n=4) and (E, F) stage 27 (n=11). The black arrow indicates the specific signal in the 
tubules and the white arrow indicates the specific signal in the duct.  	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4.2.2.5.3 Late tailbud markers, atp1b1, Xlim1 and pax2 
To describe in more details the delay of development observed in the 
pronephric tubules and duct at late tailbud stages when ADAMTS9 was 
knocked-down, terminal differentiation markers of these structures such as the 
transcription factors paired box gene 2 (pax2) and LIM homeodomain 
transcription factor Lhx1 (known as Xlim1 in Xenopus laevis) known to be 
necessary for kidney development were used to visualise the nephrostomes 
and the tubules and duct and the ion transporter atp1b1 (ATPaseNaþ/Kþ 
transporting beta1) was used to visualise tubules and duct (Agrawal et al., 
2009) (Buisson et al., 2015). Injected embryos with 40ng of both ADAMTS9S 
and ADAMTS9L morpholinos (and 600pg of GFP mRNA) on one side in the 
pronephros were selected to carry out WISH.  
On the injected sides of the embryos compare to the non injected sides a 
lack of proximal and intermediate tubules organisation was observed for all 
three markers indicating a delay of development (pink arrows figure 4-18 A). 
The expression of atp1b1 and Xlim1 in the distal tubules and duct were wilder 
and less defined on the injected sides that on the non injected side showing a 
delay in morphogenesis of these structures (black arrows figure 4-18 A). The 
expression profile of pax2 on the injected side revealed a pronephros structure 
more similar to the one observed at stage 27, using pax8 as a marker (figure 4-
17 E), rather than the structure observed on the non injected side of the same 
embryo (figure 4-18 A). A lack of signal was observed in the nephrostomes on 
the injected sides compared to the non injected side, using Xlim1 and pax2 as 
markers (grey arrows figure 4-18 A), showing a delay of development of the 
pronephros. The delay of pronephros development on the injected sides of the 
embryos was quantified for each markers (figure 4-18 B) and was observed for 
more than 80% of the embryos for pax2 and Xlim1 and for more than 50% for 
atp1b1. Partial and complete loss of atp1b1 signal was observed for 15% of the 
embryos indicating a delay more important of development of these injected 
embryos. 
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Figure 4-18:	   Wholemount in situ for atp1b1, Xlim1 and pax2 in Xenopus laevis 
injected embryos with both ADAMTS9L and ADAMTS9S morpholinos. (A) On the 
left side are non injected embryos and on the right side are injected embryos. All 
embryos are at stage 33/34 according to (Nieuwkoop and Faber, 1994).The pink 
arrows indicate the specific signal in the proximal and intermediate tubules, the black 
arrows indicate the distal tubule, the white arrows the duct and the grey arrows the 
signal in the nephrostomes. (B) Percentage of the observed phenotypes on the 
injected sides of the embryos with atp1b1, Xlim1 and pax2 staining which are normal 
(green), delay of development (grey), complete (red) and partial (blue) loss of signal.	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4.2.2.5.4 Late markers, 4a6 
In order to investigate if the delay of development of the pronephric 
tubules and duct, observed at tailbud stages persists at tadpole stages, the 4a6 
antibody was used to visualise the distal tubules and the pronephric duct in 
Xenopus laevis tadpoles (Vize et al., 1995). 
Xenopus laevis embryos were injected into the V2 blastomere on one 
side with 40ng of ADAMTS9S morpholino, 40ng of ADAMTS9L morpholino, 
40ng of both ADAMTS9S and ADAMTS9L morpholinos and 40ng and 80ng of 
control morpholino as a negative control to assess the specificity of the 
observed phenotypes to ADAMTS9 morpholinos. All were co injected with 
600pg of GFP mRNA. Wholemount immuno staining with 4a6 antibody was 
carried out on injected tadpoles (stage 40) to visualise the distal tubules and the 
pronephric duct. Observed phenotypes were classified into two categories, 
partial loss and complete loss, based on their degree of loss of 4a6 signal 
(figure 4-19A). The percentage of distribution of these different phenotypes in 
injected embryos was quantified, with normal phenotype defined on being when 
the injected side looked identical to the non-injected side (figure 4-18B). Partial 
and complete loss of 4a6 signal in injected embryos with ADAMTS9L 
morpholino and ADAMTS9S morpholino with more complete loss with 
ADAMTS9S morpholino was observed (figure 4-19B first two columns on the 
graph). A very low percentage of normal phenotype (no loss of the 4a6 signal) 
was observed in tadpoles injected with both ADAMTS9L and ADAMTS9S 
morpholinos, most of the observed phenotypes were partial and complete loss 
of the 4a6 signal (figure 4-19B third column on the graph). When embryos were 
injected with the control morpholino at 40ng or 80ng no effect was observed 
(figure 4-19B last two columns on the graph). 
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Figure 4-19:	   Wholemount immuno staining with 4a6 antibody on injected 
Xenopus laevis embryos with ADAMTS9S, ADAMTS9L and control morpholinos. 
(A) Phenotypes observed in stage 40 embryos with 4a6 staining, partial loss of the 
signal (top pictures) or complete loss of the signal (bottom pictures) on the injected 
side (right pictures) compare to the injected side (left pictures). The signal in the 
tubules is indicated by the black arrows and the signal in the duct is indicated by the 
white arrows. (B) Percentage of the observed phenotypes with 4a6 staining, which are 
complete (red), partial (blue) loss and no loss (green) of 4a6 signal on the injected side 
compared to the non injected side. The number of injected embryos is indicated on the 
top of the columns. On the horizontal axis is indicated the morpholino and the quantity 
injected (ng) into the V2 blastomere. 9L for ADAMTS9L, 9S for ADAMTS9S and Co for 
control morpholinos.	  
 
	   103 
4.2.2.6 Morpholinos efficiency 
In order to show the specificity of the translational blocking morpholinos on 
their ADAMTS9 target genes (ADAMTS9L and ADAMTS9S) the level of 
ADAMTS9 translated protein in injected embryos has to be assessed. There 
were no specific ADAMTS9 antibodies against the Xenopus protein and the 
ADAMTS9 genes are large (around 6kb) so only the 5’-UTR containing the 
binding site of the morpholinos, the signal peptide and the pro-domain followed 
by a C-terminal Human influenza hemagglutinin (HA) tag was cloned allowing 
the detection by an anti-HA antibody to assess the translation inhibition of 
ADAMTS9 by the morpholinos. The function of ADAMTS9 was not investigated 
in this experiment so a truncated protein could be used. Embryos were injected 
with 1ng and 5ng of mRNA of the different constructs, ADAMTS9S-HA and 
ADAMTS9l-HA, obtained by in vitro transcription and with GFP mRNA (600pg) 
in order to select injected embryos only. Ten injected embryos were selected at 
stage 9 for protein extraction in order to assess the amount of translated protein 
by western blot. 20μg of protein was loaded, to check if the truncated proteins 
were translated and not degraded during the maturation process. A α-actin 
antibody was used as a loading control. Non-injected embryos were used as a 
negative control and cmyc-HA protein as a positive control for the HA antibody 
(figure 4-20E and F). A dose response of ADAMTS9S-HA protein related to the 
amount of mRNA injected was observed (figure 4-20A and B). No signal was 
detected for the ADAMTS9l-HA protein (figure 4-20C and D). 
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Figure 4-20:	  Western blot for ADAMTS9S-HA and ADAMTS9L-HA. Lanes A and B 
show ADAMTS9S-HA protein signal from ten injected embryos with 1ng and 5ng of 
ADAMTS9S-HA mRNA, lanes C and D show ADAMTS9L-HA protein signal from ten 
injected embryos with 1ng and 5ng of ADAMTS9L-HA mRNA, lane E shows the 
negative control from ten non injected (NI) embryos and lane F shows the positive 
control (PC) cmyc-HA rotein signal from ten injected embryos with cmyc-HA mRNA. 
20µg of protein was loaded on the gel.	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4.3 Discussion 
4.3.1 ADAMTSs expression in Xenopus 
In this chapter the expression profile of the ADAMTS family in Xenopus 
embryonic development was assessed. A phylogenetic study previously 
showed that the ADAMTS family is conserved between Xenopus, human and 
mouse suggesting possible conservation of their functions (chapter III). They 
were all expressed in Xenopus tropicalis, visualised by RT-PCR, and had 
dynamic profiles showing variation in time and intensity of expression from egg 
to tadpole stages (stage 45) (figure 4-3). The hyalectanases family of 
ADAMTSs were the focus for the rest of the study as their substrate, the 
hyalectan/lectican family of chondroitin sulfate proteoglycans, are known to be 
widely expressed in the extracellular matrices during development (Brunet et 
al., 2012). To have a more precise view of the expression profiles of ADAMTS1, 
ADAMTS4, ADAMTS5, ADAMTS8, ADAMTS9, ADAMTS15, ADAMTS20 and 
VCAN during Xenopus laevis development qRT-PCR were carried out from 
blastula (stage 6) to tadpole (stage 42) stages (figure 4-6). High-resolution 
RNA-seq time course, showing transcripts per embryo, during Xenopus 
tropicalis embryonic development was published in open access in 2016 
(Owens et al., 2016) allowing the comparison of published profiles of the 
hyalectanases family with the data obtained by qRT-PCR (figure 4-21). The 
expression profiles were conserved for all of them (ADAMTS4, ADAMTS5, 
ADAMTS15, ADAMTS9 and ADAMTS20) except for ADAMTS8 that showed a 
high expression at stage 6 (maternal expression) in Xenopus laevis but not in 
Xenopus tropicalis and ADAMTS1 that showed a peak of expression during 
gastrulation (stage 11) (figure 4-21). It has been shown that ADAMTS1 plays a 
role in Xenopus laevis development at blastula to gastrula stage as a negative 
regulator of FGF by its C-terminal region, independent to its protease activity 
(Suga et al., 2006).  
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Figure 4-21:	   Hyalectanases family expression profile by RT-qPCR in Xenopus 
laevis and by RNA-seq in Xenopus tropicalis. RT-qPCR graphs show the 
expression using the 2-ΔCt method (black and white graphs) and RNA-seq graphs show 
the expression by the quantification of the number of transcripts per embryo (colour 
graphs) from (Owens et al., 2016).	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Wholemount in situ hybridisation (WISH) for all ADAMTSs in Xenopus 
tropicalis embryos and for the hyalectanases family in Xenopus laevis embryos 
did not show specific signal, with the exception of ADAMTS1 in Xenopus laevis 
(figure 4-7) and ADAMTS9 in both Xenopus tropicalis and Xenopus laevis 
(figure 4-4, 4-8). The weak expression level and the high similarities of the 
ADAMTS genes in Xenopus could explain the lack of specific signal. New 
probes could be generated in different areas of the genes and locked nucleic 
acid (LNA) probes could be used. They are composed of modified RNA 
nucleotides, which have an additional bridge that bonds the 2’ oxygen and the 
4’ carbon of the pentose, and are highly sensitive and specific and have been 
used to do WISH in Xenopus for miRNA (You et al., 2006) (Ahmed et al., 2015).  
ADAMTS9 spatio-temporal expression profiles, assessed by RT-PCR (figure 
4-3), RT-qPCR (figure 4-6) and WISH (figure 4-4 and 4-8), were found similar in 
Xenopus tropicalis and Xenopus laevis from unfertilised egg to tadpole stages. 
ADAMTS9 was highly expressed from early tailbud in the eye, the midbrain 
hindbrain boundary, and the migrating cells along the branchial arches (possibly 
neural crest cells) (figure 4-4 and 4-8). At tadpole stages ADAMTS9 expression 
was seen in the retinal pigment epithelium, in the branchial arches, in the 
pronephros, in the pronephric duct and in the pancreas (figure 4-4, 4-8, 4-9 and 
4-10). ADAMTS9 expression in the brain, the craniofacial structures, the kidney 
and the pancreas are similar for mouse and Xenopus (Jungers et al., 2005). 
These similarities reinforce the hypothesis of a conserved function in these two 
species.  
ADAMTS9 expression was found in the midbrain hindbrain boundary (MHB) 
from tailbud stages (figure 4-4 and 4-8) whereas its substrate VCAN was not 
expressed in this area (figure 4-13) (Casini et al., 2008). FGF8 is known to be 
expressed in the MHB and to be essential for MHB development (Fletcher et 
al., 2006). ADAMTS1 has been shown to negatively regulate FGF 
independently to its catalytic activity (Suga et al., 2006). ADAMTS9 could play a 
role in the regulation of FGF signaling in the MHB development independently 
to its protease activity. 
It has been shown that VCAN, a substrate of ADAMTS9, was expressed in 
Xenopus laevis at early stages during gastrulation and neurulation, and at 
tailbud and tadpole stages the expression was found in the migrating neural 
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crest, in the branchial arches, heart and pronephros (figure 4-13) (Casini et al., 
2008). The co expression of ADAMTS9 and its substrate VCAN in the 
pronephros, pronephric duct, migrating neural crest and their derivative 
structures, such as the branchial arches, suggest a role of ADAMTS9 in the 
extracellular matrix remodeling during the development of these structures. In 
order to investigate this hypothesis, loss of function experiments for ADAMTS9 
were carried out in Xenopus tropicalis and in Xenopus laevis. 
4.3.2 Functional study of ADAMTS9 in Xenopus tropicalis and in 
Xenopus laevis 
In order to carry out loss of function experiments for ADAMTS9 in 
Xenopus, translational blocking morpholinos were used. 
4.3.2.1 ADAMTS9 knockdown in Xenopus tropicalis and in Xenopus laevis 
embryos 
Mice homozygous for a mutation in ADAMTS9 gene, leading to a 
knockout, do not survive past gastrulation (E7.5). However conditional and 
heterozygous mice for ADAMTS9 mutation survive and show soft tissue 
syndactyly (STS), when two or more digits are fused together, and cardiac 
defect, respectively (Dubail et al., 2014) (Kern et al., 2010). Knockdown 
experiments for ADAMTS9 in Xenopus tropicalis and in Xenopus laevis, for 
each copy, using morpholinos did not shown a phenotype (figure 4-5 and 4-12). 
The lack of phenotype could be due to lack of efficiency of the morpholinos, 
which has to be assessed in order to establish the optimal concentration of 
morpholino to inject in order to obtain an efficient knockdown of ADAMTS9, 
and/or to the redundancy of the ADAMTS family..  
4.3.2.2 ADAMTS9 knockdown in neural crest of Xenopus laevis 
It has been shown by in vivo and in vitro study that versican is a 
nonpermissive matrix for NC migration leading them to the correct migratory 
direction by creating restrictive boundaries. The correct confinement is essential 
for collective NC migration during Xenopus development (Szabo et al., 2016). 
V0 and V1 are the most abundant versican isoforms found in neural crest cells 
(Dutt et al., 2006). These studies suggest a role of the hyalectanases family of 
ADAMTSs in NC migration by remodeling of the ECM by degradation of 
versican. Versican can be cleaved by ADAMTS9 (Somerville et al., 2003). After 
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loss of function experiments of ADAMTS9 specifically in NC population using 
morpholinos against both copies, the phenotype of NC migration was analysed 
at tailbud stage by wholemount in situ hybridisation for sox10, a marker of NC, 
and at tadpole stage by observation of NC derivatives population, such as 
melanocytes and craniofacial cartilage. No disruptions of the different NC 
migration pathways, in the anterior part of the embryo and in the trunk, were 
seen at tailbud stage and no pigmentation and craniofacial phenotypes were 
observed at tadpole stage (figure 4-14). These results suggest that ADAMTS9 
could not be the main ADAMTS necessary for the correct ECM remodeling 
promoting NC migration in Xenopus or that it could be compensated by an other 
member of the hyalectanases family.  
ADAMTS1 has been shown to have a similar expression profile to 
ADAMTS9 in Xenopus laevis, such as in the branchial arches, and to have a 
possible role in NC formation (figure 4-7) (Suga et al., 2006). These data 
suggest cooperation between these two ADAMTSs in NC and compensation 
after knockdown of ADAMTS9 in NC explaining the lack of phenotype. 
ADAMTS5 has been shown to be expressed in neural crest derivative tissues in 
mouse such as in Schwann cells and cartilage (McCulloch et al., 2009a). 
ADAMTS9 and ADAMTS20 have been shown to cooperate in the colonisation 
of skin by neural crest derived melanoblasts in mouse (Silver et al., 2008). 
These data suggest cooperation of several ADAMTSs in NC development, 
which could explain why no phenotype was observed after a knockdown of 
ADAMTS9 alone.  
The next experiments will be to knockdown several ADAMTSs from the 
hyalectanases family in NC, in Xenopus laevis, by injection of multiple 
morpholinos against different ADAMTSs and standard control morpholino in 
order to assess that the obtained phenotype is specific to the knockdown of the 
targeted genes. Multiple knockdowns by injection of morpholinos has previously 
been used in Xenopus in order to assess cooperation of genes and by inhibition 
of compensation between them, seen when only a single gene was knocked 
down, a phenotype could be observed (Tomlinson et al., 2008). The effects on 
NC migration of ADAMTS9 knockdown and the multiple knockdowns of several 
hyalectanases could be investigated in more detail by using other NC markers, 
such as twist and sox9 (Lander et al., 2013).   
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4.3.2.3 ADAMTS9 knockdown in the pronephros of Xenopus laevis 
ADAMTS9 expression was found in the pronephros and the pronephric 
duct from early tailbud stages (figure 4-8 and 4-10), which overlap with the 
expression of its substrate VCAN (figure 4-13) (Casini et al., 2008) suggesting a 
role of ADAMTS9 in the ECM remodeling during pronephros development in 
Xenopus. Morpholinos were used to knockdown both ADAMTS9 copies (L and 
S) in Xenopus laevis.  
Using wt1 as an early marker for glomus development by in situ 
hybridisation, no disruption of development was observed when ADAMTS9 was 
knocked down (figure 4-16) whereas a phenotype was observed using pax8, as 
a marker of pronephric tubules and duct in the early tailbud (figure 4-17) and 
atp1b1 in late tailbud (figure 4-18), Xlim1 and pax2 as markers for nephrostomes, 
tubules and duct in late tailbud (figure 4-18) and 4a6 antibody, as a late marker of 
intermediate and distal tubules and pronephric duct (figure 4-19). At tailbud 
stages a default of nephrostomes, tubules and duct formation on the injected 
side of embryos where ADAMTS9 was knocked-down was observed 
suggesting a delay of development (figure 4-17 and 4-18). At tadpole stages 
severe phenotypes characterised by the partial or complete loss of 4a6 signal 
were observed in the distal tubules and in the pronephric duct suggesting that 
these structure might be present although not in a final differentiated state 
allowing the detection by the 4a6 antibody (figure 4-19). This supports the 
hypothesis of a delay of development when ADAMTS9 was knocked down 
(figure 4-17 and 4-18). Injection of standard control morpholino should be 
carried out on order to assess the specificity of the delay phenotype observed 
at tailbud stages. The 4a6 immuno staining could be carried out on later stages 
of development (stage 42) in order to verify this hypothesis and check if the 4a6 
signal would be present in injected embryos. These results suggest an 
important role of ADAMTS9 in pronephros development, specifically in the 
formation of the pronephric tubules and duct possibly by the degradation of 
versican, which is necessary for the correct ECM remodeling during pronephros 
development.  
VCAN is expressed in the pronephros and in the pronephric duct from 
tailbud stages but is not expressed in tadpoles (figure 4-22) (Casini et al., 2008) 
	   111 
suggesting a transient role in the pronephros development, supporting the 
hypothesis that degradation by the hyalectanases family of ADAMTSs is crucial. 
 
	  
Figure 4-22:	  The expression pattern of VCAN in Xenopus laevis embryos. Lateral 
views of embryos with anterior on the left and posterior on the right. (A) At stage 33, 
the expression is present in the pronephros (pn) and in the pronephric duct (pd). (B) At 
stage 38 the expression is not present in the pronephros (indicated by the black arrow). 
 
 The same profile of expression of VCAN has been shown in mice kidney 
development but the amount of cleaved versican, at the specific ADAMTSs 
cleavage site, was not affected by the knockout of ADAMTS1 and ADAMTS4 
(Boerboom et al., 2011), suggesting the role of other members of the 
hyalectanases family, which could possibly be ADAMTS9. To verify this 
hypothesis future experiments should investigate the expression profile of 
VCAN in injected embryos to check if the expression would be found in the 
pronephros at tadpole stages suggesting a delay of development due to 
ADAMTS9 knockdown and the amount of cleaved versican in Xenopus laevis 
pronephros. However the ADAMTSs cleavage site is not conserved in the 
Xenopus VCAN so the antibody specific to the new epitope generated after 
cleavage at this site cannot be used.  
Aggrecan is another ADAMTS9 substrate and has been shown to be 
weakly expressed in the kidney during development in mouse (Boerboom et al., 
2011) whereas it was not expressed in the Xenopus pronephros (Suzuki et al., 
2012).  
ADAMTS1 and ADAMTS4 knockout mice died soon after birth and 
showed a kidney phenotype characterised by a marked renal medulla thinning 
(Boerboom et al., 2011) suggesting a role of these two ADAMTSs independent 
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of their proteases activity on versican. ADAMTS1 is expressed in the kidney in 
mouse and knockout mice for ADAMTS1 show a dysgenic malformation 
affecting the renal medulla from birth associated with the beginning of its 
function (Mittaz et al., 2004) (Mittaz et al., 2005). ADAMTS1 has a similar 
expression profile to ADAMTS9 in Xenopus laevis in the pronephros (Suga et 
al., 2006).  
In addition, ADAMTS13 has been shown to be expressed in human 
podocytes, specialised epithelial cells that line the urinary side of the glomerular 
basement membrane (GBM) in the Bowman's capsule (glomus in Xenopus) 
with a complex cellular morphology that are responsible for the size exclusion 
barrier and for preventing large molecules from exiting the blood stream in 
addition to the synthesis of the GBM. ADAMTS13 function, as well as von 
Willebrand factor cleavage could be responsible for the GBM remodeling. 
ADAMTS13 mutation is associated with congenital thrombotic 
thrombocytopenic purpura characterised by the presence of ultra-large von 
Willebrand factor (ULVWF) multimers in the blood circulation due to deficiency 
of ADAMTS13 responsible of their cleavage. In TTP patients ADAMTS13 was 
expressed in podocytes but was not secreted suggesting reduced extracellular 
ADAMTS13 activity leading to the accumulation of ULVWF multimers and 
causing the formation of platelet plugs in the glomeruli (Manea et al., 2007). 
These data, supported by the findings of the present study, suggest that 
the ADAMTS family plays a crucial role in pronephros development possibly by 
a different mode of action at specific pronephric localisation and time of 
development. Injection of multiple morpholinos targeting several ADAMTSs in 
Xenopus laevis could be carried out in order to assess cooperation in 
pronephros development. . In order to characterise in more detail the function of 
ADAMTS9 in Xenopus laevis pronephros development, other markers should 
be used such as transcription factors pronephric terminal differentiation markers 
such as 3g8 antibody (Agrawal et al., 2009) (Buisson et al., 2015).	  
Surprisingly no compensation by an ADAMTS9 copy when the other 
copy was knocked down by the ADAMTS9 morpholino occurred, which was 
characterised by the lack of rescue of the phenotype observed in the tubules 
and pronephric duct (figure 4-13). These results suggest that both copies must 
be expressed, which support gene dosage hypothesis resulting in the 
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conservation of both copies of a gene in the two Xenopus laevis subgenomes 
(see chapter III) (Watanabe et al., 2016). An RT-PCR for ADAMTS9L of injected 
Xenopus laevis embryos with ADAMTS9S morpholino would show if the level of 
ADAMTS9L mRNA increases or not when the other copy, ADAMTS9S is 
knocked down, and the same experiment would be carried out for ADAMTS9S 
expression in embryos when injected with ADAMTS9L morpholino. 
4.3.2.4 Morpholinos efficiency 
 In order to test the efficiency of the morpholinos used in this study 
against ADAMTS9 in Xenopus laevis ADAMTS9S and ADAMTS9L 5’-UTR 
containing the binding site of the morpholino, the signal peptide and the pro 
domain with an HA tag at the C-terminal position to detect the presence of the 
protein by western blot were successfully cloned. The truncated ADAMTS9S 
protein with an HA tag at the C-terminal position in Xenopus laevis embryos 
was expressed and visualised by western blot using an anti-HA antibody (figure 
4-20). This construct will allow to test the efficiency of the ADAMTS9S 
morpholino by injecting it and ADAMTS9S-HA mRNA into Xenopus laevis 
embryos and visualise by western blot a decrease of the ADAMTS9S-HA signal 
when co-injected with the translational blocking ADAMTS9S morpholino 
compared to the ADAMTS9-HA signal when co-injected with control morpholino 
that is not specific to ADAMTS9S. However ADAMTS9L-HA signal was not 
seen by western blot suggesting that the protein did not get translated, although 
the sequencing of the construct showed no mutations, or was degraded. 
Increasing the number of protein domains to create a longer truncated protein 
could possibly lead to ADAMTS9S-HA translation. 
To confirm the specificity of the ADAMTS9 morpholinos phenotype in 
Xenopus laevis a rescue experiment could be carried out by injecting 
ADAMTS9 mRNA with a mutation at the binding site of the morpholino, to avoid 
its translational blocking action. The compensation of the ADAMTS9 protein 
should rescue the observed phenotypes, in the kidney for this study. As 
ADAMTS9 is a large gene it has proven to be difficult to avoid cloning 
mutations, resulting in a non-functional protein. The Suneel Apte team cloned 
the human ADAMTS9 and a non-functional ADAMTS9 with a C-terminal myc-
HIS6 tag (Somerville et al., 2003). The presence of this tag will enable 
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visualising by western blot of the human ADAMTS9 protein if it is translated in 
Xenopus laevis. Using pronephric markers from this study the ability of the 
human ADAMTS9 to rescue the phenotype caused by Xenopus ADAMTS9 
knockdown by morpholinos will be assessed. ADAMTS9S and ADAMTS9L 
morpholinos used in this study will not bind to the human ADAMTS9 sequence. 
In order to performe loss of function experiments, another technique 
called CRISPR/Cas9 has been developed and used in Xenopus (Guo et al., 
2014). Guide RNA have been designed to target ADAMTS9 in Xenopus 
tropicalis and Xenopus laevis but none of them showed the efficiency of binding 
to the target gene in order to allow the cleavage of the DNA sequence by the 
Cas9 in the embryos. 
 In this chapter the investigation on the ADAMTS family in Xenopus 
development was carried out up to tadpole stages. This project will progress to 
investigate the ADAMTS family in later stage of development in Xenopus laevis, 
specifically during metamorphosis, in collaboration with the Pr. Barbara 
Demeneix laboratory at the Museum d’Histoire Naturelle in Paris.  
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5 Chapter V: Characterisation of the ADAMTS family, 
metalloproteinases and extracellular components in 
Xenopus laevis during metamorphosis and heart 
regeneration 
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5.1 Introduction 
As part of the European Marie Curie Initial Training Network called DevCom, 
for Developmental and Computational Biology, there was an opportunity to do a 
secondment in a partner laboratory of this network. This secondment was 
realised in collaboration with the Prof. Barbara Demeneix laboratory at the 
Museum d’Histoire Naturelle in Paris under the supervision of Dr. Laurent Coen 
and Dr. Fabrice Girardot. They look at the regulation of Xenopus laevis 
metamorphosis by thyroid hormone, the capacity of Xenopus laevis tadpole to 
regenerate their heart and the loss of this capacity past metamorphosis. At that 
time they were not looking at the extracellular matrix (ECM) or at 
metalloproteinases in these different processes. Both labs agreed that this 
would be an area in which to collaborate. 
It has been shown that the extracellular matrix and matrix 
metalloproteinases are important for organ remodeling during Xenopus laevis 
metamorphosis. The regulation of cell-ECM interactions is important to control 
apoptosis of embryonic cells and proliferation of adult cells (Fu et al., 2007) 
(Hasebe et al., 2007b). However the role of other metalloproteinases, such as 
ADAMTSs and ADAMs, has not been investigated as well as other matrix 
components such as versican and aggrecan. Little was known about heart 
regeneration in Xenopus but studies on limb, retina and nerve tissue 
regeneration have shown that they have the ability to regenerate at tadpole 
stages but not past metamorphosis (Vivien et al., 2016). It would therefore be 
interesting to know if it is true for heart regeneration as well and analyse the 
difference in gene expression that leads to this loss of cardiac regeneration 
after metamorphosis.  
ECM components, metalloproteinases, tissue inhibitor of metalloproteinases 
genes expression were investigated in the brain, the skin and the heart 
undergoing remodeling during Xenopus laevis metamorphosis and in the heart 
after ventricular resection to determine regeneration during Xenopus laevis 
metamorphosis. Expression profiles were analysed using quantitative PCR and 
by microfluidic so that a large number of genes with a small amount of tissue 
could be analysed. 
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5.1.1 Brain remodeling during Xenopus laevis metamorphosis 
Before metamorphosis the central nervous system in Xenopus is 
composed of the spinal cord and the brain. The brain can be divided into three 
sections from the spinal cord that is caudal to rostral position: the 
rhombencephalon (hindbrain) comprising the medulla oblongata and the 
cerebellum, the mesencephalon (midbrain) comprising the optic tectum and the 
tegmentum and the prosencephalon (forebrain) comprising the diencephalon 
where the hypothalamus is located, the telencephalon and the olfactory bulb. 
The brainstem that provides the main motor and sensory innervation is 
composed of the mesencephalon and the rhombencephalon. Similar to all non-
mammalian vertebrates, Xenopus does not possess corticospinal tracts, which 
connect the prosencephalon with the spinal cord which control voluntary motor 
control of the limbs and the trunk. All motor control is integrated in the 
brainstem. The sensory and motor tracts between the brainstem and the spinal 
cord are called supraspinal nerve tracts and are conserved in vertebrates. In 
Xenopus neurogenesis of these neurons is mostly complete at pro-
metamorphosis stage (Lee-Liu et al., 2016) (Pratt and Khakhalin, 2013).  
The composition of the ECM changes during brain development. 
Embryonic ECM is mostly composed of proteoglycans such as neurocan and 
versican V1 and glycoproteins such as tenascin-C whereas the ECM in the 
adult brain is mostly composed of tenascin-R and chondroitin sulfate 
proteoglycans (CSPG) such as brevican, versican V2 and aggrecan. 
Hyaluronan (HA) is the backbone of the ECM in the brain by binding to 
proteoglycans that are linked to glycoproteins such as tenascins; this ECM is 
called HA-based CM. The ECM functions in the brain during embryonic 
development are to regulate the formation of glia and neurons, cell migration, 
directing of axon growth and their myelination and formation of synapses. The 
functions of the adult ECM are regulation of synapses formation and their 
plasticity, protection of the neurons and their interactions with glia cells and 
homeostasis regulation. ECM interacts with cells via cell surface receptors such 
as integrins. The changes from an immature brain ECM to a more rigid adult 
brain ECM mediate the transition from a juvenile to an adult plasticity by 
restricting the neuronal organisation (Happel and Frischknecht, 2016).  
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The adult brain is composed of three ECM, which differ in their 
composition and functions. The basement membrane or basal lamina (BL) 
surrounds blood vessels and pial surface (most inner layer of the meninges that 
are the membranes that envelops the brain and the spinal cord) and is mostly 
composed of collagen, fibronectin, laminin and proteoglycan such as perlecan. 
It maintains the blood–brain barrier (BBB) between blood vessels and the brain 
parenchyma (composed of neurons, glia cells and interstitial ECM) and 
regulates the maturation of endothelial cells. The perineuronal nets (PNNs) are 
mostly composed of proteoglycans such as aggrecan, HA and tenascin-R. It 
enwraps synapses, which protect and maintain their plasticity. The neural 
interstitial matrix is the ECM in the parenchyma and is mostly composed of 
proteoglycans, HA and tenascins with a minority of collagen, fibronectin and 
laminin that forms a dense three-dimensional network (Vecino and Kwok, 
2016). In addition to these main components the brain ECM is composed of 
reelin, thrombospondins and guidances molecules. ECM components regulate 
the axon growth. Laminin and fibronectin promote the axon growth whereas 
chondroitin sulphate proteoglycans (CSPGs) create barriers where axons 
cannot grow creating paths for the axons to grow at the correct location to the 
precise target. CSPGs inhibit axonal regeneration and neurogenesis after brain 
injury such as spinal cord injury or Alzheimer’s disease and mutations in 
CSPGs can cause neuropsychiatric disorders such as bipolar disorder and 
schizophrenia (Barros et al., 2011) (Avram et al., 2014). ECM remodeling by 
metalloproteinases is crucial for brain development and the dysregulation of this 
process can cause neuropsychiatric diseases (Gottschall and Howell, 2015).  
5.1.2 Skin remodeling during Xenopus laevis metamorphosis 
At pro-metamorphosis the embryonic epidermis is composed of three cell 
layers; apical, skein and basal cells, which is separated from the dermis (a 
single layer of fibroblasts and melanophores) by a thin acellular collagen 
lamella composed of type I collagen secreted by basal embryonic cells. All the 
layers of epidermal cells proliferate. At climax, when the concentration of thyroid 
hormone increases, only the basal epidermal cells differentiate into adult stem 
cells and proliferate to give rise to adult skin whereas the two other layers, skein 
and apical cells, undergo apoptosis in a cell-autonomousl manner (Schreiber 
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and Brown, 2003). The dermis and the collagen lamella are thicker and 
presumptive secretory glands (PSGs) form. Fibroblasts migrate from the 
connective tissue into the collagen lamella (Suzuki et al., 2009). The adult skin 
is formed post-metamorphosis with a multi layer epidermis where only the basal 
cells replicate, similar to the ‘germinative’ adult epithelium in all vertebrates. 
Mature glands are present in the dermis, composed of the collagen lamella and 
connective tissue (Schreiber and Brown, 2003). In tail remodeling, embryonic 
basal cells of the epidermis do not give rise to adult cells and only apoptosis 
occurs which leads to the tail resorption (Schreiber and Brown, 2003).  
Proteoglycans are important components of the ECM in the skin; they provide 
hydration, viscoelasticity, scaffold for a good ECM structure by interacting with 
other components such as collagen and fibrillin, growth factors to regulate cell 
signaling, ECM components, migration and proliferation (Smith and Melrose, 
2015).  
5.1.3 Heart remodeling during Xenopus laevis metamorphosis 
Xenopus cardiogenesis starts at gastrulation (stage 10) when cardiac 
progenitors cells, from precardiac mesoderm migrate anteriorly to the ventral 
midline where they fuse posteriorly to the cement gland in a crescent-like 
structure by stage 13. The precardiac mesoderm is located on either side of the 
Spemann’s organiser on the dorsal side of the embryo. The resultant cell 
population of cardiac progenitors splits into two different cell lineages called the 
first heart field (FHF) and the second heart field (SHF). The SHF forms the 
outflow tract (OFT) and the FHF forms the single ventricle and the two atria. 
These two differentiating patches of cells fuse into a single cardiogenic plate, 
which then rolls to create a lumen and gives rise to the primary heart tube at 
stage 32. Morphogenetic movements lead the heart tube to loop and it contains 
differentiated cardiomyocytes which are able to contract at stage 35. Then 
remodeling defines the different chambers and the ventricular myocardium 
undergoes trabeculation, the creation of a supporting tissue in the form of small 
beams, giving rise to a functional embryonic heart by stage 40 (Hempel and 
Kühl, 2016). 
 ECM remodeling is an important process for heart development. During 
heart formation, a mature ECM composed of hyaluronan, proteoglycans, 
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collagens, elastin, fibrilin, tenascin, fibronectins, and laminins replaces the 
initially immature versican-rich ECM. Degradation of the ECM by 
metalloproteinases during cardiac development is an essential process 
(Lockhart et al., 2011).  
5.1.4 Heart regeneration during Xenopus laevis metamorphosis 
The adult Xenopus laevis heart does not regenerate after ventricle 
resection but shows a deposition of fibrotic tissue and hypertrophy of the 
amputated ventricle, this is characteristic of a non regenerated heart seen in 
adult mammals (Marshall et al., 2017). Xenopus laevis tadpoles at pro 
metamorphosis stage can regenerate their hearts after amputation (unpublished 
data, Coen L.). However the reasons of the loss of the cardiac regenerative 
capacity past metamorphosis in Xenopus laevis are unknown. Studies on heart 
regeneration in the newt, another amphibian, shows that ECM remodeling is a 
key process. (Mercer et al., 2013) proposed a model where after an amputation 
of the distal ventricular tip (around 20%) a regeneration-specific matrix 
containing tenascin-C, HA and fibronectin regulates the proliferation of 
progenitor cells in the myocardium that migrate with the help and support of the 
regenerative ECM. This regenerative ECM is rich in HA, creating a highly 
hydrated matrix, which promotes cell migration toward the wound site, where 
they dedifferentiate to regenerate the amputated part. In addition, this 
regeneration-specific ECM is a reservoir of signaling factors that can be 
released by metalloproteinases regulating cell behaviour of progenitor cells 
such as migration, proliferation and differentiation state. Cells participating in 
the regeneration of the missing heart tissue can be dedifferentiated 
cardiomyocytes or activated stem cells. This ECM remodeling model seems to 
be conserved between vertebrates capable of heart regeneration (Mercer et al., 
2013). In axolotl, both cardiomyocytes and epicardial cells proliferate after 
amputation, which suggests that several cell types are involved in this process 
(Vivien et al., 2016). 
ECM components, metalloproteinases, tissue inhibitor of metalloproteinases 
genes expression and regulation were assessed in the brain, the skin and the 
heart undergoing remodeling during Xenopus laevis metamorphosis and in the 
heart after ventricular resection. Their expression profiles were measured 
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quantitative PCR and by microfluidic to be able to look at a large number of 
genes with a small amount of tissue. 
5.2 Results 
5.2.1 ADAMTSs, versican, aggrecan and TIMPs expression in the skin 
and the brain during Xenopus laevis metamorphosis 
 To look at gene expression during metamorphosis, body skin (head and 
trunk) and brain samples were dissected from stage 57 and 61 Xenopus laevis 
tadpoles and from stage 66 juvenile frog (froglet) (figure 5-1A). cDNAs 
synthesised from the RNA of these samples were used to carry out RT-qPCR 
(figure 5-1B and C) for the ADAMTS gene family, versican (VCAN), aggrecan 
(ACAN) and the TIMP family (TIMP1, TIMP2 and TIMP3). TIMP4 is not present 
in the X.laevis and X.tropicalis genome. Primers for VCAN recognise the N-
terminal G1 domain common to all five isoforms.  
Ct data from RT-qPCR were collected using ExpressionSuite Software 
(Applied Biosystems) and analysed using Excel (Microsoft). ΔCt were first 
obtained using Ct values of each gene of interest normalised against pten, the 
housekeeping gene (gene Ct - pten Ct). Then ΔCt values were converted to 
relative gene expression using the 2-ΔCt method. This method was used rather 
than the fold change method in order to look at gene expression level in each 
stage rather than gene regulation compared to one condition. The results 
showed that in general the level of gene expression of the ADAMTS gene 
family and the TIMP family was higher in the body skin than in the brain 
whereas the gene expression level for VCAN was similar (figure 5-1B and C). 
ADAMTS6 was the most expressed gene of the ADAMTS family in the brain 
with an up-regulation at and after metamorphosis compared to before 
metamorphosis. The hyalectanases family members were expressed in the 
brain with ADAMTS5, ADAMTS8 and ADAMTS4 being the most expressed, 
ADAMTS1, ADAMTS9 and ADAMTS15 less expressed whereas ADAMTS20 
was not expressed at all. With the exception of ADAMTS8 and ADAMTS15 that 
were downregulated at the metamorphic climax, all members of the 
hyalectanases family were up regulated at and after metamorphosis compared 
to before. ADAMTS2 and ADAMTS17 were also detected and showed the 
same expression profile (figure 5-1B’). ACAN and VCAN showed opposite 
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profiles of expression, ACAN was upregulated at and after metamorphosis 
compared to before, whereas ACAN was downregulated although their 
expression levels were similar at and after metamorphosis (figure 5-1B’’). Of the 
TIMPs, TIMP2 was the most expressed with no difference of expression in 
function of the metamorphosis periods. TIMP3 was upregulated at and after 
metamorphosis compared to before, whereas TIMP1 was expressed at a low 
level for all metamorphosis periods (figure 1B’’’). All ADAMTSs (except the 
lesser expressed ADAMTS12, ADAMTS17 and ADAMTS19) were upregulated 
in the skin at metamorphosis and even more so after, compared to before. 
Members of the hyalectanases family were all expressed with ADAMTS8, 
ADAMTS15 and ADAMTS1 being the most expressed and ADAMTS9 and 
ADAMTS20 the least expressed. ADAMTS2 was highly expressed as well as 
ADAMTS6 (figure 5-1C’). ACAN was not detected but VCAN was expressed at 
similar levels in the skin during metamorphosis (figure 5-1C’’). TIMP1 was the 
most expressed member of the TIMP family in the skin and had a peak of 
expression at the metamorphic climax. TIMP1 was more expressed after 
metamorphosis than before. TIMP2 showed the same profile of expression and 
TIMP3 was up regulated in the skin at and after metamorphosis compared to 
before (figure 5-1C’’’). 
 
  
	   123 
 
 
 
 
Figure 5-1: Gene expression of the ADAMTS family, versican (VCAN), aggrecan 
(ACAN) and TIMP1, TIMP2 and TIMP3 evaluated by RT-qPCR on brain and skin 
tissues from Xenopus laevis tadpole and juvenile during metamorphosis. (A) 
Xenopus stages used in this study to dissect out the body skin and the brain. Graphs 
show gene expression fold differences before (St.57), at (St.61) and after (St.66) 
metamorphosis. The results show the mean with standard error of the mean (SEM) for 
one (results without error bars) or two independent (results show with error bars) 
experiments. (B) Gene expression in the brain during metamorphosis of (B’) the 
ADAMTS family, (B’’) ACAN and VCAN, (B’’’) TIMP1, TIMP2 and TIMP3. (C) Gene 
expression in the skin during metamorphosis of (C’) the ADAMTS family, (C’’) VCAN, 
(C’’’) TIMP1, TIMP2 and TIMP3. The developmental stages representations are from 
(Nieuwkoop and Faber, 1994). 
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5.2.2 Gene expression in the heart undergoing remodeling and in the 
heart after ventricular resection during Xenopus laevis metamorphosis 
 In order to look at the expression of a large number of genes in the small 
amount of tissue that is the Xenopus laevis heart, the microfluidic technique 
was used, which allows for fast and efficient quantitative PCR reactions in 
nanoliter volumes. Ten hearts from Xenopus laevis tadpoles at pro-
metamorphosis (stage 57), at metamorphic climax (stage 61) and post-
metamorphosis stages from juvenile and adult frogs were collected at 1, 3 and 
7 days post amputation (dpa) for each experimental condition (control, SHAM 
and amputated) (figure 5-2). The genes selected for this study included ECM 
components, metalloproteinases, tissue inhibitor of metalloproteinases genes 
expression gene expression in the heart during metamorphosis (table 5-1). The 
control hearts were used to look at normal heart remodeling during 
metamorphosis. SHAM were used as placebo control where just the pericardial 
sac was opened but the heart was not amputated. The amputated hearts were 
cut using a ventricular resection procedure removing around 4% of the ventricle 
(Marshall et al., 2017).  
 
Figure 5-2: Schematic of the different experimental conditions used to look at 
gene expression in the heart during Xenopus laevis metamorphosis. The control 
hearts were used to look at normal heart remodeling during metamorphosis. SHAM 
hearts were used as placebo control where just the pericardial sac was opened but the 
heart was not amputated. The amputated hearts were cut using a ventricular resection 
procedure (removing around 4% of the ventricle). Samples were collected at 1, 3 and 7 
days post amputation (dpa). Ten hearts were used for each experimental procedure 
(n=10).  
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Table 5-1: List of genes analysed in heart development and regeneration during 
Xenopus laevis metamorphosis.  The different gene categories are indicated in the 
first two rows and the specific gene name is indicated below. For ADAMTS, ADAM, 
MMP, TIMP and syndecan only the gene number is indicated in the column meaning 
ADAMTS1, ADAM7, MMP2, TIMP1 and syndecan1 are for all different genes. tPA: 
tissue plasminogen activator; PAI1: plasminogen activator inhibitor-1; uPAR: urokinase 
plasminogen activator receptor. 
metalloproteinases    
ADAMTS ADAM MMP TIMP ECM plasminogen syndecan 
1 9 2 1 VCAN tPA 1 
2 10 9 2 ACAN PAI1 2 
3 11 7 3 
tenascin-
C 
uPAR 3 
4 12 1  
fibronectin 
1 
 4 
5 15 14  
collagen 
1a1 
  
6 17      
7 19      
8 22      
9 23      
10 28      
12 33      
13       
14       
15       
16       
17       
18       
19       
20       	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5.2.2.1 Gene expression in the heart undergoing remodeling during 
Xenopus laevis metamorphosis 
 The quantitative PCR was carried out using primers listed in table 1 and 
primers for fibronectin 1 (fn1) and collagen, type I, alpha 1 (col1a1) from Dr. 
Laurent Coen with the microfluidic method. The results were grouped into four 
groups, according to (Nieuwkoop and Faber, 1994) (NF) Xenopus laevis stages, 
NF57 (pro-metamorphosis), NF61 (metamorphic climax), juvenile and adult 
(post-metamorphosis). The first analysis was carried out using the Real-Time 
PCR Analysis v4.1.3 software (Fluidigm) to look at the quality of the results and 
discard any data without any or non-specific gene amplification (Ct values). In 
order to normalise the data five housekeeping genes (baf60, hand2, pten, akt1 
and smn2), previously established by Dr. Laurent Coen’s team to be stable in 
the experimental conditions, were used in this study to obtain the delta Ct (ΔCt) 
values. In the controls hearts the data from the three different time points (1, 3 
and 7 days post the amputation, figure 5-2) for each stage of development were 
combined to carry out the analysis of gene expression during Xenopus laevis 
metamorphosis (n=30). The ΔCt values were used to create a heat-map 
showing the level of expression at the different stages of development (figure 5-
3). The analysis of the heat-map showed three distinct groups of genes in 
function of their level of expression in the heart during metamorphosis. One 
group showed a high level of expression (indicated in blue on the heat-map) 
such as syndecan2, VCAN, ADAMTS1, ADAM9, MMP14 and TIMP3 (figure 5-
3). Genes such as ADAMTS8, ADAM17, MMP9, tPa and TIMP1 showed a 
moderate level of expression whereas genes such as ADAM22, ADAMTS16, 
ACAN and MMP1 were lowly expressed (figure 5-3). 
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Figure 5-3: Heat-map of gene expression in the heart during Xenopus laevis 
metamorphosis. Xenopus stages are indicated at the top according to (Nieuwkoop 
and Faber, 1994) (NF) and gene names are indicated on the left of the heat-map. The 
level of gene expression is indicated in blue for a high level, in grey for a moderate 
level and in red for a low level of expression. fn1: fibronectin 1; col1a1: collagen, type I, 
alpha 1. 
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To look at the variation of gene expression between the four different 
Xenopus laevis stages, NF57 was established as the group control and the 
other three stages were normalised with it to obtain the delta delta Ct (ΔΔCt) 
values and then the fold change (FC) values were obtained using the formula 
2^-ΔΔCt. Graph Pad Prism 6 software was used to create graphs and look at 
statistical differences. The ROUT method was used to identify outliers that were 
far enough from the mean of the data set to be called outliers based on the ΔCt 
values. Statistics were carried out on ΔCT values using the D’Agostino-
Pearson omnibus normality test (alpha=0.05) to assess if the data had a normal 
distribution (data were distributed in a ‘bell shape’, clustered around the mean) 
or not (data points were distributed far and/or unequally from the mean). This 
test was necessary to know which statistical test to use. The samples (four 
different stages) were all compared to each other so if the data passed the 
normality test the parametric Ordinary one-way ANOVA test (P value < 0.05) 
was applied and if they did not the non-parametric Kruskall Wallis test (P value 
< 0.05) was applied. In order to create graphs to look at the variation of 
expression the log2FC was used for the y axis in function of the stages of 
development on the x axis. The analysis revealed different gene expression 
profiles in the heart in function of the stages of development during 
metamorphosis (figure 5-4, appendix 3). Some genes showed an upregulation 
of expression such as col1a1 (figure 5-4A and A’), or a downregulation of 
expression such as MMP14 (figure 5-4B and B’) during metamorphosis from 
stage 57 to the adult stage. Some genes showed specific regulation at the 
metamorphic climax (stage 61), some were upregulated such as ADAMTS5 
(figure 5-4C and C’) and some were downregulated such as ADAMTS20 (figure 
5-4D and D’). Some expression profiles did not show a difference of expression 
in the heart during metamorphosis such as TIMP3 (figure 5-4E and E’). 
The analysis of the results from the quantitative PCR, realised using the 
microfluidic method, on Xenopus laevis heart sample at stage 57 (pro-
metamorphosis), stage 61 (metamorphic climax), juvenile and adult (post-
metamorphosis) showed different level and regulation of ECM components, 
metalloproteinases and TIMPs gene expression (table 5-2).  
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Figure 5-4: Different profile of gene expression in the heart during Xenopus 
laevis metamorphosis. Control hearts from stage 57 (NF57), stage 61 (NF61), 
juvenile and adult Xenopus laevis, corresponding at pro-metamorphosis, metamorphic 
climax and post-metamorphosis period, were used to look at gene expression. (A) 
Some genes were upregulated during metamorphosis such as col1a1 (A’) whereas (B) 
some genes were downregulated during metamorphosis such as MMP14 (B’). (C) 
Some genes were upregulated at metamorphic climax such as ADAMTS5 (C’) whereas 
(D) some genes were downregulated at metamorphic climax such as ADAMTS20 (D’). 
(E) Some genes did not show a change in their expression in the heart during 
metamorphosis such as TIMP3 (E’). Stages were according to (Nieuwkoop and Faber, 
1994) (NF). The height of the box shows the interquartile range (IQR), the line in the 
box shows the median and the whiskers show the minimum and the maximum values. 
Stars on the graphs show statistical differences with *, p < 0.05, **, p < 0.01, ***, p < 
0.001, ****, p < 0.0001. 	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Table 5-2: Summary table of the different gene expression profiles in the heart 
during Xenopus laevis metamorphosis. Some genes were highly expressed (written 
in blue), some had a moderate expression level (written in grey) and some were lowly 
expressed (written in red) in the Xenopus laevis heart undergoing metamorphosis. 
During metamorphosis from stage 57 to the adult frog some gene expression showed 
no change such as TIMP3 (first column), some genes were upregulated such as 
col1a1 (second column) or downregulated such as ADAMTS1 (third column). Some 
genes were specifically upregulated such as VCAN (fourth column) or downregulated 
such as syndecan2 (fifth column) at the metamorphic climax.  
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5.2.2.2 Gene expression in the heart after ventricular resection during 
Xenopus laevis metamorphosis 
 As described in section 5.2.2.1 for the control hearts gene expression 
analysis the quality of the results was analysed using the Real-Time PCR 
Analysis v4.1.3 software (Fluidigm) and any data without any or non-specific 
gene amplification (Ct values) were discarded. Data were normalised using the 
same five housekeeping genes that were baf60, hand2, pten, akt1 and smn2 to 
obtain the delta Ct (ΔCt) values. The results were grouped into four groups, 
according to (Nieuwkoop and Faber, 1994) (NF) Xenopus laevis stages, NF57 
(pro-metamorphosis), NF61 (metamorphic climax), juvenile and adult (post-
metamorphosis). Ten hearts were collected at 1, 3 and 7 days post the 
amputation procedure for all the experimental conditions (figure 5-2). SHAM 
samples were used as the placebo control for the ventricular resection surgery. 
Embryos were treated the same way for both procedures but for the SHAM 
embryos, the pericardial sac was opened but the ventricle was not amputated 
(figure 5-2). In order to look at the variation of gene expression between the 
four different developmental stages and the three different time points for each 
one, the data from the amputated hearts (ΔCt values) were normalised using 
the data from the SHAM hearts (ΔCt values) in order to obtain the delta delta Ct 
(ΔΔCt) values and then subsequently the fold change (FC) values were 
obtained using the formula 2^-ΔΔCt. Graph Pad Prism 6 software was used to 
create the graphs and look at statistical differences. The ROUT method was 
used to identify outliers that were far enough from the mean of the data set to 
be called outliers based on the ddCt values. Statistics were carried out on ΔΔ
Ct values using the D’Agostino-Pearson omnibus normality test (alpha=0.05) 
to assess if the data had a normal distribution (data were distributed in a ‘bell 
shape’, clustered around the mean) or not (data points were distributed far 
and/or unequally from the mean). This test was necessary to know which 
statistical test to use. Each amputated sample for each stage and each time 
point was compared to the corresponding SHAM sample. If the data passed the 
normality test, the parametric unpaired Welch's t-test (P value < 0.05) was 
applied (this test compared two independent groups, SHAM and amputated, 
that could be of unequal variance and sample size but with a normal 
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distribution). If they did not pass the normality test, the non-parametric Mann–
Whitney U test (P value < 0.05) was applied. In order to create graphs to look at 
the variation of expression, the log2FC was used for the y axis in function of the 
stages of development and the experimental conditions on the x axis. The 
analyses revealed different interesting gene expression profiles in the heart in 
function of the stages of development during metamorphosis and in function of 
the day post amputation (figure 5-5, appendix 4). Some genes were 
upregulated in all stages after amputation during metamorphosis such as PAI1 
at 1, 3 and 7 dpa (figure 5-5A). Some genes were only upregulated after 
amputation at stages NF57 and NF61 such as ADAMTS14 at 1 and 3 dpa 
(figure 5-5B). Some genes were upregulated after amputation at metamorphic 
climax such as col1a1 at 1,3 and 7 dpa (figure 5-5C) and some genes were 
downregulated after amputation such as ADAMTS5 in stage 57, stage 61 and 
juvenile at 1dpa (figure 5-5D).  
The analysis of the results from the quantitative PCR, investigated using 
the microfluidic method, on Xenopus laevis SHAM and amputated heart 
samples of stage 57 (pro-metamorphosis), stage 61 (metamorphic climax), 
juvenile and adult (post-metamorphosis) frogs at 1, 3 or 7 day post amputation 
showed a different regulation of ECM components, metalloproteinases and 
TIMPs expression (table 5-3).  
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Figure 5-5: Different gene expression profiles in the heart after ventricular 
resection during Xenopus laevis metamorphosis. SHAM and amputated hearts 
from stage 57 (NF57), stage 61 (NF61), juvenile (JUV) and adult Xenopus laevis, 
representative of the pro-metamorphosis, metamorphic climax and post-
metamorphosis periods respectively, were used to look at gene expression at 1, 3 and 
7 days post amputation (dpa). SHAM hearts were used as placebo controls for the 
surgery and were used for the gene regulation analysis to normalise the data from the 
amputated hearts. (A) Some genes were upregulated in all stages after amputation 
during metamorphosis such as PAI1. (B) Some genes were only upregulated after 
amputation at stages NF57 and NF61 such as ADAMTS14. (C) Some genes were 
upregulated after amputation at metamorphic climax such as col1a1 and (D) some 
genes were downregulated after amputation such as ADAMTS5. Stages were 
determined according to (Nieuwkoop and Faber, 1994) (NF). The height of the box 
shows the interquartile range (IQR), the line in the box shows the median and the 
whiskers show the minimum and the maximum values. Stars on the graphs show 
statistical differences with *, p < 0.05, **, p < 0.01, ***, p < 0.001, ****, p < 0.0001. 	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Table 5-3: Summary table of the different gene expression profiles in the heart 
after ventricular resection during Xenopus laevis metamorphosis. During 
metamorphosis from stage 57 to adult frog some genes were upregulated in all stages 
such as tPa (first column) whereas some genes were only upregulated in stage NF57 
and NF61 such as MMP14 (second column). Some genes were mostly upregulated in 
stage NF61 such as col1a1 and some genes were downregulated such as ADAMTS5 
(fourth column). Some genes were highly expressed (written in blue), some had a 
moderate expression level (written in grey) and some were lowly expressed (written in 
red) in the Xenopus laevis control hearts undergoing metamorphosis. 
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5.3 Discussion 
5.3.1 ADAMTSs, versican, aggrecan and TIMPs expression in the skin 
and the brain during Xenopus laevis metamorphosis 
5.3.1.1 Brain remodeling during Xenopus laevis metamorphosis 
In the Xenopus laevis brain from stage 57 to the adult stage, ACAN and 
VCAN were expressed and the hyalectanases family members were the most 
expressed ADAMTSs (figure 5-1 B’ and B’’). It is known that 
lecticans/hyalectans (aggrecan, versican, neurocan and brevican) are the most 
abundant CSPGs in the brain and the hyalectanases family of ADAMTSs 
comprising ADAMTS1, 4, 5, 8, 9, 15 and 20, can cleave them. Aggrecan can be 
cleaved by all of them except by ADAMTS20, versican by all of them except by 
ADAMTS8, brevican by ADAMTS4 and 5 and neurocan by ADAMTS4 (Kelwick 
et al., 2015a) (Tauchi et al., 2012). ADAMTS1 (Krampert et al., 2005), 
ADAMTS5 (McCulloch et al., 2009b), ADAMTS9 (Jungers et al., 2005), 
ADAMTS20 (Llamazares et al., 2003), ADAMTS8 (Dunn et al., 2006), 
ADAMTS4 and ADAMTS15 (Levy et al., 2015) are expressed in the brain in 
physiological conditions. The conservation of expression of these ADAMTSs in 
the brain suggests Xenopus laevis is a good model to study brain remodeling 
during development.  
PCSG and ADAMTSs have been shown to have a region dependent 
expression profile in the brain mostly in perineuronal nets such as aggrecan 
and brevican (Dauth et al., 2016) and ADAMTS15 and ADAMTS8 (Rossier et 
al., 2015) (Levy et al., 2015). It will be interesting to look in more detail at the 
specific location of the ADAMTSs in the Xenopus laevis brain by in situ 
hybridisation. ADAMTS4 has been shown to promote neurite growth by 
degrading CSPGs, independent of it proteolytic activity, by activating MAP/ERK 
(mitogen activated protein/extracellular signal-regulated kinase) signaling 
pathway (Hamel et al., 2008). ADAMTS4 and 5 play a role in brain development 
by cleaving reelin, an extracellular signaling protein essential for neuronal 
migration, synapse development and function (Krstic et al., 2012). ADAMTS4, 
ADAMTS8 and ADAMTS5 were the most expressed hyalectanases in the 
Xenopus laevis brain suggesting that their function might be conserved and that 
they may play a role in brain development (figure 5-1 B’).  
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Interestingly ADAMTS6 was the most expressed gene of the ADAMTS 
family in the Xenopus laevis brain (figure 5-1 B’). However nothing is known 
about its function in brain development. It has been shown that ADAMTS6 
disrupts the deposition of microfibrils at heparan sulphate-rich cellular interfaces 
(such as focal adhesions and epithelial cell-cell junctions) by its 
metalloproteinase activity in vitro in retinal epithelial cells whereas ADAMTS10 
downregulates ADAMTS6 and is required for the integrity of these structures. 
The depletion of ADAMTS10 can be rescued by syndecan4 that can be cleaved 
by ADAMTS6 (Cain et al., 2016). Syndecan4 is expressed in the brain and has 
been shown to play a role in neural cell proliferation and axon formation in 
zebrafish (Luo et al., 2016). The high level of remodeling in the Xenopus laevis 
brain during metamorphosis could explain the high expression of ADAMTS6 
needed to disorganize focal adhesions by cleavage of syndecan4 promoting 
cell migration and the low level of ADAMTS10 expression that modulates this 
action.  
The ECM remodeling by metalloproteinases is crucial during brain 
development and has to be highly regulated. TIMP2 and TIMP3 were more 
expressed than TIMP1 in the Xenopus laevis brain during metamorphosis 
(figure 5-1 B’’’), which has been shown in mouse (Pagenstecher et al., 1998). 
TIMP2 plays a role in the development of the central nervous system (Brew and 
Nagase, 2010) and TIMP3 can inhibit several ADAMTSs such as ADAMTS4 
and ADAMTS5 important during brain development (Lim et al., 2010). 
After brain injury CSPGs inhibit axonal regeneration (Barros et al., 2011) 
(Avram et al., 2014). Some ADAMTSs such as ADAMTS1, ADAMTS5 and 
ADAMTS9, are induced after spinal cord injury (Demircan et al., 2013). Local 
delivery of ADAMTS4 has been shown to promote spinal cord recovery such as 
motor recovery and axonal regeneration (Tauchi et al., 2012). These findings 
suggest that the ADAMTSs can play different roles after brain injury, and could 
be an attractive therapeutic option. Xenopus laevis is a good model to study the 
regeneration of the central nervous system after injury and neurodevelopmental 
disorders (Lee-Liu et al., 2016) (Pratt and Khakhalin, 2013).  
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5.3.1.2 Skin remodeling during Xenopus laevis metamorphosis 
In the skin at metamorphosis and even more so after metamorphosis 
compared to before, members of the hyalectanases family were all expressed 
and upregulated with ADAMTS8, ADAMTS15 and ADAMTS1 being the most 
expressed and ADAMTS9 and ADAMTS20 the least expressed (figure 5-1 C’). 
ACAN was not detected but VCAN was expressed at similar levels in the skin 
during metamorphosis (figure 5-1C’’). Different phenotypes were seen using 
different strains of ADAMTS5 knockout mice. In one study it has been shown 
that the accumulation of non-degraded versican in the PCM of fibroblasts leads 
to their transition to myofibroblasts, which is necessary for wound healing 
(Hattori et al., 2011). In the other study, the accumulation of non-degraded 
aggrecan blocked the transition of fibroblast immature cells to mature contractile 
fibroblasts necessary for wound healing (Velasco et al., 2011). The process of 
transition between fibroblasts and myofibroblasts has been shown to be 
regulated by TGFβ and the PCM composition in aggrecan and versican 
associated with hyaluronan (HA) that could bind to the cell receptor CD44 could 
regulate this signaling pathway (Hattori et al., 2011) (Velasco et al., 2011).  
ADAMTS20 mutant mice (called belted) show a phenotype in 
melanoblast colonisation of the skin causing white belts in their lumbar region, 
possibly caused by the dysregulation of the ECM composition such as the 
accumulation of versican and the dysregulation of Kit signaling by inhibition of 
the response to soluble Kit ligand (sKitl), which is necessary for melanoblast 
development by direct action or due to abnormal ECM composition (Silver et al., 
2008). The high expression of the hyalectanases family in the Xenopus laevis 
skin suggests that they may play a role in the versican turnover necessary for 
skin remodeling.  
ADAMTS2 was highly expressed in the Xenopus laevis skin (figure 5-1 
C’) and it has been shown that it is crucial for fibrillar collagen organization. 
Mutant mice for ADAMTS2 show skin fragility. The aminoprocollagen (a chain of 
collagen with a propeptide at the N-terminal position due to the lack of cleavage 
by ADAMTS2) accumulates and does not assemble correctly, creating a 
structure with poor mechanical properties leading to skin fragility (Bekhouche 
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and Colige, 2015). The high expression of ADAMTS2 in Xenopus laevis skin 
suggests that it plays a role in skin remodeling. 
TIMP1 was the most expressed member of the TIMP family in the 
Xenopus laevis skin (figure 5-1 C’’’) and has been shown to play a role in skin 
homeostasis (Hornebeck, 2003). 
5.3.2 Gene expression in the heart undergoing remodeling and in the 
heart after ventricular resection during Xenopus laevis metamorphosis 
5.3.2.1 Heart remodeling during Xenopus laevis metamorphosis 
ECM components, metalloproteinases and TIMPs had different 
expression (figure 5-3) and regulation profiles (figure 5-4) in the Xenopus laevis 
heart during metamorphosis (table 5-2).  
ECM components were upregulated in heart undergoing remodeling 
during metamorphosis. Col1a1 were up regulated during metamorphosis (figure 
5-4A and A’). This suggests that it is an important ECM component for cardiac 
ECM remodeling from tadpole stage to adult stage. Similar results have 
previously been reported in mouse (Peacock et al., 2008). fn1 and VCAN were 
upregulated at metamorphic climax (appendix 8-12) suggesting their role in the 
heart remodeling from tadpole to froglet stage. Studies on mutant mice for 
versican (called hdf (heart defect) mice) have a homozygous lethal 
chromosomal 13 insertion that was mapped to the Cspg2 (VCAN) gene, 
showed that homozygous mutant mice died before birth between ED10.5 and 
11.0 with severe heart development defects (Yamamura et al., 1997). These 
phenotypes were also seen in mutant mice for hyaluronan (HA) that can bind to 
versican (Camenisch et al., 2000). Mutant mice for fibronectin died before birth 
at ED10 due to cardiovascular and vascular defects and fn1 played a role in 
heart development by regulating Notch signaling (Lockhart et al., 2011) (Wang 
et al., 2013). These results confirm previous studies on the important role of 
ECM components during heart development. 
ECM remodeling by metalloproteinases is an important process during 
heart development. Most of the metalloproteinases were upregulated in 
Xenopus laevis hearts during metamorphosis. The pro-collagen N-
propeptidases ADAMTS2 and ADAMTS3 (appendix 8-10) showed the same 
upregulation of expression as col1a1 during metamorphosis suggesting their 
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role in the collagen maturation during cardiac ECM remodeling from tadpole 
stage to adult stage. Several ADAMTSs have been identified to be expressed in 
the developing heart and play a role in heart formation, especially members of 
the hyalectanase family that cleave the early versican-rich cardiac ECM. 
ADAMTS5 and ADAMTS9 were upregulated at the metamorphic climax in 
Xenopus laevis heart, suggesting their role in the remodeling of the early 
versican-rich ECM, which is replaced by the mature cardiac ECM (figure 5-4C’, 
appendix 8-12). ADAMTS9 expression has been shown in the developing 
mouse heart at the same location as the neo-epitope DPEAAE, which is 
exposed after cleavage of versican by this protease. Hemizygous mutated mice 
for ADAMTS9 showed a decrease of detection of this neo-epitope, an 
accumulation of non-cleaved versican and heart defects suggesting an 
important role of ADAMTS9 for ECM remodeling of the early versican-rich 
matrix (Kern et al., 2010). Heart phenotype was also seen in knockout mice for 
ADAMTS5 due to the reduction of versican cleavage. This phenotype was 
rescued by intercrossing the mutant mice for ADAMTS5 with heterozygous 
mutant mice for versican suggesting that ADAMTS5 is also an important 
protease to clear the initial versican-rich cardiac ECM (Dupuis et al., 2011). 
ADAMTS20 is downregulated at the metamorphic climax suggesting that the 
regulation of hyalectanases is necessary for cardiac ECM remodeling.  
Several metalloproteinases such as ADAMTS1, ADAMTS6, ADAMTS10, 
MMP14, MMP9 and ADAM9 (figure 5-4A and A’, appendix 8-11) were 
downregulated during metamorphosis suggesting that they play a role in early 
cardiac remodeling during metamorphosis but not in the adult heart. MMP9 and 
MMP14 have been identified in heart development and can cleave fibrillar 
collagen that is present in the cardiac ECM (Fan et al., 2012). Knockout mice 
for ADAM17 and ADAM19 and knockout mice for ADAM9 and ADAM18 show 
heart defects when mutated for both genes suggesting function redundancy of 
these proteases during cardiac development (Horiuchi et al., 2005). It has been 
shown that ADAMTS1 cleaves versican at early stages and during 
trabeculation; knockout mice show a heart phenotype and hypertrabeculation 
due to accumulation of intact versican (Stankunas et al., 2008).  
The expression of the ECM components and the metalloproteinases was 
conserved in mammals and the morphological organisation of the mammalian 
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heart is conserved, which makes the Xenopus laevis heart a good model to 
study heart development and suggests the involvement of ECM in heart 
congenital diseases (Hempel and Kühl, 2016).  
5.3.2.2 Heart regeneration during Xenopus laevis metamorphosis 
 After cardiac injury three major processes are necessary for heart 
regeneration: (1) the removal of damaged cardiac structures associated with an 
inflammatory response site, (2) the reparative process and (3) the repopulation 
of the wound site with cardiomyocytes for regeneration (Uygur and Lee, 2016). 
The infiltration of the damaged tissue by neutrophils and macrophages is 
associated with an increase of MMP9 expression and activity to allow the 
migration of the inflammatory response cells through the damaged site (Tao et 
al., 2004). The reparative process starts with the rebuilding of a new highly 
hydrated cardiac ECM composed of collagen, fibronectin, tenascin-C and HA to 
maintain robustness of the damaged ventricular wall and to allow 
cardiomyocytes proliferation and migration toward the wound site (Mercer et al., 
2013) (Wang et al., 2013). Adult Xenopus laevis hearts do not regenerate after 
ventricle resection but show a deposition of fibrotic tissue (excess of collagen 
and fibronectin) and a hypertrophy of the amputated ventricle characteristic of a 
non regenerate heart as seen in adult mammals (Marshall et al., 2017). Past 
metamorphosis juvenile and adult Xenopus laevis frogs cannot regenerate the 
heart after ventricle resection (unpublished data, Coen L.) suggesting a 
difference in gene expression, regulation and function before and after 
metamorphosis 
The present study was focused on the early response (1, 3 and 7 days 
post amputation (dpa)) of the ECM components, metalloproteinases and their 
inhibitors to heart injury. A heart injury model was established by carrying out 
ventricular resection in the Xenopus laevis tadpole at pro-metamorphosis (stage 
57), at metamorphic climax (stage 61) and post-metamorphosis (juvenile and 
adult frog). Gene regulation in response to ventricle injury was stage- and time-
dependent (figure 5-5, appendix 4).  
The most regulated genes observed after ventricle amputation were 
genes involved in the urokinase-type/tissue-type plasminogen activator 
(uPa/tPa), plasmin, MMPs pathway and the inhibitor of uPA/tPa, plasminogen 
	   143 
activator inhibitor 1 (PAI1). tPa is a serine protease that converts the zymogen 
plasminogen to the active serine protease plasmin that activates the zymogen 
pro-MMP9 to active MMP9. tPa is inhibited by PAI1 (Ghosh and Vaughan, 
2012) (figure 5-6). Under physiological conditions, PAI1 regulates 
uPA/tPa/plasmin/MMP proteolytic activities to maintain tissue homeostasis but 
under pathological conditions (such as fibrosis after cardiac injury caused by 
myocardial infarction) PAI1 is highly regulated and contributes to the 
accumulation of non-degraded ECM such as ECM rich in collagen leading to 
fibrotic tissue (Takeshita et al., 2004). However it has been shown that a 
transient collagen-rich scar is necessary for heart regeneration in zebrafish and 
this process is regulated by TGFβ that recruits fibroblast-like cells, which 
synthetize collagen, at the wound site (Chablais and Jazwinska, 2012). PAI1 
has been shown to be regulated by TGFβ and latent TGFβ is activated by 
plasmin, which is activated by tPa, and by MMP9, which is activated by plasmin 
(Ghosh and Vaughan, 2012) (Lyons et al., 1990) (Yu and Stamenkovic, 2000) 
(figure 5-6). In the present study tPa, PAI1 and MMP9 were upregulated in all 
stages after amputation (figure 5A, appendix 4) confirming the important 
regulation of this signaling pathways in response to heart injury and for cardiac 
regeneration (figure 5-6). 
 
	  
Figure 5-6: Model of regulation of the cardiac regeneration process by the 
uPA/tPa/plasmin pathways and the inhibitor PAI1. Activation of zymogen pro-MMP9 
by plamin, activated by tPa is necessary to clear the wound site of ECM debris. Active 
TGFβ, activated by the pathway tPa/plasmin, recruits fibroblast-like cells to synthetise 
the collagen rich regenerative ECM at the wound site. Regulation of the tPa/plasmin 
pathway by the inhibitor PAI1, positively regulated by TGFβ, is necessary to inhibit the 
action of MMP9 against the transient regenerative ECM. 
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ECM components of the transient regenerative cardiac ECM, such as 
collagen (col1a1), fibronectin (fn1) and tenascin-C, were upregulated after 
ventricle amputation at 1, 3 and 7 dpa in stages before and past metamorphosis 
(figure 5-5C, appendix 4). This suggests that the early creation of a transient 
ECM scar deposition is common at all stages and is not the cause of the loss of 
regeneration observed in adult Xenopus laevis. Upregulation of CSPGs such as 
VCAN and ACAN was also observed after heart amputation, mostly at 3 dpa in 
pro and past metamorphosis stages (appendix 4). A study in rats shows that in 
response to aortic banding, proteins are upregulated as well as VCAN and 
ACAM mRNA levels (Vistnes et al., 2014). CSPGs can interact with HA to 
create a highly hydrated ECM, such as the regenerative cardiac ECM, and are 
expressed in the immature cardiac ECM (Mercer et al., 2013) (Lockhart et al., 
2011). The data presented in this study suggests that versican and aggrecan 
could be components of the transient ECM scar, creating a highly hydrated 
matrix promoting cell migration. Although the deposition of a collagen-rich scar 
has been shown to be essential for heart regeneration, its degradation by 
proteases is crucial to allow its replacement by new cardiomyocytes (Chablais 
and Jazwinska, 2012).  
ADAMTS5 has been shown to clear the initial versican-rich cardiac ECM 
(Dupuis et al., 2011). ADAMTS5 was downregulated at 1 dpa in all stages 
except the adult stage (figure 5-5D). These data suggest that the early inhibition 
of ADAMTS5 is necessary for the formation of the transient scar ECM 
composed of CSPGs. Some genes were only upregulated at stage 57 and 
stage 61, corresponding at before and at metamorphic climax, such as 
ADAMTS14 and ADAMTS2 (figure 5-5B, appendix 4). These two ADAMTSs are 
pro-collagen N-propeptidases and ADAMTS2 and ADAMTS14 have been 
shown to be necessary for the maturation of the collagen by cleaving the 
propeptide of the α chains (Bekhouche and Colige, 2015). Mature α chains 
assemble to form collagen fibrils. These data suggest that ADAMTS2 and 
ADAMTS14 could be necessary for the correct organisation of the collagen-rich 
scar after cardiac amputation. ADAMTS9 has been shown to play a role in the 
remodeling of the initial versican-rich cardiac ECM (Kern et al., 2010). 
ADAMTS9 is upregulated in stage 61 only at 7dpa (appendix 4) suggesting it 
has a role in the degradation of the transient regenerative ECM necessary for 
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its replacement by new cardiomyocytes. A study in rats shows that in response 
to aortic banding, ADAMTS4 and ADAMTS1 mRNA and proteins were 
upregulated (Vistnes et al., 2014). In the present study an upregulation of 
ADAMTS4 after 1 and 7 dpa in pro and past metamorphosis stages and a low 
upregulation of ADAMTS1 in adult heart at 1 and 3 dpa were observed 
(appendix 4). This could be explained by the difference in the heart injury 
procedure. 
Syndecan4 was upregulated in all stages at 1, 3 and 7 dpa (appendix 4). 
Full-length syndecan4 has been shown to be pro-fibrotic in heart fibrosis 
whereas syndecan4 shedding fragments have been shown to have an anti-
fibrotic effect (Lunde et al., 2016). Several MMPs, ADAMs and ADAMTSs were 
upregulated after ventricle resection in Xenopus laevis, suggesting a regulation 
of syndecan4 activity by the proteases leading to pro-fibrotic effects in the post 
metamorphosis heart, which cannot regenerate, or anti-fibrotic effects before 
metamorphosis when the Xenopus laevis heart has the capacity to regenerate.  
TIMP1 has been shown to be up regulated after cardiac injury and 
TIMP3 plays a role in remodeling following myocardial infarction (Fan et al., 
2012). TIMP1 was upregulated in all stages at 1, 3 and 7 dpa whereas TIMP3 
was mostly upregulated at 1 and 3 dpa (appendix 4) suggesting they have a 
function in the inhibition of the metalloproteinases activities against the early 
ECM scar deposition at the wound site.  
To summarize, ECM components, proteases and their regulators were 
differently regulated after ventricle resection in Xenopus laevis depending on 
the stage of development and the time after the amputation. This suggests they 
have an important role in cardiac regeneration. Some expression and regulation 
profiles were similar to previous studies in other model organisms 
demonstrating that Xenopus laevis could be a good model to study cardiac 
regeneration. The loss of this ability past metamorphosis is similar to the 
embryonic and adult transition in mammals.  
The present study looked at 1, 3 and 7 days post amputation showing 
short-term transcriptional responses of ECM components, proteases and their 
regulators before, at and after metamorphosis and in the future it would be 
interesting to look at these long-term gene responses, in months, after ventricle 
resection to show their role in the regeneration process or fibrosis processes 
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depending on the regenerative capacity of the Xenopus laevis stages of 
development. 
All the data of this chapter were gene expression data, which does not 
show protease activity, as it is known that most of the metalloproteinases 
studied here require proteolytic activation to be active and might be inhibited by 
their inhibitors. In order to assess the activity of the metalloproteinases 
antibodies against neo-epitope generated after cleavage of their specific 
substrate can be used (Genovese et al., 2014). 
Interestingly it has been shown that thyroid hormone (T3) can regulate 
the gene expression of MMPs, such as MMP9 and MMP14 in Xenopus laevis, 
by binding to its nuclear receptor that acts as a transcriptor factor by forming a 
complex with RXR that bind to TRE motifs on the gene promoter (Fujimoto et 
al., 2007) suggesting a role of the TH in the regulation of ECM remodeling by 
modulating metalloproteinase expression.  
The presented results showed that some ECM components and 
metalloproteinases were specifically up- or down- regulated at the metamorphic 
climax when there is a peak of TH, suggesting a regulation of their expression 
by the TH pathway. To follow this study, in collaboration with Dr. Laurent Coen’s 
team, genes that showed an interesting profile in the heart during 
metamorphosis (table 5-4) were selected in order to look at their modulation of 
expression in tadpoles treated with T3 hormones during metamorphosis. The 
analysis of the results is on going but preliminary analysis showed an 
interesting profile for some genes such as MMP9, previously showed to be 
regulated by TH in other organs by its TRE motif. Genomic analysis of the most 
interesting genes, which would appear to be regulated by TH could show if a 
TRE motif is present in their promoters.  
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Table 5-4:	   List of genes analysed in heart development during Xenopus laevis 
metamorphosis in embryos treated with T3.  The different gene categories are 
indicated in the first two rows and specific gene name is indicated below. For 
ADAMTS, ADAM, MMP, TIMP and syndecan only the gene number is indicated in the 
column meaning ADAMTS1, ADAM7, MMP2, TIMP1 and syndecan1 for all different 
genes. PAI1: plasminogen activator inhibitor-1. 
metalloproteinases    
ADAMTS ADAM MMP TIMP ECM plasminogen syndecan 
1 9 9 3 VCAN PAI1 1 
2 10 7  ACAN  2 
4 12 14  
tenascin-
C 
 3 
5 15     4 
6 22      
8 23      
9       
10       
13       
14       
15       
16       
17       
19       
20       
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6 Chapter VI: Discussion 
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6.1  The ADAMTS family in Xenopus genome 
 In this study Xenopus was used as a model organism to begin to study 
the extracellular matrix (ECM) remodeling during development and specially the 
role of the metalloproteinases family, the A Disintegrin and Metalloproteinase 
with Thrombospondin type-1 motifs (ADAMTS) family. The 19 members of the 
ADAMTS family were identified in Xenopus and their evolutionary history was 
conserved with mouse and human suggesting a conservation of their functions 
between these species. Xenopus tropicalis and Xenopus laevis were used in 
this study. Xenopus tropicalis has the advantage of being diploid, which can 
facilitate genetic manipulation to carry out functional experiments such as loss 
of function using morpholinos and CRISPR/Cas9 (Guo et al., 2014), however 
the embryos are small making targeted injection into specific blastomere more 
difficult (Harland and Grainger, 2011). Xenopus laevis has the disadvantage of 
being allotetraploid (genome composed of subgenome L and subgenome S) 
meaning that both copies of a gene have to be targeted in order to accomplish 
genetic manipulation to carry out functional experiments. A recent version of the 
Xenopus laevis genome has been published (Session et al., 2016) with better 
sequencing and gene annotation, moreover the embryos are bigger than the 
Xenopus tropicalis embryos facilitating manipulation such as targeted injection 
and visualisation of phenotypes (Harland and Grainger, 2011). These two 
Xenopus species diverged from each other around 48 million years ago (Ma) 
before the divergence of the two diploid species (that are still unknown) that 
gave rise to the X. laevis subgenomes L and S, which occurred around 34 Ma 
(Session et al., 2016). The conservation of the chromosomal gene organisation 
(synteny) and the phylogeny of the ADAMTS family between X. tropicalis and X. 
laevis were established to help understand the evolutionary history of the 
Xenopus laevis genome and assess which subgenome was more conserved to 
the Xenopus tropicalis genome representing the ancestral genome. The 19 
ADAMTS genes were found in the Xenopus laevis subgenome L and in 
Xenopus tropicalis, the same as in mammals, whereas only 12 were present in 
the subgenome S due to a loss of copies for seven ADAMTSs (ADAMTS7, 
ADAMTS8, ADAMTS12, ADAMTS13, ADAMTS16, ADAMTS19 and 
ADAMTS20). These proportions follow the ones found for the general 
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conservation of the protein coding genes between the Xenopus laevis 
subgenomes and the Xenopus tropicalis genome (Session et al., 2016) and 
contribute to the understanding of the evolutionary history of Xenopus laevis 
and Xenopus tropicalis. The chromosomal organisation on the X. laevis 
subgenome L was more similar to the one on X. tropicalis genome than the X. 
laevis subgenome S supporting the hypothesis that the ancestral chromosomal 
organisation is the one found in Xenopus tropicalis and in the subgenome L of 
Xenopus laevis. In addition identified ADAMTSs genes in this study were not 
annotated and were located on scaffolds (part of genomic DNA not allocated to 
a chromosome during genome assembly). By analyses of the synteny of these 
genes compared to their homoeologous in Xenopus laevis subgenomes and 
their orthologous in Xenopus tropicalis, they were assigned to their 
corresponding chromosome contributing to the improvement of Xenopus 
genomes assembly and annotation. 
6.2  ADAMTS9 in the pronephros 
Xenopus diverged from mammals some 360 million years ago and has 
been shown to be a good animal model relative to human as they are both 
tetrapod, their genomes show conserved synteny and their organ development 
and function are highly similar (Wheeler and Brandli, 2009).  
In this study, in addition to showing that the evolutionary history of the 
ADAMTS family was conserved between Xenopus and human, their expression 
in different tissues such as kidney, brain, skin and heart were shown to be 
similar to that found in human (see chapters IV and V). The ECM remodeling 
during development was investigated; Xenopus is a good model to study these 
events during embryonic development because it can be seen externally unlike 
in mammals where embryonic development is in utero. This advantage allows a 
good visualisation of the phenotypes due to the disruption of a gene, by gain or 
loss of function experiments, and can help to define the timing of the apparition 
of these phenotypes.  
ADAMTS9 knockdown caused a defect of pronephros development in 
Xenopus laevis embryos. It has been shown that segmentation and molecular 
markers are conserved between the Xenopus pronephros and the mammalian 
metanephric nephron (Lienkamp et al., 2012). Different markers expressed at 
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different times of development were used and their analysis lead to the 
conclusion that the loss of function of ADAMTS9 in the pronephros in Xenopus 
laevis disrupt the development of the pronephric tubules and duct from early 
tailbud stages (using pax8 as a marker), to tadpole stages (using 4a6 antibody 
as a marker), but not the development of the glomus, using wt1 as a marker 
(see chapter IV). In Xenopus the kidney tubulogenesis can be visualised 
through the surface ectoderm, by injecting mRNA encoding membrane-bound 
green fluorescent protein (GFP) to allow single cell definition. This advantage 
helped to understand in an in vivo context where cells differentiate, migrate and 
interact to assemble the pronephros whereas fixed tissues or organ culture was 
used to study mammalian kidney development (Lienkamp et al., 2012) 
(Lienkamp et al., 2010). It would be interesting to use these visualisation 
techniques to characterise in more detail the phenotypes obtained during 
tubulogenesis when ADAMTS9 was knocked down.  
Chronic kidney disease (CKD) is a common pathological condition, 14.8% 
of the adult population in the USA had CKD in 2011-2014 as estimated by the 
US Renal Data System 2016 Annual Data Report, which can lead to an end-
stage renal disease (ESRD) with kidney transplant as only treatment. Renal 
fibrosis is associated with CKD. Recent studies looked at the ECM components 
and metalloproteinases as potential biomarkers to improve the prognosis and 
as the potential treatment in a non-invasive manner avoiding the renal biopsy 
often used (Genovese et al., 2014). Several studies show that some MMPs, 
such as MMP-2, -7 and -9, have increased expression in kidney diseases 
(Genovese et al., 2014). ADAMTS7 expression was increased in elderly mouse 
kidney, compared to adult mouse kidney, from renal inflammation caused by 
angiotensin II administration, which is known to play a role in the progression of 
chronic kidney damage, contributing to renal inflammation and fibrosis. This 
suggests ADAMTS7 plays a role in early inflammatory kidney damage 
associated with aging (Gao et al., 2013). ADAM19 and ADAM17 expression are 
up regulated in kidney diseases (Melenhorst et al., 2006) (Mulder et al., 2012). 
In this study ADAMTS9 was shown to play a role during kidney development 
possibly by the degradation of its substrate versican expressed in the 
developing kidney. It has been shown that the expression of V0 and V1 
isoforms of versican were increased in patients with CKD suggesting versican 
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as a potential biomarker (Rudnicki et al., 2012). However they did not look at 
the neo epitope of versican generated by its specific cleavage by ADAMTSs. 
The increase of V0 and V1 could be due to an increase of intact versican 
suggesting a lack of action of ADAMTSs or could be due to an increase of 
cleaved versican suggesting an increase of ADAMTSs activities, possibly of 
ADAMTS9. Looking at the neo-epitope generated after specific cleavage of 
ECM components by metalloproteinases such as ADAMTSs, ADAMs and 
MMPs is called protein fingerprint technology. A comparison of the amount of 
the cleaved forms compare to the amount of their intact forms could be used as 
a biomarker for diseases such as CKD by indicating renal fibrosis for example 
(Genovese et al., 2014). This technology is more reliable than looking at the 
level of expression of metalloproteinases, as most of them require post 
translational modifications to be active in order to assess their roles in CKD and 
potentially their used as biomarkers.  
The only treatment for ESRD is kidney transplant causing a high demand 
for transplantable organs higher than the amount of available organs leading to 
the development of organ bioengineering and regeneration as potential 
inexhaustible sources of organs (Orlando et al., 2013). It has been shown that 
ECM is essential to a correct kidney development in vitro, by addition of ECM 
components in organ culture (Sebinger et al., 2013) or by using whole-kidney 
ECM scaffolds used after their decellularization (Orlando et al., 2013). Xenopus 
is a robust model to study kidney development in vitro by isolating animal caps 
dissected from embryos at blastula stage and treated with activin and retinoic 
acid in order to differentiate and form pronephric organoids. These organoids 
can be transplanted into a host embryo, previously removed of its pronephric 
anlage tissue, and be functional as proven by the lack of oedema formation that 
is characteristic of kidney failure. However the success of these transplantations 
was only of 21% (Krneta-Stankic et al., 2017). These data suggest the essential 
influence of ECM on correct kidney development in vitro and the data in this 
study, showing the role of ADAMTS9 in pronephros development in Xenopus 
laevis, support the importance of ECM and the secreted proteins present in the 
ECM. It would be interesting to carry out the transplant experiment in Xenopus 
laevis with animal cap explants from injected embryos with ADAMTS9 
morpholinos and analyse their capacity to form pronephric organoids compared 
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to control embryos as well as adding ECM components, such as versican, to 
explants in culture to look at the improvement of their development. These 
explants could be then transplanted and could potentially obtained a higher 
success rate than previous studies. 
6.3  ECM and metalloproteinases in post embryonic development  
 In this study, the ECM and metalloproteinases gene expression in 
Xenopus laevis during metamorphosis, which is similar to the postembryonic 
development in mammals, were investigated. This process is regulated by a 
peak of thyroid hormone (TH) concentration and is comparable to the one 
during birth in humans, which suggests Xenopus is a good model to study ECM 
remodeling during this important time of development (Brown and Cai, 2007). In 
Xenopus the thyroid hormone signalling pathway regulates main events that 
occur during metamorphic climax such as the creation of adult organs, organ 
remodeling, regression of embryonic organs and apoptosis of embryonic cells 
replaced by adult cells (Buchholz, 2015). Organ remodeling includes pancreas, 
liver, blood, immune system, skeleton, intestine, brain, olfactory organ and skin 
(Brown and Cai, 2007).  
ECM has been shown to play an important role in organ remodeling 
during metamorphosis as it is a structural scaffold and can regulate cell-cell and 
cell-ECM interactions. ECM can interact directly with cells by cell surface 
receptors, such as integrin, and can indirectly affect these interactions by 
regulating the availability of various factors, such as growth factors. Cell-cell 
and cell-ECM interactions determine cell-fate such as programmed death or 
proliferation. These two processes are highly regulated by TH in time and space 
during metamorphosis (Fu et al., 2007). The remodeling of the ECM is mainly 
due to metalloproteinases. Organ remodeling under the control of TH during 
Xenopus metamorphosis is a good model to identify these proteins. By 
remodeling the extracellular matrix they alter the cell-ECM interactions and 
regulate cell death and proliferation in specific organs during metamorphosis. 
The resorption of the tail has been established as a model system since 1962 
using an in vitro tail culture called tail fins (Gross and Lapiere, 1962). The 
remodeling of the intestine is another good model as it can be cultured in vitro 
(Su et al., 1997) as well as the resorption of gills (Derby et al., 1979). These 
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model systems helped to identify proteases, due to the abundance of matrix 
degradation, cell death and cell proliferation. Most studies looked at MMPs 
regulation by TH during metamorphosis. MMP14, MMP11 and MMP9TH have a 
high affinity between their TRE on their promoter and the TR/RXR heterodimer 
forming a stable complex, which leads to a rapid response to the increase of 
plasmatic TH (Fujimoto et al., 2007).  
In this study the ADAMTSs expression in physiological condition have 
been shown to be conserved in Xenopus laevis brain and skin and have 
previously been shown to be conserved with human and mouse by 
phylogenetic study (see chapter III). This suggests that their function would be 
conserved. Functional studies would confirm these hypotheses for ADAMTSs 
genes with known function in the brain, such as ADAMTS4 and ADAMTS5 
(Krstic et al., 2012), and in the skin, such as ADAMTS2 (Bekhouche and Colige, 
2015). However these studies could generate new findings in regard to 
ADAMTSs genes function in these processes, such as ADAMTS6, which 
showed a high expression level in these organs during metamorphosis. The 
juvenile and adult Xenopus laevis brain and skin organisation is conserved in 
mammals. ECM components and metalloproteinases gene expression and 
regulation profiles, such as VCAN, ADAMTS5 and ADAMTS9, in the Xenopus 
laevis heart development were similar to the ones found in mammalian heart 
studies suggesting their conserved function in Xenopus laevis (Yamamura et 
al., 1997) (Kern et al., 2010) (Dupuis et al., 2011). Functional experiments, such 
as loss of functions, using morpholinos and CRISPR/cas9, for genes of interest 
could be carried out to look at their function in Xenopus laevis and their role in 
organ remodeling during development from juvenile to adult organisation. 
Genes of interest would include ECM components and metalloproteinases 
known to be expressed and have a function in the mammalian brain, skin and 
heart development or genes which showed interesting expression and 
regulation profiles but are not known to play a role in these organs. In order to 
look at their regulation by TH during metamorphosis tadpoles could be treated 
with TH and TH disruptor and genes expression would be compared to the one 
obtained in this study in normal conditions.  
A transgenic Xenopus laevis line has been created by Pr. Barbara 
Demeneix in order to look at the effect of chemicals on thyroid hormone 
	   155 
signaling during development. This line, called Tg(thibz:eGFP), expresses GFP 
under the control of a regulatory region of the TH/bZIP, a leucine zipper 
transcription factor highly sensitive to thyroid hormone regulation that contains a 
consensus thyroid hormone element (TRE), known to be an optimal TH 
response gene (Fini et al., 2007). By using this transgenic line they were able to 
identify chemicals disrupting thyroid hormone signaling affecting brain 
development (Fini et al., 2017).  
It would be interesting to look at the expression of ECM genes that have 
been identified as potential genes regulated by thyroid hormones, following the 
experiment with embryos treated with T3 during metamorphosis, in the 
presence of chemicals disrupting thyroid hormones and their impact on brain, 
skin and heart development in Xenopus laevis. This could suggest the same 
impact in humans as thyroid hormone signaling and the structures of these 
organs are highly conserved. It is known that TH signaling is important for 
human heart fetal and postnatal development (Li et al., 2014) so it would be 
interesting to know the impact of chemicals on ECM during this process as 
ECM has been shown to be important for heart development (Lockhart et al., 
2011). The results of gene expression showed in the present study could be 
used as a control for gene expression analysis of these genes in disease 
conditions as Xenopus has been shown to be a good model for 
neurodevelopmental disorders (Pratt and Khakhalin, 2013) and for congenital 
heart defects (Hempel and Kühl, 2016). Functional studies of genes of interest 
could allow the identification of new ECM genes involved in these different 
diseases and their potential therapeutic application. 
6.4  ECM and metalloproteinases in heart regeneration 
 This study showed ECM components, metalloproteinases and tissue 
inhibitor of metalloproteinases genes expression in Xenopus laevis following 
heart injury by ventricular resection. It is known that ECM and MMPs are 
regulated by the inflammatory response following injury. The inflammatory 
response is divided in three phases: acute (hours after injury), granulation (days 
after injury) and maturation (weeks after injury). After myocardial infarction, 
cardiac fibroblasts secrete proinflammatory cytokines and chemokines such as 
tumour necrosis factor α (TNFα) and interleukin-1 (IL-1) and MMPs such as 
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MMP-1, -2, -3, -9 and -14 to degrade the ECM in the acute phase. In the 
granulation phase they migrate, proliferate and differentiate into myofibroblasts 
in the damaged zone and secrete MMPs and pro-angiogenic molecules such as 
vascular endothelial growth factor (VEGF) to promote revascularisation. In the 
maturation phase, the inflammation response is inhibited by anti-inflammatory 
cytokines and myofibroblasts secrete new ECM components to form a scar in 
response to profibrotic signals for example, transforming growth factor-β (TGF
β), angiotensin II and basic fibroblast growth factor (bFGF). Cardiac fibroblasts 
regulate MMP activity after myocardial injury by secreting their inhibitors, TIMPs 
such as TIMP-1 (van Nieuwenhoven and Turner, 2013) (Turner et al., 2010).  
In this study gene expression was analysed at 1,3 and 7 days post 
amputation corresponding to the acute and granulation phases of inflammation 
characterised by metalloproteinases secretion and angiogenesis. It has been 
previously shown in adult human cardiac myofibroblasts that have been treated 
with IL-1 for 6 hours, thus reproducing an acute inflammatory response after 
myocardial infarction, that MMP-1, MMP-9 and MMP-14 are up regulated as 
well as ECM components such as col1a1, fibronectin 1, versican, and TIMP1 
whereas ADAMTS1 was downregulated (Turner et al., 2010). ADAMTS1 
inhibits neovascularization through the inhibition of VEGF signaling (Luque et 
al., 2003) and by the release of anti-angiogenic peptides from 
thrombospondins-1 and -2 (Lee et al., 2006). This study suggests that IL-1, by 
inhibiting ADAMTS1, promotes angiogenesis after myocardial infarction (Turner 
et al., 2010). An upregulation of col1a1, fibronectin 1, VCAN, MMP-1, MMP-9 
and MMP-14 as well as TIMP1 after ventricle resection in Xenopus laevis 
during metamorphosis was showed in this study, which supports previously in 
vitro published data (Turner et al., 2010). Downregulation of ADAMTS1 was not 
observed; suggesting that ADAMTS1 regulation by IL-1 is a fast response 
(hours) to inflammation signals. However ADAMTS1 was upregulated in the 
adult frogs suggesting a role in the inhibition of the angiogenesis leading to the 
lack of regeneration. It has been shown that ADAMTS1 is positively regulated 
by the mitogen-activated protein kinase (MAPK) p38 (Turner et al., 2010), which 
is up regulated in heart failure associated with a diminution of the vasoreactivity 
such as endothelial dysfunction (Arabacilar and Marber, 2015). Little is known 
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about the downstream mechanisms of MAPK p38 in heart failure but ADAMTS1 
could be a potential factor. The ADAMTS family has been the main focus of the 
present study. Several ADAMTSs have been shown to be expressed in 
atherosclerosis, an inflammatory coronary artery disease characterised by 
endothelial dysfunction and the accumulation of lipid and cholesterol in the 
intima (inner layer) eventually resulting in the formation of a cholesterol-rich 
plaque. ADAMTS4, ADAMTS8 and ADAMTS9 were upregulated after 
stimulation with TNFα, ADAMTS4 and ADAMTS8 were expressed in 
macrophage-rich areas known to secrete metalloproteinases during 
inflammation response (Wagsater et al., 2008). Several studies showed that 
ADAMTS7, by cleavage of its substrate COMP, can promote vascular smooth 
muscle cell (VSMC) migration in the arterial intima and vascular calcification 
leading to the development of an atherosclerotic plaque. This suggests 
ADAMTS7 is a potential therapeutic target for atherosclerosis (Patel and Ye, 
2013). An upregulation of ADAMTS4, ADAMTS8 and ADAMTS9 was observed 
suggesting these proteases have been stimulated in response to the 
inflammatory signal after ventricle resection. However no upregulation of 
ADAMTS7 was observed, which could be due to its timing of regulation being 
before 1 day post amputation or after 7 days post amputation or that ADAMTS7 
could not be regulated during inflammation following ventricle resection. Little is 
known about the mode of actions of these ADAMTSs in inflammation but they 
could be good candidates for a therapeutic application in order to manage the 
inflammatory response following heart injury to improve the recovery. 
Angiogenesis is an important process for cardiac regeneration after injury 
(Marin-Juez et al., 2016).  
The ADAMTS family have been shown to have pro- and anti- angiogenic 
properties. ADAMTS1 (Luque et al., 2003) (Lee et al., 2006), ADAMTS4, 
ADAMTS8 (Vazquez et al., 1999), ADAMTS2 (Dubail et al., 2010), ADAMTS12 
(Llamazares et al., 2007) and ADAMTS5 (Sharghi-Namini et al., 2008) have 
been shown to have anti-angiogenic activities independent of their protease 
activity whereas the ADAMTS9 (Koo et al., 2010) anti-angiogenic action is 
dependent on its protease activity but the mode of action is unknown. 
ADAMTS13 has been shown to promote angiogenesis by its C-terminal TSP1 
motif, which upregulates VEGF and the phosphorylation of VEGFR2 (Lee et al., 
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2015). An upregulation of these ADAMTSs after ventricle resection at 1, 3 and 7 
dpa was observed. Angiogenesis is needed for heart regeneration and is a fast 
response after injury (hours) (Marin-Juez et al., 2016). ADAMTSs shown to 
have anti-angiogenic properties could be downregulated early after cardiac 
injury. This was not observed in this study however in heart remodeling after 
injury the ADAMTS family could play a different role promoting ECM remodeling 
and regulating angiogenesis.  
To complete the mRNA data, antibody staining on the Xenopus laevis 
amputated hearts for the ADAMTS family could show their localisation in the 
ECM or in the endothelial cells, giving an indication on their possible role in the 
process of heart regeneration. It would be interesting to see if their profile of 
expression differ from Xenopus laevis tadpoles that have the capacity to 
regenerate their heart compared to juvenile and adult frogs that loose this 
capacity. This would indicate their potential as a therapeutic target to improve 
treatment after heart injury promoting regeneration. 
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8 Appendices  
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8.1 Appendix 1: Primers used in this study 	  
Appendix 8-1: Sequences and terms of use of each primer set for RT-qPCR and 
microfluidic in Xenopus laevis. 
Xenopus laevis 
gene name 
Product 
length 
(bp) 
Tm 
(°C) Sense primer Anti-sense primer Reference 
ADAMTS1 124 57 CAGGAGGCACGAGGAAGAA 
ATGAGGGTGAGG
AGATAATGTTTC Primerdesign 
ADAMTS4 99 56.6 CTATCGCCGCTATCAACTACAA 
TGAGTCCTCCAC
CTTCCAAG Primerdesign 
ADAMTS5 90 57 GGGCAAGGTGGGCTACAT 
CTGAAGTGGGGA
GACAACAAC Primerdesign 
ADAMTS8 129 56.4 TTTAGTTCCTGATGATGCTTTTCTT 
GCTGCCAGTGGT
TCCATAC Primerdesign 
ADAMTS15 91 56.7 AATCCAATCAACATTGTCGTTGTG 
TCAGTGTCATGG
CGGCATT Primerdesign 
ADAMTS9 98 56.4 GCCCGACTGGAATACAATGAT 
ATGTTTTGCGTTT
TACTGAAGAGA Primerdesign 
ADAMTS20 88 56.8 TTAGAACCACTGATGAAACCTGAT 
AATGTTTGACTTT
GTGCTTGTAGA Primerdesign 
ADAMTS2 123 57 TCCGAACAGTTAAGTGTATTCAGC 
GAGCAGGACAAG
GTTGACGA Primerdesign 
ADAMTS3 129 56.6 CGAACATTTGCGAATTGTAAACAA 
GTGACCCTTGTA
GCACCACT Primerdesign 
ADAMTS14 130 56.7 CAGAACAGTCTTACAGTCAGGATG 
CCTCCGTATGAT
GGCTCTGG Primerdesign 
ADAMTS13 110 56.8 CGAGCAGTTGGAAGTGTGAAG 
ATGTTGAGGTTG
GTTAGGATGTAT
C 
Primerdesign 
ADAMTS7 91 56.7 AGCCTCTGTGACCATGAACC 
GAGTGCAGGAGA
CATTGTTCTG Primerdesign 
ADAMTS12 127 56.9 GCCTTACAAGAATGAACTGTACCA 
CGTACCATCAAT
CACCGCATC Primerdesign 
ADAMTS6 128 56.7 GCAAGCACTTTCACTTAAACCTG 
TCCTGTATAGTG
GCAGTTGTCTAT
A 
Primerdesign 
ADAMTS10 95 56.4 GGTAATAGATGACAAGCCTTGGAA 
CTTGCTGTGTCT
GGTTGGATC Primerdesign 
ADAMTS16 109 56.8 ATTCTGTGAAGGTTCCTCACGA 
CGGCTTGCTGTT
ATACTCTGC Primerdesign 
ADAMTS18 105 57 CAGTGTGTTCAGAAATCTACAATGC 
GCAGTCCTGAAT
GTTACAAGCC Primerdesign 
ADAMTS17 117 56.7 CAGAGTAACTGCCATGTTGTATCA 
CTCCACGCTGTG
CTCTTCA Primerdesign 
ADAMTS19 86 56.9 CGCATCGTGTTTACAGGAGAAA 
TGTAACTCCACA
GTATGGCTGAT Primerdesign 
ADAM7 129 56.6 GGCTCATCCAGACGGAAGG 
TATATGTTGTGTT
GTCCACTCCAC Primerdesign 
ADAM9 129 56.9 TACAGTGGCGTGAGACTAACC 
CGGCATGACTTC
TGGAACATAC Primerdesign 
ADAM10 106 56.6 TTTAAATTGGAGGTTGGAGGAGAAA 
CAACAACAGATC
CGTGACTCAA Primerdesign 
ADAM15 124 56.8 AGTTGGTGTTGGTGGCAGATA 
CGGACATTGAGA
GGTCGGTAA Primerdesign 
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ADAM19 126 56.9 GGACATTCCATCCAGTTAGAGGA 
GTCAGCCACCAG
GTACAGTT Primerdesign 
ADAM17 118 56.8 TAGTTGTGGCTGACCATCGG 
CACGAGGTGTTC
TTGTAGATGTC Primerdesign 
ADAM28 114 56.8 TGTTATCCAGGATCACAGCCAA 
GATGAGCAAGTA
CAGTGAGGTTC Primerdesign 
ADAM22 118 56.9 CCTCAGCACCTCGGCATG 
CTCGCATGAGCC
AGATGGAT Primerdesign 
ADAM33 127 57 CAAGAGGCTGTATCATGGCT 
TTGGCATGTTGA
ATAGGCACATT Primerdesign 
ADAM23 111 56.8 CTCCTGCTGCTGCTGTCC 
GTCTTCTTCTGC
CAATCTACCAG Primerdesign 
ADAM12 130 56.8 ATTGTAGCGGATAATCGTGAGTATC 
CAACCAGAGCCA
CTCGTATATTC Primerdesign 
ADAM11 116 56.6 AGGCAGAACTGGATTCAGTGTA 
CTCATACTGGTG
ATGTCTCCATTC Primerdesign 
MMP14 110 56.7 GAGACGGAAGAGATACGCCAT 
TCGCCTCATAGG
TAGAATACTCG Primerdesign 
MMP1 89 56.6 ATCCTCCAATCCAGTCCAACC 
CTCTCATGGTGG
TGACAGCA Primerdesign 
MMP7 130 57 TCGCCAAGTGGTAGATGACG 
TCCATGCGTGCG
TGCTC Primerdesign 
MMP9 108 56.8 CACTTACCGTATTCTGAACTACTCC 
GTGAAGGACAGA
GGTGTGACA Primerdesign 
MMP2 85 57.2 TCAAGGCAACACATACAACAGC 
CTTGTCATAGTCT
TCTGTGGTAGC Primerdesign 
TIMP1 90 57 GGCTTCGAGGAGGTGTATCG 
GCACTGGCTGTC
CGACTC Primerdesign 
TIMP3 72 56.7 TACTACCTTCCCTGTTTCATCACT 
GTAGCCGAAGTT
GGAGAGCA Primerdesign 
TIMP2 107 56.7 CACATTGACATTCCAACACCAAC 
CATATCAACACA
AGCATAGCAAGA
G 
Primerdesign 
uPAR 97 56.7 GTGACCTATTGCTCTACCACTTAC 
TTTGTGTGAAATT
GTTACAGTTGCT Primerdesign 
tPA 79 57 CTGTGCGGAGGAACACTCAT 
GTGGTGCTGTTG
AGATATCATTGA Primerdesign 
PAI1 130 56.9 CAAGCCAAGGACATCATTAATCAAT 
TGCCACTGAAGT
GTATAGCACT Primerdesign 
SYNDECAN4B 119 56.9 CATTCAACGAGAACAACGAGATTG 
TCTCTGGAAGAA
TCCTGAAGACC Primerdesign 
SYNDECAN2B 95 56.9 ATGATTACTCTTCTGGATCTGGCT 
GCTGCTTATAAG
TGTCTGGACAG Primerdesign 
SYNDECAN1 73 56.9 GCACACTGATACGATGGACAAG 
CGTTACAGCCAG
CGAGCA Primerdesign 
SYNDECAN3 78 56.6 GGCTGCTCTTCATCATCACAC 
GATCAACAGGTC
GCTCATCTTC Primerdesign 
ACAN 111 56.8 CTCCTGCTGCTGCTGTCC 
GTCTTCTTCTGC
CAATCTACCAG Primerdesign 
TENASCIN-C 118 56.7 TCTGGTACAAGAACTGTCACAGA 
TCGGCAAACTGA
ATGGAGTATTC Primerdesign 
VCAN 124 56.8 TCATTATCTGGAAGAGTGAATCTGC 
CATCTCTGCTCT
GGACAATCTTG Primerdesign 
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Appendix 8-2: Sequences and terms of use of each primer set for RT-PCR in 
Xenopus tropicalis. ADAMTS9 and ADAMTS20 primers highlighted in orange are 
used to make probes as well. 
Xenopus 
tropicalis 
gene name 
Product 
length 
(bp) 
Tm 
(°C) Sense primer Anti-sense primer Reference 
ADAMTS1 180 59.2 CTTTTCTTGCCCCGGACTTC 
CTCGGTAGAAGAAG
GCTCCC 
PRIMER3/S
IGMA 
ADAMTS4 173 59.2 GACCCCAGTTTTCTCTCCGA 
TGCAGAACCCCAACA
AGAGA 
PRIMER3/S
IGMA 
ADAMTS5 218 59.1 TACGCGGATGGGAAGAAGTT 
TAATGGGCATGCTTG
ACTGC 
PRIMER3/S
IGMA 
ADAMTS8 200 58.9 GACCTTGCGATTTACTGCACT 
CACCCTGAACACCTT
TGCAT 
PRIMER3/S
IGMA 
ADAMTS15 151 59.2 CTATGCACTTCCCTGGCTCT 
TATTCCTCCCCTTGG
TAGCC 
PRIMER3/S
IGMA 
ADAMTS9 693 62 TTAGCAGTGGTCCATGATGAA 
TTCCCGGCTCACATT
CG 
PRIMER3/S
IGMA 
ADAMTS20 522 59 GGGCTTGTCTGTCATCTCT 
AGGTGTGGTTTGTTG
TGCTC 
PRIMER3/S
IGMA 
ADAMTS2 151 58.9 AGTTCCGGACAGTGAAGTGT 
TGAGACCAAGGCCC
AATTCT 
PRIMER3/S
IGMA 
ADAMTS3 174 59.1 AAAGCTGTGGAAGTTCTGGC 
CAGACCATGCCCCT
GTTTTC 
PRIMER3/S
IGMA 
ADAMTS14 224 59.1 AGCCAAAACCAATACGCAGA 
TGGTGTCCGATTACA
GGGTC 
PRIMER3/S
IGMA 
ADAMTS13 208 59 CAATGGGGTGGTACTGGAGT 
GGGTTCCAGGTCCAT
GTACA 
PRIMER3/S
IGMA 
ADAMTS7 232 59 GGAGATGGTGGACAAGGGAA 
GTGCCTCTGACTGG
GTACTT 
PRIMER3/S
IGMA 
ADAMTS12 164 58.8 ATGAGCCGTGTGATTCCTCT 
TGGTAAGAAGATGCG
CCTCT 
PRIMER3/S
IGMA 
ADAMTS6 178 58.9 CCTTGTCATGGCTTCATCGG 
ACTCCTCCTCCTCCT
CAAGT 
PRIMER3/S
IGMA 
ADAMTS10 242 59 GAGGTCTGGACTGGAAGCAT 
CTCCAAGTGTTGACG
TTGCA 
PRIMER3/S
IGMA 
ADAMTS16 134 58.3 ACCAAGGAAGATTCAAACGATCA 
TGTCAACACGTAGGT
AGTAATGT 
PRIMER3/S
IGMA 
ADAMTS18 245 58.6 GAGATCAGCGCGAAGTTCAA 
GGAAACCTGACATGC
CATCA 
PRIMER3/S
IGMA 
ADAMTS17 184 58.9 ACAGAGGAGAGGGACCAAAC 
TCCCTGGTTTTCTCC
TCCAC 
PRIMER3/S
IGMA 
ADAMTS19 217 59.2 CAACCAACGCATCATCTCCC 
GAAGATCCTCTCCAC
TCCCG 
PRIMER3/S
IGMA 
	  
Appendix 8-3: Sequences and terms of use of M13 primer set for PCR on 
plasmids.	  
Primers 
name 
Product 
length (bp) 
Tm 
(°C) Sense primer Anti-sense primer Reference 
M13 
depending 
on the 
plasmid 
used 
55 CGCCAGGGTTTTCCCAGTCACGAC 
TCACACAGGAAACAG
CTATGAC 
PRIMER3/SI
GMA 	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Appendix 8-4: Sequences and terms of use of each primer set to make Xenopus 
laevis probes. 
Xenopus 
laevis gene 
name 
Product 
length 
(bp) 
Tm 
(°C) Sense primer Anti-sense primer Reference 
ADAMTS4 577 62 GACCCCAGTTTTCTCTCCGA 
CCGCCTTTCCAATCA
CAACA 
PRIMER3/
SIGMA 
ADAMTS5 590 60 ACATGCCCACTACACCATCA 
CGTGCTCATCATCC
AGTTGG 
PRIMER3/
SIGMA 
ADAMTS8 556 58 ATGTGGAGTATGCGGAGGAG 
TCCACCCTCCACAT
CTTGAC 
PRIMER3/
SIGMA 
ADAMTS15 579 58 TGCGATCCAAAACGTAGCTG 
AGTCCGGGAACATT
GACCAT 
PRIMER3/
SIGMA 
ADAMTS9 717 58 TTAGCAGTGGTCCACGATGAA 
AGGAACACATACTC
CATATCTG 
PRIMER3/
SIGMA 
ADAMTS20 699 59 GTGTGCTGTAACATGTGGAA 
GAATGTACTTGTTGA
CTGGCAC 
PRIMER3/
SIGMA 
VCAN 562 59 GTTTCAGCGGAGATCAATGTGA 
GCATTTTCTACCAAA
GGAGGCT 
PRIMER3/
SIGMA 
 
Appendix 8-5:	  Sequences and terms of use of each primer set to make Xenopus 
tropicalis probes	  
Xenopus 
tropicalis 
gene name 
Product 
length 
(bp) 
Tm 
(°C) 
Sense primer Anti-sense primer Reference 
ADAMTS1 528 59.1 GTAAAGGCAGGCTGT
GATCG 
TTCGATGACCCATTC
CGACA 
PRIMER3/
SIGMA 
ADAMTS4 649 59 GACCCCAGTTTTCTCT
CCGA 
CGCAGAAGTTCCTC
AGCATC 
PRIMER3/
SIGMA 
ADAMTS5 599 59.1 TACGCGGATGGGAAG
AAGTT 
TTCCCGTACTTCTTG
GCCAT 
PRIMER3/
SIGMA 
ADAMTS8 587 59 ATCAGTGCAGGATGT
GACCA 
CATTCTACTGCCCGT
CGTTG 
PRIMER3/
SIGMA 
ADAMTS15 647 59.1 CTATGCACTTCCCTGG
CTCT 
CCATTTCTTCTGCCA
CCCAC 
PRIMER3/
SIGMA 
ADAMTS2 681 58.9 AGTTCCGGACAGTGA
AGTGT 
GTTGTGGCACTTCG
TTCTGT 
PRIMER3/
SIGMA 
ADAMTS3 539 59 TCGGTGTAGTGGTCA
GGAAC 
GTTGACACTGTTGG
GCTCTG 
PRIMER3/
SIGMA 
ADAMTS14 638 58.6 AGCCAAAACCAATACG
CAGA 
TGGAGTCAAACTGG
TAGGGG 
PRIMER3/
SIGMA 
ADAMTS13 581 59 CGGTATCCAAAGCCG
TCAAG 
ACTCCAGTACCACC
CCATTG 
PRIMER3/
SIGMA 
ADAMTS7 575 59 TGGACATTGGCCTGAT
TCCT 
TGTTCTCTTTTGCAG
GCCAC 
PRIMER3/
SIGMA 
ADAMTS12 577 59.1 ATTCCTTGACGCGGT
GATTG 
AGTCGCACTACAGT
CTGTCC 
PRIMER3/
SIGMA 
ADAMTS6 510 59 CCTTGTCATGGCTTCA
TCGG 
TCATGGCTGTAGTG
CTTGGA 
PRIMER3/
SIGMA 
ADAMTS10 668 59 GAGGTCTGGACTGGA
AGCAT 
GCCACTCTCCGAAA
TTGCAT 
PRIMER3/
SIGMA 
ADAMTS16 516 59.1 ACCAAGGAAGATTCAA
ACGATCA 
CATCGTGGACCATG
CCAAAA 
PRIMER3/
SIGMA 
ADAMTS18 657 58.9 GAGATCAGCGCGAAG
TTCAA 
ACGCTGTCTTTGCC
ATGTTT 
PRIMER3/
SIGMA 
ADAMTS17 593 58.9 ACAGAGGAGAGGGAC
CAAAC 
CTGCACCATGTCCG
AATCAG 
PRIMER3/
SIGMA 
ADAMTS19 618 59.1 CAACCAACGCATCATC
TCCC 
TTCTAGTGGCTTCTG
GTCCG 
PRIMER3/
SIGMA 
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8.2 Appendix 2: Melt curve of primers used for the microfluidic 
	  
Appendix 8-6: Melt curve of primers used for RT-qPCR and microfluidic 
experiments in Xenopus laevis. Five different dilutions of cDNA (1/20, 1/200, 1/2000, 
1/20000 and 1/200000) was used to test the efficiency and the specificity of cDNA 
amplification of the primers and negatives controls were water (NTC) and a negative 
control of cDNA synthesis reaction made without adding the Reverse Transcriptase 
enzyme to look at any genomic DNA contamination (RT-). 
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Appendix 8-7: Melt curve of primers used for RT-qPCR and microfluidic 
experiments in Xenopus laevis. Five different dilutions of cDNA (1/20, 1/200, 1/2000, 
1/20000 and 1/200000) was used to test the efficiency and the specificity of cDNA 
amplification of the primers and negatives controls were water (NTC) and a negative 
control of cDNA synthesis reaction made without adding the Reverse Transcriptase 
enzyme to look at any genomic DNA contamination (RT-). 
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Appendix 8-8:	   Melt curve of primers used for RT-qPCR and microfluidic 
experiments in Xenopus laevis. Five different dilutions of cDNA (1/20, 1/200, 1/2000, 
1/20000 and 1/200000) was used to test the efficiency and the specificity of cDNA 
amplification of the primers and negatives controls were water (NTC) and a negative 
control of cDNA synthesis reaction made without adding the Reverse Transcriptase 
enzyme to look at any genomic DNA contamination (RT-). 
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Appendix 8-9: Efficiency of the genes analysed in heart development and 
regeneration during Xenopus laevis metamorphosis.  The different genes 
categories are indicated in the first two rows and specific gene name is indicated 
below. For ADAMTS, ADAM, MMP, TIMP and syndecan only the gene number is 
indicated in the column meaning ADAMTS1, ADAM7, MMP2, TIMP1 and syndecan1 
for all different genes. The percentage of efficiency is written in bold under the 
corresponding gene name. ADAM, a disintegrin and metalloproteinase; tPA, tissue 
plasminogen activator; PAI1, plasminogen activator inhibitor-1; uPAR, urokinase 
plasminogen activator receptor.	  
metalloproteinases    
ADAMTS ADAM MMP TIMP ECM plasminogen syndecan 
1 
112.67 
13 
111.17 
9 
116.05 
2 
115.63 
1 
108.39 
VCAN 
109.84 
tPA 
112.33 
1 
100.27 
2 
103.34 
14 
113.77 
10 
116.79 
9 
111.6 
2 
112.85 
ACAN 
165.17 
PAI1 
115.96 
2 
106.67 
3 
113.98 
15 
109.53 
11 
115.39 
7 
110.92 
3 
111.22 
tenascin-
C 
115.6 
uPAR 
116.69 
3 
107.03 
4 
108.86 
16 
109.88 
12 
113.22 
1 
111.31 
   
4 
104.18 
5 
112.98 
17 
114.18 
15 
106.74 
14 
110.44 
    
6 
109.02 
18 
99.46 
17 
107.81 
     
7 
111.95 
19 
106.54 
19 
101.08 
     
8 
113.13 
20 
116.19 
22 
104.05 
     
9 
113.88 
 23 
100.1 
     
10 
114.7 
 28 
90.36 
     
12 
111.6 
 33 
94.86 
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8.3 Appendix 3: Graphs of gene expression and regulation in the heart 
during Xenopus laevis metamorphosis 	  
	  
Appendix 8-10: Genes up regulated in the heart during Xenopus laevis 
metamorphosis. Graphs show gene expression in the heart at stage 57 (NF57), stage 
61 (NF61), juvenile and adult Xenopus laevis in log2FC (y axis) in function of the 
stages of development according to (Nieuwkoop and Faber, 1994) (NF) (x axis). The 
width of the box shows the interquartile range (IQR), the line in the box shows the 
median and the whiskers show the minimum and the maximum values. Stars on the 
graphs show statistical differences with P < 0.05.  
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Appendix 8-11:	   Genes down regulated in the heart during Xenopus laevis 
metamorphosis. Graphs show gene expression in the heart at stage 57 (NF57), stage 
61 (NF61), juvenile and adult Xenopus laevis in log2FC (y axis) in function of the 
stages of development according to (Nieuwkoop and Faber, 1994) (NF) (x axis). The 
width of the box shows the interquartile range (IQR), the line in the box shows the 
median and the whiskers show the minimum and the maximum values. Stars on the 
graphs show statistical differences with P < 0.05.	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Appendix 8-12:	  Genes up regulated in the Xenopus laevis heart at metamorphic 
climax. Graphs show gene expression in the heart at stage 57 (NF57), stage 61 
(NF61), juvenile and adult Xenopus laevis in log2FC (y axis) in function of the stages of 
development according to (Nieuwkoop and Faber, 1994) (NF) (x axis). The width of the 
box shows the interquartile range (IQR), the line in the box shows the median and the 
whiskers show the minimum and the maximum values. Stars on the graphs show 
statistical differences with P < 0.05.	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Appendix 8-13:	   Genes down regulated in the Xenopus laevis heart at 
metamorphic climax. Graphs show gene expression in the heart at stage 57 (NF57), 
stage 61 (NF61), juvenile and adult Xenopus laevis in log2FC (y axis) in function of the 
stages of development according to (Nieuwkoop and Faber, 1994) (NF) (x axis). The 
width of the box shows the interquartile range (IQR), the line in the box shows the 
median and the whiskers show the minimum and the maximum values. Stars on the 
graphs show statistical differences with P < 0.05.	  
	  
Appendix 8-14:	   Genes showing no change of expression in the heart during 
Xenopus laevis metamorphosis. Graphs show gene expression in the heart at stage 
57 (NF57), stage 61 (NF61), juvenile and adult Xenopus laevis in log2FC (y axis) in 
function of the stages of development according to (Nieuwkoop and Faber, 1994) (NF) 
(x axis). The width of the box shows the interquartile range (IQR), the line in the box 
shows the median and the whiskers show the minimum and the maximum values. 
Stars on the graphs show statistical differences with P < 0.05.	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8.4 Appendix 4: Graphs of gene expression and regulation in the heart 
after ventricular resection during Xenopus laevis metamorphosis. 
Appendix 8-15:	  Different profile of gene expression in the heart after ventricular 
resection during Xenopus laevis metamorphosis. SHAM and amputated hearts 
from stage 57 (NF57), stage 61 (NF61), juvenile and adult Xenopus laevis, 
corresponding at pro-metamorphosis, metamorphic climax and post-metamorphosis 
period, were used to look at gene expression at 1, 3 and 7 days post amputation (dpa). 
SHAM hearts were used as placebo controls for the surgery and were used for the 
gene regulation analysis to normalise the data from the amputated hearts. Stages were 
according to (Nieuwkoop and Faber, 1994) (NF). The width of the box shows the 
interquartile range (IQR), the line in the box shows the median and the whiskers show 
the minimum and the maximum values. Stars on the graphs show statistical differences 
with P < 0.05. 
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61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.25
0.50
1
2
4
lo
g2
FC
ADAMTS12-7dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.0625
0.1250
0.2500
0.5000
1
2
lo
g2
FC
syndecan1-7dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.125
0.250
0.500
1
2
4
lo
g2
FC
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tPa-1dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.125
0.250
0.500
1
2
4
8
16
lo
g2
FC
** **** *** ***
ADAM11-1dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
2-20
2-10
20
210
220
lo
g2
FC **
ADAMTS13-1dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
2-5
20
25
210
215
220
225
lo
g2
FC
** ****
ACAN-1dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
2-5
20
25
210
215
220
lo
g2
FC
ADAMTS5-1dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.125
0.250
0.500
1
2
lo
g2
FC
**** *
tPa-3dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.125
0.250
0.500
1
2
4
8
16
32
lo
g2
FC
***
*** ***
ADAM11-3dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
2-20
2-10
20
210
220
lo
g2
FC
ADAMTS13-3dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
2-5
20
25
210
215
220
lo
g2
FC
** **
ACAN-3dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
2-20
2-10
20
210
220
230
lo
g2
FC
***
*
****
ADAMTS5-3dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.25
0.50
1
2
4
lo
g2
FC
tPa-7dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.25
0.50
1
2
4
8
16
32
64
lo
g2
FC
*
***
**
ADAM11-7dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
2-20
2-10
20
210
220
lo
g2
FC
*
**
ADAMTS13-7dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
2-10
20
210
220
lo
g2
FC
ACAN-7dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
2-20
2-10
20
210
220
lo
g2
FC
*
ADAMTS5-7dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.25
0.50
1
2
4
lo
g2
FC
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ADAMTS9-1dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.125
0.250
0.500
1
2
4
8
lo
g2
FC
MMP14-1dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.25
0.50
1
2
lo
g2
FC
MMP7-1dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.03125
0.06250
0.12500
0.25000
0.50000
1
2
4
8
16
32
lo
g2
FC
**
***
**
MMP9-1dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.0625
0.1250
0.2500
0.5000
1
2
4
8
16
32
lo
g2
FC
*
***
**
tenascin-C-1dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
2-20
2-15
2-10
2-5
20
25
210
lo
g2
FC
****
ADAMTS9-3dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.125
0.250
0.500
1
2
4
lo
g2
FC
MMP14-3dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.5
1
2
4
lo
g2
FC
*
MMP7-3dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.0625
0.1250
0.2500
0.5000
1
2
4
8
16
32
lo
g2
FC
***
*
*
MMP9-3dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.03125
1
32
1024
lo
g2
FC *
**
tenascin-C-3dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.125
0.250
0.500
1
2
4
8
16
32
64
128
lo
g2
FC
** ** ** **
ADAMTS9-7dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.125
0.250
0.500
1
2
4
lo
g2
FC
**
MMP14-7dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.5
1
2
4
lo
g2
FC
*
*
MMP7-7dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.03125
0.06250
0.12500
0.25000
0.50000
1
2
4
8
16
32
lo
g2
FC
MMP9-7dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.03125
0.06250
0.12500
0.25000
0.50000
1
2
4
8
16
32
lo
g2
FC
***
tenascin-C-7dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
2-20
2-10
20
210
lo
g2
FC
** *
* *
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ADAMTS4-1dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
2-20
2-10
20
210
lo
g2
FC
**** *
*
ADAMTS6-1dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.0625
0.1250
0.2500
0.5000
1
2
4
8
lo
g2
FC
***
ADAMTS7-1dpa
NF
57
-S
HA
M-
1d
pa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
0.0625
0.1250
0.2500
0.5000
1
2
4
lo
g2
FC
ADAMTS8-1dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.25
0.50
1
2
4
8
lo
g2
FC
***
*
ADAMTS10-1dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
2-20
2-15
2-10
2-5
20
25
lo
g2
FC
*
ADAMTS4-3dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
2-30
2-20
2-10
20
210
lo
g2
FC
ADAMTS6-3dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.25
0.50
1
2
4
8
16
lo
g2
FC
ADAMTS7-3dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.0625
0.1250
0.2500
0.5000
1
2
4
lo
g2
FC
ADAMTS8-3dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.25
0.50
1
2
4
lo
g2
FC
ADAMTS10-3dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.125
0.250
0.500
1
2
4
8
lo
g2
FC
***
ADAMTS4-7dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
9.8×10-4
0.03125
1
32
1024
32768
lo
g2
FC ** *
ADAMTS6-7dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
2-20
2-15
2-10
2-5
20
25
lo
g2
FC
ADAMTS7-7dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.125
0.250
0.500
1
2
4
8
lo
g2
FC
ADAMTS8-7dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.25
0.50
1
2
lo
g2
FC
ADAMTS10-7dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.125
0.250
0.500
1
2
4
lo
g2
FC
*
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fn1-1dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.25
0.50
1
2
4
lo
g2
FC
****
col1a1-1dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.0625
0.1250
0.2500
0.5000
1
2
4
8
lo
g2
FC
***
ADAMTS1-1dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.25
0.50
1
2
4
8
lo
g2
FC
*
ADAMTS2-1dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.125
0.250
0.500
1
2
4
lo
g2
FC
*
ADAMTS3-1dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
2-20
2-15
2-10
2-5
20
25
lo
g2
FC
fn1-3dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.25
0.50
1
2
4
8
16
lo
g2
FC
***
****
* **
col1a1-3dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.0625
0.1250
0.2500
0.5000
1
2
4
8
lo
g2
FC
* ****
ADAMTS1-3dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.125
0.250
0.500
1
2
4
lo
g2
FC
*
ADAMTS2-3dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.125
0.250
0.500
1
2
4
lo
g2
FC
*
ADAMTS3-3dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
2-30
2-20
2-10
20
210
220
lo
g2
FC
fn1-7dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.25
0.50
1
2
4
8
16
lo
g2
FC
*
*
***
****
col1a1-7dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.0625
0.1250
0.2500
0.5000
1
2
4
8
16
lo
g2
FC
*
**** **
ADAMTS1-7dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.125
0.250
0.500
1
2
4
8
lo
g2
FC
ADAMTS2-7dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.25
0.50
1
2
4
lo
g2
FC
*
ADAMTS3-7dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
2-20
2-10
20
210
220
230
lo
g2
FC
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ADAMTS15-1dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.125
0.250
0.500
1
2
4
8
lo
g2
FC
****
**
*
ADAMTS16-1dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
2-10
20
210
220
lo
g2
FC
ADAMTS17-1dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.0625
0.1250
0.2500
0.5000
1
2
4
8
lo
g2
FC
ADAMTS18-1dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.25
0.50
1
2
4
8
16
lo
g2
FC
*
ADAMTS19-1dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
2-20
2-15
2-10
2-5
20
25
lo
g2
FC
*
ADAMTS15-3dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.25
0.50
1
2
4
8
lo
g2
FC
**
*
ADAMTS16-3dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
2-20
2-10
20
210
220
lo
g2
FC
*
*
ADAMTS17-3dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.03125
0.06250
0.12500
0.25000
0.50000
1
2
4
8
16
lo
g2
FC
*
ADAMTS18-3dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.0625
0.1250
0.2500
0.5000
1
2
4
8
lo
g2
FC *
ADAMTS19-3dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.03125
0.06250
0.12500
0.25000
0.50000
1
2
4
8
lo
g2
FC
ADAMTS15-7dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.125
0.250
0.500
1
2
4
8
lo
g2
FC
* *
ADAMTS16-7dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
2-10
20
210
220
lo
g2
FC
****
**
ADAMTS17-7dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.03125
0.06250
0.12500
0.25000
0.50000
1
2
4
8
lo
g2
FC
ADAMTS18-7dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.125
0.250
0.500
1
2
4
8
lo
g2
FC **
ADAMTS19-7dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.125
0.250
0.500
1
2
4
lo
g2
FC
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ADAMTS20-1dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.125
0.250
0.500
1
2
4
lo
g2
FC
**
VCAN-1dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.25
0.50
1
2
4
lo
g2
FC
MMP1-1dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
2-30
2-20
2-10
20
210
lo
g2
FC
* **** *
TIMP1-1dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.125
0.250
0.500
1
2
4
8
16
32
lo
g2
FC
**
**** **
***
TIMP2-1dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.25
0.50
1
2
4
lo
g2
FC
ADAMTS20-3dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.125
0.250
0.500
1
2
4
lo
g2
FC
*
*
VCAN-3dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.125
0.250
0.500
1
2
4
8
16
lo
g2
FC
** *
MMP1-3dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
2-20
2-10
20
210
220
230
lo
g2
FC
*
***
TIMP1-3dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.0625
0.1250
0.2500
0.5000
1
2
4
8
16
32
64
lo
g2
FC
*** *** ***
TIMP2-3dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.25
0.50
1
2
4
lo
g2
FC
ADAMTS20-7dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.125
0.250
0.500
1
2
4
8
lo
g2
FC
VCAN-7dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.125
0.250
0.500
1
2
4
8
lo
g2
FC
MMP1-7dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
2-20
2-10
20
210
220
230
lo
g2
FC
* ***
TIMP1-7dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.125
0.250
0.500
1
2
4
8
16
32
64
lo
g2
FC
** **
*
TIMP2-7dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.25
0.50
1
2
4
lo
g2
FC *
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ADAM12-1dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.25
0.50
1
2
4
8
lo
g2
FC
***
ADAM15-1dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.125
0.250
0.500
1
2
4
lo
g2
FC
**
ADAM19-1dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
2-20
2-15
2-10
2-5
20
25
lo
g2
FC
* **
ADAM22-1dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
2-20
2-10
20
210
lo
g2
FC
*
ADAM23-1dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
2-20
2-15
2-10
2-5
20
25
lo
g2
FC
ADAM12-3dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.0625
0.1250
0.2500
0.5000
1
2
4
8
lo
g2
FC
ADAM15-3dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.0625
0.1250
0.2500
0.5000
1
2
4
8
lo
g2
FC
***
*
ADAM19-3dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.125
0.250
0.500
1
2
4
8
lo
g2
FC
***
ADAM22-3dpa 
NF
57
-S
HA
M-
3d
pa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
2-10
20
210
220
lo
g2
FC
**
ADAM23-3dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
2-20
2-10
20
210
220
230
lo
g2
FC *
****
ADAM12-7dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.125
0.250
0.500
1
2
4
8
lo
g2
FC
**
ADAM15-7dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.125
0.250
0.500
1
2
4
lo
g2
FC
****
ADAM19-7dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
2-20
2-15
2-10
2-5
20
25
lo
g2
FC
*
ADAM22-7dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
2-20
2-10
20
210
220
lo
g2
FC ***
*
*
ADAM23-7dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
2-20
2-10
20
210
220
230
lo
g2
FC
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ADAM28-1dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
2-20
2-10
20
210
220
lo
g2
FC
***
ADAM33-1dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.25
0.50
1
2
4
lo
g2
FC
* ****
ADAM9-1dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.25
0.50
1
2
4
lo
g2
FC
***
**
syndecan2-1dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.5
1
2
lo
g2
FC
*
syndecan3-1dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.25
0.50
1
2
4
lo
g2
FC
ADAM28-3dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
2-5
20
25
210
215
220
lo
g2
FC
*
***
*
ADAM33-3dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.25
0.50
1
2
4
lo
g2
FC
** *
ADAM9-3dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.25
0.50
1
2
4
lo
g2
FC
* *
*
syndecan2-3dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.25
0.50
1
2
4
lo
g2
FC *
syndecan3-3dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.25
0.50
1
2
4
lo
g2
FC
***
*
ADAM28-7dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
2-20
2-10
20
210
220
lo
g2
FC
ADAM33-7dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.125
0.250
0.500
1
2
4
8
lo
g2
FC
**
ADAM9-7dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.25
0.50
1
2
4
lo
g2
FC
syndecan2-7dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.25
0.50
1
2
4
lo
g2
FC ***
syndecan3-7dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.125
0.250
0.500
1
2
4
lo
g2
FC
*
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syndecan4-1dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.125
0.250
0.500
1
2
4
8
16
lo
g2
FC
****
* **
uPAR-1dpa
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
2-5
20
25
210
215
220
lo
g2
FC
PAI1-1dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.125
0.250
0.500
1
2
4
8
16
32
lo
g2
FC
** ****
****
***
syndecan4-3dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.5
1
2
4
8
lo
g2
FC
** *
***
uPAR-3dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
2-5
20
25
210
215
220
lo
g2
FC
*
PAI1-3dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.125
0.250
0.500
1
2
4
8
16
32
64
lo
g2
FC
****
** ****
*
syndecan4-7dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.25
0.50
1
2
4
8
lo
g2
FC
*
**
uPAR-7dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.25
0.50
1
2
4
8
lo
g2
FC
**
PAI1-7dpa 
NF
57
-S
HA
M
NF
57
-A
MP
NF
61
-S
HA
M
NF
61
-A
MP
JU
V-
SH
AM
JU
V-
AM
P
AD
UL
T-S
HA
M
AD
UL
T-A
MP
0.125
0.250
0.500
1
2
4
8
16
32
64
128
lo
g2
FC
** ***
****
